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1.00 The historical aspects of photodynamic therapy 
 
 Since their existence, man has appreciated the benefits of sunlight and described some of 
its medicinal effects known as heliotherapy. Herodotus in the 6th century BC noticed that 
sunlight had beneficial effects on bone growth. Hippocrates in 460-375 BC advocated the use of 
heliotherapy for various human maladies [1]. In 1898, McCall-Anderson described skin 
photosensitivity due to porphyrin molecules [2]. In 1900, Raab using acridine orange described a 
photochemical action that led to the killing of protozoa [3]. In 1901, the Dane Niels Rydberg 
Finsen described the first scientific experiment in animals designated as phototherapy using light 
from a carbon arc. Phototherapy was defined as the use of visible or near-visible light in the 
treatment of disease [4]. He noticed that the use of ultraviolet light improved wound healing in 
smallpox in animals and lupus vulgaris in men. These studies were appreciated with naming a 
Medical Light Institute after him in Copenhagen and by awarding him the Nobel Prize for 
Physiology-Medicine in 1903. The Danish Queen Alexandra introduced the technique into the 
London Hospital in Whitechapel (now the Royal London Hospital) in 1904.  
Two medical students in Germany, Jesionek and von Tappeiner, discovered in 1903 that 
the effect of phototherapy could be amplified by using the light sensitive drug eosin. They found 
that this so called photodynamic effect made this application suitable for the treatment of 
tumours in a mouse model [5]. In 1905, they described the eradication of superficial basal 
carcinoma in humans. In that same year, Albert Einstein discovered the principles of light 
amplification by stimulated emission of radiation, the acronym for laser [6-7]. With the 
availability of laser a fundamental tool for successful photodynamic therapy became available. In 
1924, Policard in Lyon, described a natural fluorescence of experimental tumours by porphyrins, 
indicating an association between porphyrins and cancer [8]. In 1942, Auler and Banzer 
described a tumour reduction in animals using a first generation photosensitizer 
haematoporphyrin [9]. Some years later, Figge, Wieland and Mangianello in the USA reported 
that a selective accumulation of haematoporphyrin selectively accumulated in embryonic and 
regenerating tissue [10]. In 1961, Lipson introduced the haematoporphyrin derivative that could 
be visualized by its selective red fluorescence upon illumination with ultraviolet light [11]. Later, 
Diamond and colleagues reported that the photodynamic effect could be obtained by changing 
the irradiation energy [12]. In 1974, the effectiveness of photodynamic therapy in various animal 
models was described by Dougherty in Buffalo [13], USA and by Berenbaum in London [14]. 
The first photodynamic studies in men were published by Kelly and Snell in 1976 [15]. 
Since then, the development of new photosensitizers increased extensively and PDT became 
accepted in many medical fields to treat premalignant and malignant lesions, as in the field of 
dermatology, urology, interventional radiology, neurosurgery, gynaecology, and gastro-
enterology.  
 The first regulatory approval for a photodynamic drug was accorded to Photofrin® by 
the Canadian authorities in 1993. Aminolaevulinic acid (ALA, DUSA Pharmaceuticals, Inc 
DUSλ) was approved by the British authorities in 2000. 
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1.01 The fundamental physical principles of photodynamic therapy 
 
 Photodynamic therapy (PDT) is a two-step process in which first photosensitive 
molecules (photosensitizers) localise in target tissue or cells. Secondly, the photosensitizer is 
activated with appropriate light energy to generate toxic species that mediate tissue or cell 
destruction <Fig.1.1> [16]. The toxicity is generally oxygen-dependent, but the oxygen 
dependence varies with the photosensitizer [17]. 
 
 
 
 
Figure 1.1 A schematic representation of the mechanism of photodynamic therapy.  The activation of the 
photosensitizer with appropriate light results in a electonic excitation (See Figure 3.2) followed by 
the dissipation of energy via a physical route (fluorescence or phosphorescence) or a chemical 
route (generation of molecules in the singlet or triplet state). This latter route is responsible for 
the photodynamic effect. 
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1.01.1 Light 
  
 The use of visible light of one particular wavelength (monochromatic) in PDT 
characterises the core of this treatment. In PDT, it is crucial to think of visible light as energy in 
the form of sinusoidal electromagnetic radiation expressed as wave and as particle (quantum, 
photon), to perform light-dosimetry.  
Fluence is the total radiant energy traversing a small transparent imaginary spherical target 
containing the point under consideration, divided by the cross sectional area of the target (J/cm2). 
External illumination is expressed in J/cm2 and endovascular illumination is expressed in J/cm 
diffuser length (dl). With other words 100 J/cm2 is more than 100 J/cm dl. Due to endovascular 
spherical abnormalities by stenosis, the cross sectional surface to illuminate is not simple 
squared. The fluence per cm dl instead of per surface squared cm will avoid the enormous 
variance in stenosis morphology.   
The time needed to arrive at this energy dose or fluence is determined by the fluence rate 
(irradiance or power density) expressed in W/cm2.  
 
1.01.2 The light sources 
 
 In PDT the laser is mostly used as the light source. Laser is an acronym for ‘light 
amplification by stimulated emission of radiation’. ‘Stimulated’ stands for the release of a 
photon after electronical excitation of the molecule S* on interaction with a photon, namely: S* 
+ hvÆ S+2hv. The used photon has the same properties as the released photon, as described by 
Townes, Basov and Prokhorov. For this discovery, they were awarded the Nobel Prize in Physics 
in 1964 [18-20]. The unique properties of laser are that its rays are intense, coherent, so that all 
the waves are in phase, deliverable in short pulses, wavelength monochromacy, by which all 
available energy can be focussed at the maximum absorption wavelength of the photosensitizer, 
and collimated allowing parallel light beam to be transported through a fibre.  
 
1.01.3 The energy states of the photosensitizer 
 
After absorption of electromagnetic radiation, the photosensitizer will be excited to a 
higher energy state. The transfer of this excitation energy from the excited photosensitizer unto 
the surrounding molecules (non-ionising decay) may either induce a photochemical reaction 
(kinetic energy) or be re-emitted as fluorescence. These transitions of electronic energy levels 
are represented in Jablonski diagrams <Fig.1.2>. The electronic vibrational state of the 
photosensitizer is represented by the singlet ground state S0, which changes into S1 after 
absorption with a single photon, S2 with two or S3 with 3 photons [21]. These phenomena are 
known as internal conversion. From this energised state, the photosensitizer may relax back to S0 
by the emission of light (fluorescence), may inter-system cross to the triplet state, T1. This is the 
more reactive state with a relatively long lifetime and normally, the T1 by its transition into the 
ground state initiates direct photochemical reactions (Type 1) or transfers its energy to the 
ground state oxygen molecules 3O2 to give rise to excited state oxygen molecules, singlet oxygen 
1O2, that lead to photooxidative reactions (Type 2) [22;23].   
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1.01.4 The criteria to meet for a photosensitizer 
 
 Important criteria for photosensitizers to be suitable for PDT are that they are [24;25] 
stable and non-toxic without light (low dark-toxicity),  accumulate in the target tissue, and can be 
activated in the absorption spectrum between 600-900 nm, because the most important cellular 
molecules do absorp light of 200-500 nm. All porphyrin based photosensitizers have a maximum  
absorption at 400 nm (=Soret or B band) and in the 500-600 nm region usually 4 Q bands if 
complexed with monovalent metal, and 2 Q bands if complexed with a divalent metal. If the 
highest Q band is in the 500 nm region than the photosensitizer is called etio-type, at 500 and 
600 nm phyllo type, at 550 nm rhodo-type, at 550 and 600 nm oxorhodo-type and at 650 nm 
retro-etio type. Furthermore, a good photosensitizer must have a high triplet quantum yield, a 
high singlet oxygen quantum yield and a finite fluorescence quantum yield increasing the 
cytotoxic potential. Hydrophilicity and electric charge will improve the distribution of the 
photosensitizer into target tissue or target cells.   
Unfortunately, to date, the ideal photosensitizer is not yet discovered. 
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Figure 1.2 Jablonski diagram for an organic molecule, showing the transitions between the singlet (S0, S1, S2, 
S3) and triplet (T1, T2, T3) electronic levels (heavy horizontal lines). The energy levels of only the 
vibrational mode are portrayed for each electronic state (light horizontal lines). Radiative 
transitions are shown as straight arrows. Radiationless relaxation processes are shown as wavy 
arrows: vr, vibrational relaxation; ic, internal conversion; isc, intersystem crossing. The radiative 
decay processes depicted are fluorescence and phosphorescence. The diagram exemplifies three 
spin-allowed absorption processes:1. the transition from the thermally equilibrated, ground state 
(S0), to a vibrational excited level of the second excited singlet state (S2).2. The first transition 
from the thermally equilibrated, first excited singlet state (S1) to a vibrationally excited level of the 
third excited singlet state (S3). 3. The transition from the thermally equilibrated lowest triplet state 
(T1) to a vibrationally excited level of the second triplet state (T3). By so called intersystem 
crossing the singlet state can be converted into the triplet state with a relatively long half life. The 
subsequent transition into the ground state S0  allows a simultanous type I photochemical reaction  
or the type II excitation of ground state molecular oxygen (3O2 ) into singlet oxygen (1O2 ). 
Fluorescence is a spin-allowed, radiative transition from the thermally equilibrated first excited 
singlet state (S1) to different vibronic levels of the ground state (S1). Phosphorescence is a spin-
forbidden radiative transition from the thermally equilibrated lowest triplet state (T1) to different 
vibronic levels of the ground state. From fundamentals of photodynamic therapy (T.Hasan SPIE 
2000, Sc 031:22). 
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1.02 The fundamentals of aminolaevulinic acid metabolism 
 
 An exception to the second-generation exogenous photosensitizers is the prodrug 
aminolaevulinic acid, which is an endogenous heme metabolite.  It’s potential for photodynamic 
therapy is derived from the induced phototoxicity observed in porphyria. Excessive 
concentrations in tissue of ALA lead to conversion into heme metabolites, and to in particular 
the accumulation of the photosensitive protoporphyrin IX. In 1956, Berlin was the first who 
administered ALA to animals and humans to study the heme and bilirubin synthesis [26]. Our 
group started experiments with the endogenous photosensitization of liver tumors in rats at the 
end of the eighties [27]. In 1990, Kennedy described the first clinical experiments with ALA 
based PDT to treat skin tumours [28]. In 1994, Grant was the first to apply ALA in the 
prevention of intimal hyperplasia [29]. 
 
Heme and porphyrin synthesis 
 
 Heme is an essential iron-containing prosthetic group for many important proteins 
including hemoglobins, myoglobins, catalases, peroxidases and cytochromes [30]. Heme is 
synthesized from glycine and succinate in a series of reactions occuring in the mitochondria and 
cytoplasm of the cell.   
Glycine and succinyl CoA are condensed to ALA catalyzed by the mitochondrial rate-
limiting enzyme ALA synthase, also known as the Shemin pathway <Fig.1.3> [31]. Two ALA 
molecules when transported into the cytoplasm form one porphobilinogen molecule catalysed by 
porphobilinogen synthase, four porphobilinogen molecules form uroporphyrinogen 3 that will be 
converted by PBG deaminase into hydroxymethylbilane (HMB) [27]. Then, HMB may convert 
spontaneously into uroporphyrinogen 1, and subsequently via decarboxylation into 
coproporphyrinogen 1 that after oxidation is excreted in the urine as uro- and coproporhyrin. 
Alternatively, HMB will be converted into uroporphyrinogen 3 by uroporphyrinogen 3 
cosynthase, and next by uroporphyrinogen 3 decarboxylase into coproporphyrinogen 3. 
Coproporphyrinogen is converted by coproporphyrinogen oxidase into protoporphyrinogen IX 
and subsequently converted into the photosensitizer protoporphyrin IX by the action of 
protoporphyrinogen oxidase. Finally, heme is formed by the insertion of iron catalyzed by the 
enzyme ferrochelatase. 
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Figure 1.3 
 
 
                                                                                                                            Chapter 1                  
 9 
1.03 The historical aspects of vascular photodynamic therapy 
 
In 1983, Spears described that the haematoporphyrin derivative (HpD) accumulated 
selectively in experimental atherosclerotic plaques [32]. In 1985, Litvack presented the first PDT 
effect with HpD on atherosclerotic arteries and noticed that the selective accumulation of HpD 
was due to the high mitotic activity of smooth muscle cells (SMC) <Table 3.1>. This started the 
investigations of using the high energy of lasers in 1987 by Pollock [33], in 1992 by Asahara and 
in 1993 by Tang to ablate the photosensitive impregnated plaques. Unfortunately, it was 
impossible to ablate the calcified noncellular coatings of the plaque. In vitro studies performed 
by Dartsch in 1990 indicated that PDT of SMCs of human atherosclerotic plaques using the 
photosensitizer Photofrin inhibited their proliferation [34]. On this basis, the rationale to prevent 
intimal hyperplasia in hyperproliferative restenotic lesions was born. In 1988 and 1991, Mackie 
published the first successful inhibition of intimal hyperplasia in coronary arteries of dogs using 
dihaematoporphyrin ester. One year later Eton used external PDT with the first generation 
photosensitizer Photofrin to inhibit intimal hyperplasia of the rabbit and Ortu used the second 
generation photosensitizer chloroaluminium sulfonated phtalocyanine (CASPc) for that purpose 
in the balloon injured carotid artery of the rat. In 1993, LaMuraglia and colleagues described the 
selective accumulation of CASPc in the proliferative part of the injured rat carotid artery. In 
1994, the same group reported that external vascular PDT resulted in inhibition of intimal 
hyperplasia lasting the observation period of 16 weeks. This benificial effect was likely due to 
persistent erradication of smooth muscle cells in the tunica media. In the same year, Grant was 
the first to use ALA as prodrug for protoporphyrin IX based external PDT in the balloon injured 
rat femoral artery. In 1996, Gonschior reported for the first time the use of endovascular PDT 
with Photofrin in the balloon injured femoral pig artery. In 2001, Hayase described the effects of 
the second-generation  photosensitizer texapherin (Antrim®) in the balloon injured rabbit iliac 
artery <Table 1.1>[28;35-64]. Third generation photosensitizers have an additional targeting 
system, like monoclonal antibodies, and are in an early stage of development.  
 
1.03.1 The evaluation of vascular PDT in the clinic 
 
In 1999, the UK group led by S. Bown was the first to publish the effects of ALA-PDT in 
patients with stenosis of the femoral arteries [65]. Promising initial results marked a brake 
through in the application of PDT. However, no complete eradication of synthetic SMCs was 
obtained and back-growth of intimal hyperplasia was still the case. The first clinical trial treating 
patients with stenosis of peripheral arteries using texaphyrin is underway in the USA [66]. 
 
1.03.2 The evaluation of vascular PDT in anastomotic models 
 
While inhibition of intimal hyperplasia after balloon injury models in rats, rabbits, dogs, 
monkeys and pigs was obtained, the inhibition of IH with PDT at the anastomotic site in surgical 
reconstructions is more difficult to obtain [67]. Further improvements in this field are required 
before evaluating PDT as a clinical adjuvant tool in anastomotic (by-pass) surgery. 
Introduction 
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Irradiance Fluence Method Photo- Dose Wavelength Peak Model 
mW/cm2 J/cm2  sensitizer mg/kg nm hours design 
12-33 32-288 int HPD 5-20 636 72 rabbits 
500 20-410 int 1cm DHE 2.5 632 24 dogs 
nk 2.7 int HPD Nk nk nk rabbits+BI 
80 7.6 ext 1 cm Photofrin 5 630 48 rabbits+BI 
100 100 ext 2 cm CASPc 5 675 0.33 rats+BI 
32-256 1.6-60 int Photofrin 2.5-5 630 48 rabbits 
100 100 ext 2 cm CASPc 5 675 24 rats+BI 
nk 50 ext AlS2Pc 0.5-5 675 48 rats 
1000 120 int 1 cm Photofrin 2.5 630 24 swine+BI 
150 100 ext 1 cm AlS2Pc 5 675 1 rats 
 250  ALA 200 630 3  
nk 100 ext AlS2Pc 5 675 1 rabbits 
   ALA 200 630 3  
nk 25 ext AptS 2.5 672 0.5 rabbits+BI 
1000 120-240 int 1 cm Photofrin 5 630 0.33 rabbits+BI 
100-180 50 ext 1 cm ALA 20-200 630 0.5-1.5 rats+BI 
70 100 ext Pheoph 1 647 24 rabbits 
100 100 int 1.5 cm Photofrin/l  5 630 0 pigs 
150-200 50 i-ext 1 cm AlS2Pc 5 675 0.5 rats+BI 
100 100 int 1.5 cm Photofrin/l 5 630 0 pigs+BI 
200-400 120 int  HPD 5 630  rabbits+BI 
100 100 ext 2 cm CASPc 5 675 24 rats+BI 
10 1.8 int 2 cm absent  632  rabbits+BI 
100 20 ext 2 cm Chlorine6 2.5 661 4 rats+BI 
 40  BSA/e6 2.5  4  
<120 50(20%f) int 4 cm ALA 60 635 5-7 patients 
100 50-200 ext 2 cm BPD 0.5-25ug 690 0.25 rats+BI 
100 100 ext 1 cm Met.blue 250 
ug/ml 
660 0.08 rats+BI 
180 300 int 2 cm Zinc-Pc/l  20 ug/ml 6-700 0.5 rabbits+BI 
100-200 50(20%f) int 2 cm ALA 120 635 4-6 pigs+BI 
  int 4 cm      
100/dl 12.5-50 int 2 cm ALA 200 633 2-3 rats+BI 
nk 50-200 int 2-3 cm Miravant 1-3  2-6 rabbits/swine 
250/dl 180/dl int 3 cm Antrin 1.2 736 0.25 rabbits+BI 
 
 
Table 1.1 A summary of chronologically published in vivo studies of photodynamic therapy on restenosis. 
 
  The following abbreviations mean:  
 
 / dl= mW/cm diffuser length; 20%(f)=20%; fractionated illumination;  
int 1cm=internal illumination at a spotsize of 1 cm; ext 1 cm= external  
illumination at a spotsize of 1 cm;HPD= hematoporphyrin derivative;DHE=  
dihydroxyporphyrinesther; CASPc= chloroaluminosulfurphtalocyanine; AlS2Pc= alumino  
disulphurphtalocyanine; ALA=aminolaevulinic acid; BPD= bi-porphyrin derivative; +BI= with   
balloon injury 
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Chl No. Artery Groups FU PDTeffect on IH Media effect MLD R 
dt N= type amount wk mm2 mm2 mm  
y 15 car/fem 2 PDT 2 damage fissured nk 35 
n 9 coronary 2 low vs high 4 no IH vs IH damage vs spasm nk 36 
y 30 iliac 3 BI vs PDT 4 nk IMR: 3.4vs0.9sd0.7 nk 37 
n 10 carotid 3 BI vs PDT 5 24vs16 sd2.1 nk nk 38 
n Nk carotid 2 BI vs PDT 2 0.17vs 0.06 sd0.05 ns nk 39 
n 35 aorta 2 BI vs PDT 4 0.7 mm vs0.5 sd0.1 nk ns 40 
n 33 carotid 2 BI vs PDT 16 0.12vs0.03 sd0.02 ns ns 41 
n 75 carotid 4 PDT 24 Depletion repopulation >24w nk 42 
y 12 iliac 2 pre vs post 4 Nk nk 39.2vs35.9 sd41% 43 
n Nk femoral 4 BI vs PDT 24 0.01vs0.02-0.10 nk nk 44 
         
n 18 carotid 4 BI 3 nk nk bp:5.3 sd0.9 bar 45 
   PDT Al-ALA  nk nk 7.0 sd1.7 bar  
n 120 carotid 4 BI vs PDT 6 0vs0.02  nk 28-143vs22%  46 
n 24 iliac 4 BI vs PDT 4 nk IMR: 1vs0.3 sd0.2 nk 47 
n 40 carotid 3 BI vs PDT 4 nk IMR:0.7vs0  nk 48 
y 15 aorta 3 PDT 24 h denudation foam cells nk 49 
n 70 femoral 4 BI vs PDT 3 1.57vs0.1 sd0.05 nk loss 38vs3 % 50 
n 100 carotid 4 BI vs PDT 26 100% vs 51% IH nk nk 51 
n 72 femoral 4 BI vs PDT 3 1.57vs0.1 sd0.05 IMR: 1vs0.3 sd0.2 loss 30vs3% 52 
y 20 femoral 2 BI vs PDT 1 nk IMR:0.5vs0 sd0.02 nk 53 
n 24 carotid 2 BI vs PDT 16 0.16vs0.07 sd0.03 0.1vs0.05 sd0.01 0.82vs1.02 54 
n 15 aorta 2 BI vs PDT 8 25.3vs4.2 sd0.7 IMR: 2.1vs0.3sd0.0 1.62vs2.32  55 
n 15 aorta 2 Chle6 48 h loss 20-50% 0% nk 56 
   Bcle6  loss 60-80% loss 20-40% nk  
 8 femoral 1 6 m 3:100% success 3:25% rst 2:40%  57 
n 32 carotid 4 BI vs PDT 2 0.16vs0.01 sd0.01 0.2vs0.1 sd0.02 0.94vs0.86 58 
n 18 carotid 3 BI vs PDT 2 0.19vs0 0.1vs0.06 sd0 ns 59 
         
n 52 femoral 4 BI vs PDT 4 49.4vs40.4 sd7.8 IMR:1.2vs0.6 sd0.2 nk 60 
n 13 coronary 4 BI c/i 4 0.7-0.8 sd0.8 2.9-12.5 sd1.1-5.4 1.6-7.9 sd0.7-4.8 61 
  iliac 2 BI+PDTc/i  0.4-0.7 sd0.4 2.9vs15.2 sd0.5-4.3 1.4-9.8 sd0.8-3.7  
n 33 iliac 2 BI vs PDT 4 0.15vs0.01 sd0.01 0.13vs0.2 sd0.05 nk 62 
n Nk per/cor 2 PDT 4 0 nk nk 63 
n 17 iliac 2 BI vs PDT 2 82vs73 sd10 % 3.7vs3.4 sd1 nk 64 
 
 
 
 
 
Chl dt= cholesterol diet; y=yes; n=no; No.=number; car=carotid; fem=femoral; cor=coronary, per=peripheral; 
PDT=photodynamic therapy; c/i=coronary and iliac; FU=follow-up; wk= weeks; h=hours; m=months; IH= 
intimal hyperplasia; vs=versus; sd=standard deviation; nk=not known IMR= intima to media ratio; MLD=maximal 
lumen diameter; bp=bursting pressure; R=references. 
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1.04 The pathophysiology of stenosis and restenosis: The phases in 
restenosis development 
 
Restenosis is defined as the mean narrowing after an initially successful result of vascular 
intervention [68-70]. 
Restenosis is initiated indirectly by the combined action of thrombin, platelets, neutrophils or 
macrophages in the local thrombus that accumulates at the injured arterial segment, or directly 
through the traumatisation of the artery.  Both events change the expression patterns of growth 
factors, their receptors, release of cytokines and the cell regulating proteins, resulting in a 
myofibrotic reaction of the artery. Prominent cells involved in the myofibrotic reaction of the 
artery are endothelial cells, fibroblasts and SMCs. The following phases are distinguished: 
 
1.   In the first seconds and minutes the complement-pathway is activated [71]. 
2.   In the first hours after vascular injury, the denudated region by the exposure of fibronectin     
      activates the hemostatic system, causes platelet aggregation and the release of granules by      
      platelets (peaks after several hours and lasts for a day), followed by thrombus formation  
      and thrombolysis (lasts for days to weeks). There is a correlation between the degree of  
      vascular damage and the degree of platelet aggregation and thrombus formation [71-72]. 
3.   In parallel, macrophages, neutrophils and lymphocytes accumulate at the injured site due to  
      chemoattractants. This inflammatory reaction peaks at 24 hours, and lasts for some days [71]. 
4.  The granulation phase overlaps to some extent the inflammatory response and is characterised    
      by cell proliferation lasting for about 3 weeks. This phase is characterized by migration and   
      proliferation of endothelial cells from the wound margins and SMCs or fibroblasts from the 
      adjacent tunica media to cover the wound surface and ultimately leading to intimal  
      hyperplasia. The most prominent cell in the development of intimal hyperplasia is the SMC. 
      Two phenotypes of SMCs exist: 1. Contractile (quiescent) phenotype in the normal 
      tunica media and 2. The synthetic (secretory) phenotype containing abundant 
      synthetic organelles (such as free ribosomes, Golgi-apparatus and rough 
      endoplasmatic reticulum). This type is seen in the injured arterial wall. After 7  
      days the cell proliferation and migration of SMCs slows down and the deposition 
      of chondriotin-sulfate and dermatan sulfate starts. In fact, 50 to 80% of the volume 
      of the intimal hyperplasia region is composed of extracellular matrix. The sequence of     
      phase 1,2, 3 and 4 is known as ‘response-to-injury’[73-74]. 
5.  The formation of the extracellular matrix in the tunica intima and tunica media guided by  
      local and systemic hemodynamics is initiated at 2 weeks after vascular injury and reaches a      
      plateau after 3-4 weeks, possibly lasting for months or even years. This phase of extracellular    
      remodelling is characterized by the deposition of chondroitin-sulfate, dermatan sulfate and  
      the modification of deposited proteoglycans by collagens and elastin after several months.  
      The synthetic SMCs are replaced by contractile SMCs after about 6 months. The ‘reactive-   
      adaptive remodelling’ phase 5 is the final outcome of the arterial healing [75-76]. 
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1.05 The development of dysplastic intimal hyperplasia 
 
The definition of dysplastic intimal hyperplasia is rather controversial, because it 
suggests hyperplasia of cells derived from the tunica intima. However, the proliferating synthetic 
SMCs and fibroblasts are mainly derived from the media and account for 20-50% (vs 50-80% 
extracellular matrix) of the volume of intimal hyperplasia. The term ‘intimal hyperplasia’ 
comprises phase 3 and 4 of the restenosis process and is a morphological rather than a patho-
etiological definition. It has been shown that the degree of intimal hyperplasia depends on the 
degree of arterial injury [73] and on the rate of reendothelialization [76]. 
 
1.06 The development of constrictive remodelling 
 
In phase 5 of the restenosis process, constrictive remodelling may occur at long-term. 
This is characterized by late lumen loss due to a rigorous myofibrotic reaction of the arterial 
response to injury [77-79]. Under which conditions constrictive or adaptive remodelling will 
occur is not fully understood [80], but a relation between degree of damage and degree of 
constrictive remodelling has been reported [73;81]. 
 
1.07 The role of shear stress 
 
 Many studies described the physiological phenomenon that decreased shear stress in the 
regions of vascular injury leads to the development of intimal hyperplasia [82-86]. Although the 
inverse relationship between the shear stress and the degree of intimal hyperplasia may be of 
importance in the predilection sites of (re)stenosis development, no studies support this 
hypothesis. 
 
1.08 The experimental models of restenosis  
 
 The common method to induce stenosis is balloon-induced damage of the artery, using 
overstretching of all tunicas and denudation of the tunica intima [87-89]. 
Other methods like electrocoagulation, cutting off the tunicas, cuffing the artery with 
silicon and genetic manipulation, were able to initiate restenosis as well. The carotid artery of the 
rat is widely used to study the development of intimal hyperplasia. However, its different 
morphology to the human artery makes it less suitable for comparisons with the human 
condition. Other better comparable arteries are evaluated in Chapter 3. Rabbit and pig models are 
used to mimic atherosclerosis development, because of their sensitivity to a cholesterol- and 
lipid-rich diet [90-91]. 
Despite that the size of their arteries is comparable, the dog model is not frequently used 
to study the response to arterial injury in humans because of major differences in their 
metabolism and coagulation. The coagulation pathway in monkeys is very similar to the humans, 
but their use as laboratory animals is limited because of ethical and financial reasons.  
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1.09 To date experimental endovascular-based research approaches 
 
Hyperthermia, Microwave therapy and Laser therapy are respectively based on the electro-, 
microwave or laser coagulation of arterial tissue by the generation of heat [92-94]. 
PUVA therapy, which name is derived from the use of furocoumarins containing substrates 
known as psoralens (8-MOP) and light from the ultraviolet 320-400 nm region (=UV-A). This 
kind of therapy first used to treat a fungoid infection in the skin (vitiligo) by Lerner in 1953 and 
later to treat the dermatologic autoimmune disease located in the epidermis, known as psoriasis, 
by Parrish in 1974. Perree described in 1998 PUVA therapy in animals to prevent intimal 
hyperplasia [95]. 
Brachy therapy is based on the use of gamma radiation in the range of 12-20 Gray and was for 
the first time used in animals by Friedman in 1964. In 1990, the first clinical application to treat 
in-stent stenosis in femoro-popliteal arteries was reported by Liermann. In 1997, Teirstein 
reported on the first randomised double-blind placebo-controlled intracoronary brachytherapy 
trial [96]. 
Directional or rotational atherectomy is based on the use of knives on the balloon to cut the 
occluding plaque away in order to restore the arterial patency. Clinical trials showed promising 
results, but the arterial lesions that arose in the arterial wall after cutting are prone to develop 
restenosis. [97-99]. 
Cryotherapy is an experimental application, based on the ablation or hibernation of the 
proliferative smooth muscle cells by freezing using a probe cooled by liquid nitrogen. The initial 
results are promising and the evaluation of this therapy has just started [100]. 
Silicon therapy is based on artificial outward remodelling by siliconising the arteries using 
Albastine [101]. The evaluation of this method is in phase 1. 
Gene therapy Since the mapping of the complete genome many studies started to manipulate the 
arterial healing related genes. However, the results obtained thus far are disappointing because of 
the low success rate and the low specificity of the present vectors [102-106]. 
Uncoated/ coated-stents The use of stents in atherosclerotic lesions significantly improved the 
success rate of vascular interventions. Still, the arterial healing response to the stents can lead to 
the development of intimal hyperplasia at the edges of these stents .The need to prevent the 
development of intimal hyperplasia in the stent led to the development of various coatings.  With 
particular coated stents, much better results have been obtained than the conventional stents 
[107-110].  
Photodynamic therapy Since the eighties, the effect of phototoxicity in the prevention of 
restenosis started. In this thesis, the effects of endovascular photodynamic therapy on the 
prevention of restenosis is evaluated. 
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1.10 Conclusions 
 
The effect of endovascular photodynamic therapy is based on the induction of photocytotoxicity 
in two steps. Activation of the photoactive compound protoporphyrin IX formed via conversion 
of aminolaevulinic acid using illumination with 633 nm at appropriate irradiance, initiates a 
cytotoxic type II reaction. It is conceivable that in particular proliferating cells in the vascular 
lesion may be eradicated by PDT preventing the (re)narrowing of the lumen. 
Excessive damage of the artery is believed to initiate an exagarated healing response resulting in 
the development of restenosis. Many pathways are involved in the phases of restenosis 
development, but the leading mechanism is unresolved. Therefore, adjuvant strategies are needed 
to prevent restenosis. Photodynamic therapy may be a promising tool in that respect. 
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2.00 The aims and outline of the studies in this thesis 
 
 The aim of this thesis was to evaluate in an animal model the applicability of 
endovascular ALA-PDT as adjuvant strategy to prevent vascular intervention-induced restenosis. 
The main theme is the changes in histo-morphometry as a means, 1. to elucidate the arterial 
‘response-to-injury’ and the ‘reactive-adaptive remodelling’ after endovascular ALA-PDT in 
vivo, and 2. to find the optimisation criteria for endovascular ALA-PDT. The outline of this 
thesis illustrates a step-wise approach from background information, via the model requirements 
to study endovascular PDT, and the effects of PDT on the vascular biology, and finally to the 
effects of PDT on the vascular physiology. The section heading applied in this thesis indicates 
the level at which the research  in studying endovascular photodynamic therapy is. Thus, the 
information obtained from the first described studies has been integrated in the successive 
studies.  
 
2.01 SECTION I BACKGROUND 
  
In Chapter 1 background information about photodynamic therapy (PDT), its 
fundamental principles, the conversion of the applied prodrug aminolaevulinic acid (ALA) into 
the photosensitizer protoporphyrin IX (PpIX) and information about the application of PDT in 
the field of (cardio)vascular interventions is given. In this chapter the questions like ‘What is 
PDT?’ and ‘What is known about PDT in the field of vascular interventions?’ are answered.  
Additional information about the pathophysiology of restenosis is given. A question like ‘What 
do we presently know about restenosis?’ is dealt with. The insights in this matter will help to 
understand the challenge of the performed studies in this thesis, namely ‘Can endovascular PDT 
prevent restenosis?’.  
In Chapter 2 the aims and outline of the thesis are given.  This chapter elucidates the 
rationale of the studies in this thesis  
 
2.02 SECTION II MODEL REQUIREMENTS 
 
In Chapter 3 the arterial healing response to injury is thoroughly evaluated to form the 
basis in the evaluation of the effects of endovascular PDT in the following studies. Therefore, the 
first aim was to validate a reproducible model for the induction of intimal hyperplasia and 
constrictive remodelling. The second aim was to compare the histo-geometric healing response 
to balloon injury in central and peripheral arteries as a measure for the normal-compensatory 
potential after standardised-balloon injury. The third aim was to describe the arterial healing 
after balloon injury per artery type as reference to compare the effects induced by ALA-PDT in 
later studies on ALA-PDT. The question ‘Why did we use the rat model?’ is answered. 
In Chapter 4 we deal with the question ‘What do we know about the photosensitizer 
accumulation in the arterial wall?’. To answer this, the first aim was to determine the time-
intervals at which ALA converted into PpIX in arteries for optimisation of endovascular PDT. 
The second aim was to compare the time-intervals and peak concentrations between the artery-
types as reference to compare the effects induced by ALA-PDT.  
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2.03 SECTION III ENDOVASCULAR PHOTODYNAMIC THERAPY 
 
In Chapter 5 we answer the question ‘How does the healthy artery respond to PDT in 
the validated model?’. Therefore, the first aim was to descibe the normal histo-geometric healing 
response after endovascular PDT in normal arteries. The second aim was to use this information 
as reference for ALA-PDT after balloon injury. 
In Chapter 6 the key question of this study, namely ‘Does PDT prevent the 
development of restenosis?’ is answered and evaluated in an interventional model for the 
prevention of intimal hyperplasia and constrictive remodelling. In this chapter, the first aim was 
to evaluate the histo-geometric effect of endovascular PDT in this model. The second aim was to 
find the optimal light-dose for ALA-PDT. The third aim was to describe the effect of ALA-PDT 
on the cholinergic innervation. 
 
 
2.04 SECTION IV PDT AND VASCULAR BIOLOGY 
 
In Chapter 7 the challenge is to find an answer to the question ‘How does endovascular 
PDT prevent restenosis?’. In this chapter,  the first aim was to evaluate the effect of endovascular 
PDT on the reendothelialisation of the injured vascular wall. The second aim was to describe the 
role of transforming growth factor beta (TGF-β) in the reendothelialisation process, the 
development of intimal hyperplasia and of constrictive remodelling after ALA-PDT. 
In Chapter 8 we evaluate the question ‘What is the role of the inflammatory response in 
the prevention of restenosis by endovascular PDT?’. Therefore, the first aim was to evaluate the 
effect of endovascular PDT on the inflammatory response upon vascular injury. 
 
2.05 SECTION V PDT AND VASCULAR PHYSIOLOGY 
 
In Chapter 9 we answer the question ‘Does endovascular PDT alter the strength of the 
arterial wall?’. Therefore, our aim was to evaluate the long-term effect of endovascular PDT on 
the bursting pressure of the treated artery.  
 
2.06 SECTION VI AFTERMATH 
 
In Chapter 10 we discuss the questions that are answered and new questions that have 
arisen in this thesis,  followed by the conclusions of this thesis. 
In Chapter 11 a summary of this thesis in english and dutch is given. 
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3.00 Abstract 
 
Background: Balloon injury (BI) of the rat carotid artery (CCA) is widely used to study intimal 
hyperplasia (IH) and decrease in lumen diameter (LD), but CCA’s small diameter impedes the 
evaluation of endovascular therapies. Therefore, we validated BI in the aorta (AA) and iliac 
artery (CIA) to compare it with CCA.  
Materials & Methods: Rats underwent BI or a sham procedure (control). Light microscopic 
evaluation was performed either directly or at 1, 2, 3, 4 and 16 weeks follow-up. The area of IH 
and the change in LD (LD at 16 weeks minus LD post BI) were compared.  
Results: In the BI-groups the area of IH increased to 0.14±0.08 mm2 (CCA), 0.14±0.03 mm2  
(CIA) and 0.12±0.04 mm2 (AA) at 16 weeks (NS). The LD decreased with 0.49±0.07 mm 
(CCA), compared to 0.22±0.07 mm (CIA) and 0.07±0.10 mm (AA) at 16 weeks (p<0.05). The 
constrictive vascular remodelling (CVR=wall circumference loss combined with a decrease in 
LD) was -0.17± 0.05 mm in CIA but absent in CCA and AA. No IH, no decrease in LD and no 
CVR was seen in the control groups. 
Conclusions: BI resulted in: a decrease in LD in 1. CCA due to IH, 2. CIA due to IH and CVR, 
3. no change in LD in AA. 4. Comparable IH development in all arteries, 5. CCA has no vasa 
vasorum compared to CIA and AA, 6. The CIA model combines good access for 2F 
endovascular catheters with a decrease in LD due to IH and CVR after BI. 
 
Experimental model 
  30 
3.01 Introduction 
 
It is acknowledged that restenosis is the ‘Achilles’ heel of angioplasty [1]. In vascular 
interventions like percutaneous transluminal (coronary) angioplasty (PT(C)A), it is well-known 
that balloon injury (BI) to the arterial wall induces restenosis with a typical decrease in lumen 
diameter (LD) as a result of dysplastic intimal hyperplasia (IH) with or without constrictive 
vascular remodelling (CVR), shrink or recoiling [2-7].  
To improve the long-term success rate of vascular interventions, restenosis must be 
prevented. Many strategies have already been evaluated on their potential to prevent restenosis. 
Interestingly, strategies based on local endovascular techniques adjuvant to PT(C)A and stenting, 
like experimental brachytherapy and  photodynamic therapy (PDT), showed promising results in 
the prevention of restenosis [8], while microwave or cryotherapy, are presently gaining interest 
[9].  
The common animal models for the evaluation of strategies to prevent restenosis are the 
carotid rat artery, the dog-, the baboon-, the monkey-, the rabbit-, and the pig carotid or coronary 
arteries [10]. 
Since the early eighties, the common carotid artery (CCA) in the rat model is widely applied to 
study molecular mechanisms and the role of smooth muscle cells in the arterial healing after 
arterial injury, but it has been criticised as not representative for restenosis development [11]. 
This is more than likely due to abuse or misinterpretation of the rat carotid artery studies, like 
unjustifiably comparing various artery types. The dog model has been explored mainly because 
of their arterial size comparable to humans, low cost and ready availability, but they are not very 
reactive to diets or mechanical injury. The thrombotic activity of baboons and monkeys is more 
close to humans but they are expensive, difficult to handle and to maintain in the laboratory. 
The larger rabbit and pig models are widely accepted models of restenosis development 
that mimic human disease, because they are sensitive to develop atherosclerosis after cholesterol-
rich diets in large injured arteries [12;13]. However, the evaluation of endovascular strategies to 
prevent restenosis in the rat may be cost-effective because of a wide experience and availability 
of tested antibodies in contrast to other models, but data about injury in other arteries than the 
carotid artery are not extensive. Comparisons of the effect of balloon injury between various 
arteries in the rat may add to a better understanding of the arterial healing to injury. 
A practical point of attention is that the relatively large diameters of the presently 
available local delivery devices that are used in endovascular therapies cannot be introduced in 
the rat CCA without causing major vascular wall injury. Until smaller and more flexible fibres 
and devices are produced, the present relatively large devices determine the arterial criteria of the 
animal model. Therefore, we developed a rat model using larger vessels with better access such 
as the abdominal aorta (AA) as earlier reported and common iliac artery (CIA) as never reported.  
A comparison was made with the widely used CCA model to validate the model and to 
assess artery-type-dependent differences in the healing after injury that may be of value in 
closely related research topics.  
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3.02 Materials & methods 
 
The experimental protocol was approved by The Committee on Animal Research of the 
Erasmus University of Rotterdam, The Netherlands and complied with ‘Principles of Good 
Laboratory Practice’ and ‘The guide for the Care and Use of Laboratory Animals’. Ninety-five 
inbred Wistar rats (Harlan CPB, Austerlitz, The Netherlands) weighing 250-300 grams (g) were 
used. The animals had free access to rat chow (AM II, Hope Farms, Woerden, The Netherlands) 
and tap water acidified to pH 4.0, and were maintained in a standard 12-hr light/dark cycle.
3.02.1 Study design 
 
The rats were randomly subdivided into 4 groups. In 3 groups a balloon injury was 
performed of either the right CCA-group (n=30), the AA-group (n=30) or the right CIA-group 
(n=30). A fourth group (=untreated controls; n=5) underwent a sham procedure without BI to 
serve as a baseline control in the CCA, AA and CIA. The animals were sacrificed immediately 
after intervention or after 1, 2, 3, 4 or 16 weeks for pressure fixation of the artery. Cross-sections 
were used for planimetric analysis. The weight of the rat was determined pre-operatively and at 
the time of harvesting.  
 
3.02.2 Pre-operative procedure 
 
Ketamine (35 mg/kg), atropine (40 ug/kg) and xylazine (5 mg/kg) were given 
intramuscularly for general anaesthesia.  
3.02.3 Surgical techniques 
 
Before the study was started, extensive experiments were executed to gain skill in 
handling the operative procedure. 
 
3.02.4 The common carotid-group  
 
A median neck incision was performed and the wound area was kept wet with gauzes 
embedded in 0.9% NaCl. The skin, sternocleidomastoid and omo-/thyrohyoid muscles were 
retracted with 2 Luer retractors. Then, 20 mm of the right CCA was isolated from the carotid 
sheet. The internal, external and the proximal CCA were temporary occluded with vascular 
clamps (B-2 Hemoclips) to prevent retrograde blood loss. After proximal arteriotomy, the lumen 
was flushed with 1ml heparin solution (50 IU/ml) and antegrade balloon inflation of a 15 mm 
long CCA segment performed. Xylocaine (5 mg/kg) was applied to prevent vasospasm. The 
arteriotomy was closed in 2 layers (interrupted 8-0 prolene sutures) and the clamps removed to 
restore perfusion. Finally, the neck wall was closed in 1-layer (continuous 2-0 Vicryl sutures).   
 
3.02.5 The abdominal aorta-group  
 
A medial laparotomy was performed and the intestines were wrapped in a wetted gauze 
(0.9% NaCl). The retroperitoneal fascia was opened medially to expose 20 mm of AA from the 
right renal artery to the iliac bifurcation. Then, the AA was isolated from the inferior caval vein, 
followed by temporary occlusion of the left and right ilio-lumbar arteries, the proximal and 
caudal abdominal aorta, respectively. After the arteriotomy of the AA, a 15-mm segment from 
the renal artery to the bifurcation was balloon injured (see balloon injury). The lumen was 
flushed with heparin, followed by a 1-layer closure (Prolene 8-0, interrupted) of the arteriotomy 
and a 2-layer closure (continuous 4-0 and 2-0 Vicryl sutures) of the abdominal wall.  
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3.02.6 The common iliac artery-group 
 
The surgical procedure was identical to the AA-group. The CIA was prepared from the 
aortic bifurcation to the femoral bifurcation. Both femoral bifurcations, left lumbosacral, inferior 
mesenteric and iliac bifurcation were temporarily occluded. After the arteriotomy, balloon-injury 
of a 15-mm long CIA segment was performed <Fig.3.1>. The lumen was flushed with heparin, 
followed by a 1-layer closure (Prolene 8-0, interrupted) of the arteriotomy and a 2-layer closure 
(continuous 4-0 and 2-0 Vicryl sutures) of the abdominal wall. 
 
 
 
Figure 3.1 A photograph representing the balloon injury at 2 bar of the iliac artery. The metal points (*) 
demarcate the injured segment of 15 mm (white arrow). The black clips occlude the neighbouring 
arteries. 
 
 
3.02.7 Balloon injury 
 
A 2F Fogarty Embolectomy catheter (Baxter Health Care Corp., Edward’s Div., Irvin, 
Ca., USA) was inserted to denude the arterial wall at a pressure of 2 bar (manual barometer) by 
pulling and rotating the inflated balloon from distally to proximally over a 15-mm long segment 
for 3 successive times [14]. The balloon was deflated proximally and inflated distally. Then, the 
arteries were flushed with heparin, closed with Prolene 8-0 and marked halfway the denuded 
segment with a suture (Prolene 8-0).  
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3.02.8 Post-operative procedure 
 
The rats recovered under an infrared heater to keep the body temperature at 37°C.  
 
 
3.02.9 Specimen handling 
 
After sacrifice, a standard perfusion-fixation procedure via the thoracic aorta was 
performed under ether anaesthesia at respectively 0, 1, 2, 3, 4 and 16 weeks. The lumen was 
flushed with a phosphate buffer solution (PBS) at pH 7.45 for 2 min and perfusion-fixed with 
formaldehyde 1.8% for 10 minutes via a silicon tube at 100 mm Hg for paraffin embedding light 
microscopy. The distally and half-way marked segment (single suture, 8-0 black nylon, B/Braun, 
München, Germany) of 20 mm long was harvested after length measurement and stored in fresh 
1.8% formaldehyde for at least 24 hr. 
 
3.02.10 Planimetric analysis of the cross sections 
 
The entire arterial segment was embedded in paraffin wax and cut into cross-sections of 
10 µm at an interval of 3 mm with a microtome. The sections were mounted from distally to 
proximally on a microscopic slide and stained with haematoxylin and eosin. All cross-sections 
were video taped with a digital camera and geometrically analysed using a digital manual video-
analyser <Fig.3.2> [15]. Each rat accounted for one measurement. Therefore, for calculating 
time-dependent effects different rats were used. Firstly, a change in LD was calculated using the 
maximal lumen diameter (MLD) at 0 weeks minus MLD at 16 weeks. Secondly, the absolute 
area of IH was determined. The IH expressed in mm2 was defined as the area between the lumen 
and the internal elastic lamina. Thirdly, IH-to-media-area ratio was used to compare the extent of 
IH contributing to the arterial wall composition between the CCA, AA and CIA, using the IH 
area and media area. Fourthly, the wall circumference (WALLC) was calculated in mm as an 
approximation of CVR (WALLC before minus WALLC after). Fifthly, the media area expressed 
in mm2 was defined as the area between the internal and external elastic laminae. The maximal 
thickness was expressed in mm. The role of animal growth during the experiment was corrected 
with a calculated growth factor, using the formula G=A* (x*wt)/w0, in which A has been 
iterated, x is the geometric value, w=weight at time 0 or  at time t, [16]. Asymmetry was 
corrected by using the perimeter (D=circumference/π) assuming a circular configuration to 
calculate the MLD and MWD. 
The number of vasa vasorum was counted in the tunica adventitia. 
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Figure 3.2 Schematic representation of an artery showing the geometric parameters used in this study. IH: 
Intimal Hyperplasia; media area; MLD: maximal lumen diameter; MWD: maximal wall 
diameter;maximal medial thickness. IEL: internal elastic lamina; EEL: external elastic lamina. 
The dotted line represents the lumen circumference (L circ), and the dark line the wall 
circumference (W circ). 
 
 
3.02.11 Statistical analysis 
 
Comparisons were made between different groups of rats at different time points. Each 
rat accounted for one measurement. Data were expressed as means ± standard error of the mean 
(SEM). Comparisons including the type*time relations were made using a 2-way ANOVA 
method with a General Linear Model regression analysis in SAS. Bivariate correlations 
according Pearson to describe a correlation between type*time and WALLC were used. A 
difference was considered to be significant at p values less than 0.05.  
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3.03 Results 
 
All animals appeared healthy without significant weight loss at follow-up. No 
thrombosis, arterial dissection, aneurysms, paraplegia or paralysis was encountered. The wound 
areas appeared normal besides some mild fibrosis at the suture side. Adjacent lymph nodes 
frequently covered the sutured arteriotomy.  
 
3.03.1 Planimetric analysis 
 
On microscopy, the endothelial layer was absent in the arteries immediately after BI and 
was recovered within 2 weeks after BI. In the control arteries the endothelium layer was 
continuously present.  
 
3.03.2 Lumen Diameter 
 
At 16 weeks after BI, LD decreased with 0.49±0.11 mm (CCA), 0.22±0.07 mm (CIA) 
and 0.07±0.10 mm (AA) <Fig.3.3>. The linear association of a decrease in LD in CCA and CIA 
was significant higher than in AA <Fig.4.4> (p<0.05). MLD was 0.86±0.04 mm (CCA), 
1.53±0.05 mm (AA) and 0.99±0.02 mm (CIA) at 0 weeks, and was 0.37±0.10 mm (CCA), 
1.46±0.09 mm (AA) and 0.77±0.7 mm (CIA) at 16 weeks <Table 3.1>. In time, the overall MLD 
differed significantly between the CCA, AA and CIA. A significantly decrease was seen at 4-16 
weeks (CCA), a temporarily increase at 2 weeks (AA) and a temporarily increase at 1-3 weeks 
followed by a decrease at 16 weeks (CIA) <Table 3.1>.  
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Figure 3.3 Diagram showing the mean difference in lumen diameter (MLD) as the sum of MLD at 0 weeks 
minus MLD at 16 weeks of the common carotid, abdominal aorta and common iliac artery, plotted 
against the time in weeks. The error bars are standard errors of the mean (n=5 for each time 
point).At 16 weeks: (*) CCA vs AA p<0.0002; (†) CCA vs CIA p<0.001; AA vs CIA (‡) p<0.027. 
 
 
  Chapter 3          
  37 
       
 
 
Figure 3.4 Diagram showing the mean area of intimal hyperplasia (IH) of the common carotid, abdominal 
aorta and common iliac artery, plotted against the time in weeks. The error bars are standard 
errors of the mean (n=5 for each time point).    
Type*Time Difference p<0.001: (*) CCA vs AA at 0 and 1 week NS, at 2 weeks p<0.04, at 3 weeks 
p<0.0001, at 4 weeks p<0.0001, at 16 weeks NS; (†) CCA vs CIA at 0, 1 and 2 weeks NS, at 3 
weeks p<0.007 and at 4 and 16 weeks NS; (‡) AA vs CIA at 0, 1 and 2 weeks NS, at 3 weeks 
p<0.02, at 4 weeks and at 16 weeks NS. 
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Parameter Time       CCA SEM AA SEM CIA SEM 
MLD 0 0.86± 0.04 1.53± 0.05 0.99± 0.02 
in mm 1 0.98± 0.02 1.63± 0.08 1.09± 0.02 
 2 0.89± 0.03 1.70± 0.07 1.14± 0.04 
 3 0.97± 0.04 1.45± 0.07 1.17± 0.05 
 4 0.67± 0.05 1.47± 0.09 1.06± 0.03 
 16 0.37± 0.01 1.46± 0.09 0.77± 0.07 
      
Media 0 0.10± 0.00 0.25± 0.03 0.13± 0.00 
in mm2 1 0.13± 0.01 0.32± 0.01 0.18± 0.01 
 2 0.13± 0.01 0.35± 0.02 0.21± 0.01 
 3 0.14± 0.01 0.40± 0.01 0.21± 0.01 
 4 0.11± 0.00 0.32± 0.02 0.19± 0.01 
 16 0.13± 0.01 0.28± 0.02 0.15± 0.01 
      
Medial 0 0.06± 0.00 0.09± 0.01 0.08± 0.00 
Thickness 1 0.07± 0.00 0.14± 0.02 0.09± 0.00 
in mm 2 0.08± 0.00 0.12± 0.01 0.10± 0.01 
 3 0.08± 0.01 0.14± 0.00 0.10± 0.00 
 4 0.09± 0.00 0.13± 0.01 0.09± 0.01 
 16 0.09± 0.00 0.11± 0.01 0.08± 0.00 
  
Table 3.1 A representation of the geometric changes in time expressed in weeks (vertically in ascending  
  order) after balloon injury in respectively (horizontally ordered) the right common carotid artery  
  (CCA), abdominal aorta (AA) and right common iliac artery (CIA). The mean parameters  
(maximal lumen diameter (MLD), media area and maximal media thickness) are subsequently 
given. MLD: CCA 16 vs 0 p<0.001; CIA 16 vs 0 p<0.0001;CCA 1 vs 0 p<0.0003; AA 2 vs 0 
p<0.002; CIA 3 vs 0 p<0.004. Media area: CCA 3 vs 0 p<0.001; AA 3 vs 0 p<0.0001; CIA 3 vs 0 
p<0.0001.THMAX: CCA 16 vs 0 p<0.002; AA 3 vs 0 p<0.0001; CIA 3 vs 0 p<0.0001 
 
 
3.03.3 Intimal Hyperplasia 
 
In all BI groups, the absolute area of IH increased significantly in time (p<0.017)      
<Fig.3.5a1-3.5b2>. A significant increase was seen at 2-16 weeks (CCA), at 3-16 weeks (AA) 
and at 2-16 weeks (CIA). At 16 weeks, the area of IH was 0.14±0.03 mm2 (CCA), 0.14±0.03 
mm2 (CIA) and 0.12±0.04 mm2 (AA).  
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a1.         a.2 
b1.         b2. 
 
Figure 3.5  Photographs in the left column show HE-stained cross-sections of the iliac artery at 0 weeks (a1) 
and at 16 weeks (b1) after balloon injury (BI). The area between the black arrows indicate the 
area intimal hyperplasia. The digital planigraphs in the right column show the iliac artery at 0 
weeks (a2) and at 16 weeks (b2) after BI. The white lines demarcate the IH area and the black line 
represents the external elastic lamina (border medial area=area between black and first white 
line). 
 
3.03.4 Intimal Hyperplasia to media ratio 
In all BI groups, the overall IH to media area ratio increased significantly in time 
(p<0.05). A significant increase was seen at 1-16 weeks (CCA), at 4-16 weeks (AA) and at 2-16 
weeks (CIA)(p<0.05). The IH to media area ratio was higher in CCA (1.09±0.15) than in AA 
(0.67± 0.23) and in CIA (0.95± 0.19) at 16 weeks, indicating relatively more IH development in 
CCA than in CIA and in AA <Fig.3.6>. 
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Figure 3.6      Diagram showing the mean-area-of-intimal hyperplasia-to-mean-media area ratio of the right 
common carotid, abdominal aorta and right common iliac artery, plotted against the time in 
weeks. The error bars are standard errors of the mean (n=5 for each time point).  
(*) CCA vs AA at 0 and 1 week NS, at 2 weeks P<0.0001, at 3 weeks p<0.0001, at  
4 weeks NS and at 16 weeks p<0.009; (†) CCA vs CIA at 0 and 1 week NS, at 2  
weeks p<0.0002, at 3 weeks p<0.0004, at 4 weeks p<0.007 and at 16 weeks  
p<0.003; (‡) AA vs CIA at 0, 1, 2 and 3 weeks NS, at 4 weeks p<0.009 and at 16  
weeks p<0.003. 
 
3.03.5 Constrictive vascular remodelling 
 
In all BI groups, the overall wall circumferences (WALLC) varied significantly in artery 
type and in time <Fig.3.7>. A significant increase was seen at 1-3 weeks in CCA (0.51± 0.13 
mm), an increase at 1-16 weeks in AA (0.46± 0.10 mm) and an increase at 1-4 weeks (0.37± 
0.05 mm) and a decrease at 16 weeks in CIA (-0.17± 0.05 mm). No significant correlation with 
the time was found (-0.020; p<0.68).
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Figure 3.7  Diagram showing the wall circumference of the right common carotid, abdominal aorta and 
common iliac artery, plotted against the time in weeks. The error bars are standard error of the 
mean (n=5 per time point). 
 (*) CCA at 0 vs 1 week p<0.003, 0 vs 2 weeks p<0.004, 0 vs 3 weeks p<0.0004, 0 vs 4 and 16 
weeks NS; (‡) AA at 0 vs 1 week p<0.004, 0 vs 2 weeks p<0.001, 0 vs 3 p<0.001 and 4 weeks 
p<0.001, 0 vs 16 weeks p<0.004; (†) CIA at 0 vs 1, 2, 3, 4 and 16 weeks p<0.001. 
 
 
3.03.6 Number of vasa vasorum in the tunica adventitia 
 
In the CCA groups, no vasa vasorum were seen, while in the AA and CIA respectively 
27± 2 and 13± 2 vasa vasorum per section at 0 weeks were seen in the tunica adventitia. A 
significant increase in time was assessed in the AA and CIA groups with respectively 37±2 and 
22±2 vasa vasorum/section at 16 weeks (p<0.05). Sporadically, some vasa vasorum in the tunica 
media were seen in the AA and not in the CIA and CCA groups. 
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3.04 Discussion 
 
Balloon injury of the common carotid artery (CCA) in the rat is a thoroughly studied model that 
has logistical advantages to evaluate dysplastic intimal hyperplasia (IH) and the decrease in 
lumen diameter (LD) for the evaluation of strategies to prevent restenosis, like endovascular 
based interventions. However, CCA does not fit well to evaluate endovascular techniques due to 
the relatively large diameter of endovascular devices and fibre tips.  
 Furthermore, in contrast to human arteries, the rat carotid artery has no vasa vasorum, 
contains a much thinner subintimal layer and a smaller percentage of elastin in the tunica media 
[17].  
In this study the larger –vasa vasorum containing- abdominal aorta (AA) and common iliac 
artery (CIA) in the rat were validated as an alternative model to be used for the evaluation of 
endovascular techniques.  
 In this study, the decrease in LD was higher in CCA and CIA compared to AA after BI. 
The differences in LD between CCA, AA and CIA are likely explained by an artery-type 
specific healing response after BI, expressed in the development of IH and constrictive vascular 
remodelling (CVR), due to differences in the viscoelastic composition, the vasa vasorum in the 
tunica adventitia and vessel diameter.  
 Another explanation, however, may be the lower dilatation ratio in the aorta due to its 
large diameter, causing less IH development and less remodelling. Indeed, we found that in 
CCA, AA and CIA, IH developed differently at long-term after BI. The extent of CCA IH in our 
model was similar to that in previous reported rat models [14;18]. Relatively more IH 
(expressed by the IH to media ratio) developed in CCA and CIA compared to the AA. In CCA 
and CIA, IH led to a higher decrease in LD.  
 With regard to CVR, the wall circumference temporarily increased in the CCA and CIA, 
and remained increased in AA. In CCA and in CIA a decrease of wall circumference was seen in 
contrast to the increased wall circumference of AA at 16 weeks. Apparently, AA compensated 
to IH by positive (=outward) remodelling underlining the blood reservoir capacity of AA, but 
led to shrinkage in the CCA and CIA at 16 weeks underlining the peripheral resistance capacity 
of CCA and CIA.  
 Earlier reports, using a PTA catheter or a chain-encircled balloon catheter in pig models 
described that IH is not correlated to CVR, suggesting that the pathogenesis is not similar 
[19;20]. In this study, the absence of a decrease in LD and CVR, but still the development of IH 
in the AA supports these findings, but are in contrast with a decrease in LD, increase in IH and 
an increase in CVR in the CCA and CIA.  
 With regard to the media area, no significant difference was found in CCA, AA and CIA 
in time. With regard to the maximal medial thickness, an increase was seen in CCA but not in 
CIA and AA after 16 weeks. Apparently the BI caused more damage in the CCA than in AA and 
CIA, leading to an increased proliferation in the tunica media.  
 A plausible explanation is likely in the viscoelastic differences between CCA, AA and 
CIA. The rat CCA in contrast to the human CCA is an integrating part of the circle of Willis and 
resembles the rat cerebral arteries characterised by a low elastin/ high collagen content and a 
low contraction potential. In contrast, the systemic AA and CIA have a high elastin/ moderate 
collagen content and a high contraction potential [21]. Then, the medial content of contractile vs 
synthetic SMCs varies in CCA, AA and CIA. Their role in remodelling is not fully elucidated 
but likely adapt the viscoelastic content in the extracellular matrix. Indeed, Goldberg et al 
showed in rats that an artery-type dependent variation of both synthetic and contractile SMCs 
determined the vascular wall response [22]. Notably, the attenuated response of the AA could be 
explained by the lumen diameter to BI pressure ratio as suggested earlier in a rat and rabbit 
model. 
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 Furthermore, the absence of vasa vasorum in the CCA in the tunica adventitia in contrast 
to the AA and CIA is strikingly in this study. The increased number in the latter two may favour 
the arterial healing via reperfusion that may lack in the tunica adventitia of the CCA. The 
presence of vasa vasorum may explain the difference in arterial healing between the arteries. 
Indeed, Pels described that the number of vasa vasorum in the tunica adventitia changed after 
balloon injury in pigs, which may be a component of arterial remodelling after angioplasty [23]. 
Our data of the CIA, but not of the AA support this conclusion. Badimon described a 
discrepancy between CCA and the coronary arteries [24], while Ward described a discrepancy 
between the CIA and coronary artery types after standard BI [25], indicating the importance of 
an arterial specific healing response as emphasised in our study.  
Interestingly, the arteries of rabbit, pigs and humans, are also characterised by vasa vasorum in 
the tunica adventitia. Thus, the CIA and AA of the rat are closer to the arteries the larger models 
than the CCA of the rat.  
 A limitation of this study is that no vasodilator was applied. However, geometric analysis 
of the sections within the groups did not show any significant difference, assuming that the 
contribution of reversible and chronic vasodilatory spasm was negligible.  
Another limitation was the difference in weight between the animals in time. The influence of 
increased weight on the growth of the artery is well known and was corrected in this model. 
 Further, the use of balloon catheters that precisely fit with the arterial lumen might be 
suggested for comparing BI. Indeed, the deflated catheter diameter of the 2F balloon fitted well 
in CCA, CIA and moderately in AA, but the inflated balloon diameter extended for 45-60% in 
these arteries (NS: unpublished data). Roubin described that an increased balloon injury resulted 
in an increased development of restenosis needing bypass surgery in a prospectively randomised 
clinical trial of 336 patients [26].  
 In this study, the force to over-stretch the artery was standardised and comparable 
between the balloon injured arteries. Besides differences in arterial morphology, the severity of 
injury and strain [27]- and inter-species differences [10] in the healing response and metabolism 
demand a careful extrapolation to the human situation. 
 
3.05 Conclusions 
 
 In conclusion, 1. BI using 2 bar resulted in a decrease in LD in CCA due to IH, 2. In a 
decrease in LD in CIA due to IH and CVR, 3. no change in LD in AA. 4. Comparable IH 
development in all arteries, 5. CCA has no vasa vasorum compared to CIA and AA, 6. 
Discrepancies in changes in LD by IH development and CVR after BI depend on artery type. 
This should be taken into account in the interpretation of the efficacy of interventional 
techniques to inhibit IH and a decrease in LD. 7. The CIA model is suitable to evaluate fibre-
based therapies, as it combines good access for 2F endovascular catheters with the development 
of a decrease in LD due to IH and CVR after BI. 
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4.00 Abstract 
Background: Photodynamic therapy (PDT) may prevent restenosis following transluminal 
angioplasty by inhibiting intimal hyperplasia and vascular constriction. The synthesis of the 
photosensitive heme intermediate protoporphyrin(Pp)IX in the mitochondrion can be promoted 
via exogenous administration of aminolaevulinic acid (ALA). Since the number of mitochondria 
and their activity differ between various tissues, the time-interval to reach the highest PpIX 
levels may differ among varying arteries.  
Materials & Methods: Therefore, we determined the PpIX concentration in various arteries after 
systemic ALA administration. ALA was administered i.v. (200 mg/kg) to male Wistar rats 
(n=21). At varying time intervals (0, 1, 2, 3, 6, 12, 24 hr) both central arteries and peripheral 
arteries were isolated, homogenized and the ALA, porphobilinogen (PBG), uroporphyrinogen 
(UROgen), coproporphyrinogen (COPROgen), zinc PpIX and PpIX concentration determined by 
a fluorometric extraction method.  
Results: The maximal PpIX concentration was more than two fold higher in peripheral arteries 
(20.49±3.0-24.0±7.5 pmol/mg protein) compared to central arteries (0-9.46±0.01 pmol/mg 
protein) (p<0.004). However, the amount of citrate synthase, reflecting the mitochondrial content 
of the artery, was lower (0.14-0.61 U/mg protein) in the peripheral arteries than in the central 
arteries (1.87-2.32 U/mg protein). 
Conclusion: Apparently, the level of PpIX production cannot simply be explained by the 
mitochondrial content of the arteries of the rat. The time-interval of maximal PpIX accumulation 
after ALA administration was not statistically significantly different in peripheral versus central 
arteries (2:27 vs. 2:08 hr) (p=0.13). If the efficacy of PDT in vivo is directly related to the tissue 
concentration of PpIX, more effect can be expected in peripheral arteries compared to central 
arteries. 
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4.01 Introduction 
 
Restenosis, the chronic re-narrowing of a treated stenotic artery, comprises the success 
rates of vascular interventions in treating symptomatic vascular disease. The incidence of this 
complication is between 20 and 40% within 6 months after endovascular interventions, which 
underlines the need for effective preventive strategies [1]. 
A promising tool in preventing this post-interventional restenosis is vascular 
photodynamic therapy (PDT) using the endogenous heme intermediate protoporphyrin IX 
(PpIX) as the photosensitizer [2-5]. To increase the synthesis of PpIX in the arterial wall, its 
precursor aminolaevulinic acid (ALA) is administered. Key-mechanisms of ALA-PDT as an 
adjuvant to angioplasty are the eradication of photosensitized proliferating vascular smooth 
muscle cells [6] and the induction of crosslinks between proteins of the subcellular matrix of the 
arterial wall [7-9]. 
After systemic administration, ALA is distributed to most tissues leading to PpIX 
production and accumulation in specific organ [10]. However, no data are available on the 
distribution characteristics of ALA and its conversion products in the various artery types 
following systemic administration. Intrinsic differences between the central visco-elastic arteries 
and the peripheral muscular arteries could play a role in that respect. Because the products of the 
heme biosynthetic pathway will contribute to the photosensitization of the blood vessel, 
knowledge of their accumulation in the vascular wall may of use to determine the illumination 
interval following ALA administration. Therefore, the aim of this study was to describe the 
pharmacokinetics of ALA induced PpIX in various arteries categorized as either central (thoracic 
aorta, abdominal aorta) or peripheral (carotid-, renal-, iliac artery). 
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4.02 Materials & methods 
 
4.02.1 Animals 
Male inbred Wistar rats (Harlan CPB, Austerlitz, The Netherlands) weighing 200-300g 
were used. The animals had free access to rat chow (AM ΙΙ, Hope Farms, Woerden, The 
Netherlands) and tap water acidified to pH 4.0, while maintained in a standard 12-hr light/dark 
cycle. The zinc content in food was 5 µmol/day and in drinking water 7.2 µmol/L, which is a 
normal daily intake. 
 
4.02.2 Study design 
Twenty-four rats were randomly divided into 8 groups of 3 animals each. Each rat 
received i.v. 200 mg/kg ALA (Sigma-Aldrich Chemie, Zwijndrecht, The Netherlands) dissolved 
in phosphate buffered saline (pH 7.45) at 40 mg/ml and was sacrificed at 0, 1, 2, 3, 6, 12 or 24 hr 
post administration. A control group of 3 rats received phosphate buffer only. The ALA-solution 
was freshly made for each animal and kept from light exposure. The photosensitized rats were 
kept in the dark until sacrifice to prevent skin photocytotoxicity. The experimental protocol was 
approved by The Committee on Animal Research of the Erasmus University of Rotterdam and 
complied with “the Principles of Good Laboratory Practice”. 
 
4.02.3 Blood samples 
 
At the end of the observation-period, blood samples were taken under ether anesthesia via 
a cardiac puncture and collected in plastic heparinized tubes wrapped in aluminum foil. All tubes 
were kept on ice. After centrifugation at 1300xg for 10 min, the plasma was collected, protected 
from light and stored at –70 °C until use. 
 
4.02.4 Arterial samples 
 
After collecting the blood samples, all rats underwent a combined thoracotomy and 
medial laparotomy under ether anesthesia and subdued filtered light (acrylate yellow filter, 
Wientjes BV, Roden, The Netherlands) [11]. Subsequently, the thoracic aorta and abdominal 
aorta (central arteries), and the right common-, right renal-, right common iliac- and right 
femoral artery (peripheral arteries) were harvested and flushed with saline, freeze-dried and 
stored for at least 24 hr in aluminum reservoirs at –70°C. 
 
4.02.5 Laboratory assays 
 
Chemicals 
 
PpIX disodium salt, zinc PpIX and PBG were obtained from Porphyrin Products (Logan, 
UT, USA). Uroporphyrin (URO) and Triton X-100 were obtained from Sigma Aldrich Chemie 
BV. TRIS was obtained from Boehringer Mannheim (Mannheim, Germany). All other chemicals 
were obtained from Merck (Darmstadt, Germany). 
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Sample preparation 
 
The arterial samples were kept on ice and were homogenized in water (1/5, wt/wt) using 
a Potter Elvehjem homogenizer (Kontess Glass Co, Vineland, NJ, USA). The protein content of 
the arterial samples was determined according the method of Lowry [12]. 
 
Determination of PpIX and its precursors in plasma and arterial samples 
 
Determinations of ALA and PBG in plasma and arterial samples were performed by a 
fluorimetric enzyme assay as described previously [10]. This assay is based on the conversion of 
PBG or ALA into uroporphyrinogen (UROgen) I overnight at 37°C, respectively by the addition 
to the samples of porphobilinogen deaminase (PBG-D) or aminolaevulinic acid dehydratase 
(ALA-D) and PBG-D. For the determination of UROgen no enzymes were added to the samples. 
Next, the samples were exposed to UV light (350 nm) for 5 min to convert porphyrinogens into 
porphyrins, followed by centrifugation for 30 min at 1500xg. The fluorescence of the supernatant 
was measured at an excitation wavelength of 410 nm and an emission wavelength of 656 nm 
using a LS-50B spectrofluorometer with a red sensitive photomultiplier (Perkin Elmer, 
Nieuwerkerk a/d IJssel, The Netherlands). Values were calculated according to a standard line of 
ALA or PBG converted to UROgen, or of URO. We found that if no enzymes were added to the 
tissue or plasma samples, no UROgen could be detected. 
PpIX and zinc PpIX were extracted by adding to 25 µl of plasma or tissue homogenate 50 
µl of Tris-HCl (50 mM, pH 8.0) and 425 µl of a mixture of dimethylsulfoxide and methanol 
(30:70, v/v). The samples were mixed vigorously using a vortex and left for about 30 min at 
room temperature. After centrifugation for 30 min at 1500xg, 100 µl of the supernatant was 
injected on a 10-cm Lichrosorb RP18 column (Chrompack, Middelburg, The Netherlands) for 
reversed phase HPLC analysis using acetone/methanol/water/formic acid (560:240:200:1.75, by 
vol.) as the mobile phase [13]. Elution of the porphyrins was detected using a fluorescence 
detector (LS240, Perkin Elmer, Nieuwerkerk a/d IJssel, The Netherlands) with a red-sensitive 
photomultiplier operating at excitation and emission wavelengths of 410 nm and 625 nm, 
respectively. Sporadically, a peak preceded the zinc PpIX peak that could be identified as most 
likely being coproporphyrin (COPRO). Recovery of porphyrins during the extraction was 
determined by adding a PpIX or zinc PpIX standard to the samples and amounted to 90-100%. 
The concentrations of porphyrins in the samples were calculated according to standard lines of 
zinc PpIX, and PpIX. The porphyrin levels of plasma were expressed in µmol/L and of arterial 
samples in pmol/mg protein.  
 A first-order, one-compartment model [14] was used to calculate the time (tmax) of 
maximal concentration (Cmax) of ALA, PBG, COPROgen (being the reduced counterpart of 
COPRO in the tissues), zinc PpIX, and PpIX in the arterial wall after i.v. injection of a single 
dose of ALA. The time course of the concentrations of these compounds in each artery are 
described according to the standard pharmacokinetic equation 1: 
 
in which C(t) is the concentration (pmol/mg protein) at time-point t in hours. A represents the 
absorbed fraction of the dose divided by the distribution volume, k1 the absorption rate constant 
of the metabolite into the compartment under study and k2 the elimination rate constant of the 
metabolite from that compartment expressed in hour-1.  
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The values of those three parameters were found by iteration using a non-linear regression 
analysis. Next, the parameters k1 and k2 were used to calculate the time-point at which the 
concentration C(t) is maximal (tmax), using the equation 2: 
 
After substitution of that time point for t in equation 1 the maximal concentration (Cmax) was 
found. The standard deviations were calculated using the propagation of the errors. The half-time 
(t½) in hours was calculated according to the equation 3: 
 
Determination of the amount of mitochondria in rat arteries 
  
The number of mitochondria in each artery under study was estimated based on the 
citrate synthase content of the artery. This is plausible because the enzyme citrate synthase is 
localized in the mitochondrial matrix. Under saturating substrate concentrations the enzyme 
activity is equivalent to the enzyme concentration. Citrate synthase activity was determined in 
homogenates of arterial samples diluted 20 fold (w/v) in 0.25 M sucrose, pH 7.4, according to 
the method described by Srere et al [15] and expressed in U/mg protein.  
The respiratory chain activity was assayed using high-resolution respirometry [16]. In 
short, after rapid dissection the arteries were permeabilized by treatment with saponin (50µg/ml) 
for 60 min. Next, upon the addition of various substrates to each arterial sample the rate of 
oxygen consumption was measured using a polarographic oxygen sensor (OROBOROS 
Oxygraph, Anton Paar GmbH, Graz, Austria). Respiration rate was expressed as the amount of 
oxygen consumed in nmol O2/sec/mg protein. 
 
 
4.02.6 Statistical analysis 
 
Data are expressed as means and standard error of the means (SEM). Student’s t-test or 
ANOVA according to Bonferroni’s correction for multiple comparisons were used where 
appropriate to evaluate differences between the artery types as to peak concentrations and 
corresponding time-intervals of the various porphyrins. The strength of the linear association 
between the peak concentrations of the various porphyrins and citrate synthase was quantified by 
calculating the Pearson correlation coefficient. A P-level smaller than 0.05 (p<0.05) was 
considered statistically significant. 
 
4.03 Results 
 
4.03.1 Courses of the concentrations of ALA and PBG in plasma 
 
The highest concentration of ALA (0.23±0.06 µmol/L) in plasma was found immediately 
after its intravenous administration <Fig.4.1>. The highest concentration of PBG (0.02±0.003 
µmol/L) was detected at 1 hr after intravenous ALA administration.  
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Figure 4.1 Courses of the concentrations of ALA (   ), PBG (  ) and PpIX (  ) in plasma at various time 
points after intravenous injection of ALA. Data are means with one standard error.  
 
 
4.03.2 Courses of the concentrations of ALA and PBG in arteries 
 
The time at which ALA reached the maximal level was almost similar in central and 
peripheral arteries <Fig.4.2a>. The same held for PBG <Fig.4.2b>. Of all other arteries, the 
highest peak concentration of ALA was found in the renal artery (p<0.016). However, the peak 
concentrations of ALA did not differ significantly between the central and peripheral arteries. 
The concentration of PBG reached its maximum in all arteries after the peak concentration of 
ALA. Again, the renal artery showed the highest PBG concentration (p<0.007), but no statistical 
significant difference was found between the two categories of artery as to the mean peak PBG 
concentration. Amongst all arteries, the peak concentration of ALA showed a strong, statistically 
significant association with the peak concentration of PBG (r=0.943; p=0.005).  
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a. 
 
 
 Thoracic 
aorta 
Abdominal 
aorta 
Carotid 
artery 
Renal 
artery 
Iliac 
artery 
Femoral 
artery 
Cmax (pmol/mg protein) 871.1 1290.2 1375 3413.5 1242.7 815.4 
SEM 159.3 653.2 556.8 361.9 866 189.7 
tmax (hr) 0:30 0:37 0:44 0:49 0:37 0:44 
SEM 0:12 0:48 0:42 0:36 0:12 0:30 
t½ (hr) 0:21 0:26 0:30 0:34 0:25 0:31 
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b. 
 
 
 
 
 Thoracic 
aorta 
Abdominal 
aorta 
Carotid 
artery 
Renal 
artery 
Iliac 
artery 
Femoral 
artery 
Cmax (pmol/mg protein) 377.4 226.7 374.1 1055.9 184.8 134 
SEM 72.3 105.7 79.8 95.6 70.5 81 
tmax (hr) 0:58 1:09 1:29 1:22 1:44 1:20 
SEM 0:18 0:24 0:30 0:30 0:36 0:12 
t½ (hr) 0:40 0:47 1:02 0:56 1:13 0:56 
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4.03.3 Porphyrins in plasma 
 
Plasma contained solely PpIX. The course of PpIX followed first-order kinetics reaching 
a very small maximum of 0.74±0.04 µmol/L at 4.5 hr after ALA administration <Fig.4.1>. Zinc 
PpIX and porphyrinogens were not detectable in plasma. 
 
4.03.4 Courses of the concentrations of porphyrins in arteries 
 
The time at which the COPRO(gen) concentration reached its maximum was about 
similar in the various arteries under study <Fig.4.2c>. Notably, the abdominal aorta did contain 
the highest COPRO(gen) concentration. The mean peak concentration of COPRO(gen) differed 
significantly between the two categories of artery (p=0.025) being on average a factor of 5.6 
higher in the central arteries. With exception of the abdominal aorta, in all arteries PpIX and zinc 
PpIX were found after ALA administration <Fig.4.2d, 4.2e>. The time-points at which the PpIX 
<> and zinc PpIX concentrations reached their maximum did not differ significantly between the 
artery types (p=0.13 and p=0.15, respectively). However, the mean peak PpIX concentration was 
a factor of 4.2 lower in the central (thoracic and abdominal aorta) than in the peripheral arteries 
(p<0.004) < Fig.4.2d>. If the abdominal aorta was not taken into account, the PpIX 
concentration of the peripheral arteries remained significantly higher than of the central thoracic 
aorta (p<0.05) <Fig.4.3>. Strikingly, amongst the six different arteries, the peak COPRO(gen) 
concentrations showed a strong, inverse association with the PpIX concentration (r=-0.956; 
p=0.003). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3 
 
An illustration of the PpIX 
fluorescence in the iliac artery 
at 2:30 hours after ALA 
administration 
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c. 
 
 
 
 
 Thoracic 
aorta 
Abdominal 
aorta 
Carotid 
artery 
Renal 
artery 
Iliac  
artery 
Femoral 
artery 
Cmax (pmol/mg protein) 9.46 16.05 6.17 0 3.0 0 
SEM 0.7 0.2 1.5 0 1.8 0 
tmax (hr) 2:08 2:26 2:10 0 2:17 0 
SEM - 0:30 - 0 - 0 
t½ (hr) 10:29 1:41 10:23 0 10:35 0 
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d. 
 
 
 
 
 
 
Thoracic 
aorta 
Abdominal 
aorta 
Carotid 
artery 
Renal 
artery 
Iliac 
artery 
Femoral 
artery 
Cmax (pmol/mg protein)  9.5 1 20.5 21.7 21.7 24 
SEM 0 0 3.0 7.7 13.0 7.5 
tmax (hr) 2:08 0 2:27 2:18 2:18 2:16 
SEM 0:42 0 0:49 0:24 0:24 0:18 
t½ (hr) 1:29 0 4:57 1:35 1:35 1:34 
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e. 
 
 
 
 Thoracic 
aorta 
Abdominal 
aorta 
Carotid 
artery 
Renal 
artery 
Iliac 
artery 
Femoral 
artery 
Cmax (pmol/mg protein) 1.1 0 1.7 2.2 1.6 1.6 
SEM 0.6 0 0.9 5.8 1 1 
tmax (hr) 2:24 0 6:30 4:18 4:12 4:12 
SEM 0:42 0 1:18 0:48 1:06 1:06 
t½ (hr) 9:54 0 13:54 3:00 8:48 8:48 
 
Figure 4.2 Diagrams from top to down showing the courses of the concentrations of some components of the 
heme biosynthetic pathway at 0,1,2,3,6,12 and 24 hr (each tick mark on the abscissa represents 1 
hr): a. aminolaevulinic acid (ALA), b. porphobilinogen (PBG), c. coproporphyrin(ogen) 
(COPROgen), d. protoporphyrin IX (PpIX) and e. zinc protoporphyrin IX (zinc PpIX).  
Each diagram shows from left to right the concentration courses in the following arteries: the 
thoracic aorta, abdominal aorta, carotid artery, renal artery, iliac artery and femoral artery. 
Data are means with one standard error. The predicted data are presented by the dotted line.  
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4.03.5 The mitochondrial content of the arteries 
 
To find out if the differences in PpIX concentration between the two types of artery were 
dependent on their mitochondrial mass, we assessed the concentration of the intramitochondrial 
enzyme citrate synthase in each artery. We found that the citrate synthase content of the various 
arteries ranged from 0.14 to 2.32 U/mg protein <Table 4.I>. In contrast to the low PpIX 
concentration of central arteries, the mean citrate synthase concentration of these arteries was 
about five fold higher (p=0.002) than that of the peripheral arteries, i.e., 0.4 (SD: 0.2) and 
2.1 (SD: 0.3) U/mg protein, respectively. To further substantiate this difference in mitochondrial 
mass between the two artery types, as an example we examined the complex I- and II-dependent 
respiratory chain activity of the thoracic (central) and femoral (peripheral) artery. The results 
showed that the mean oxygen consumption (in nmol O2/sec/mg protein) by the thoracic aorta 
was higher than by the femoral artery, respectively a factor of 2.9 (complex I dependent) and 4.3 
(complex II dependent) <Table 4.I>. However, if normalized for the amount of citrate synthase, 
the respiratory chain activity of both arteries was almost similar <Table 4.I>.  
 
 
 
Table 4.I. Mitochondrion-dependent characteristics of various rat arteries 
Artery Citrate synthase Respiratory rate‡ 
(nmol O2/sec/mg protein) (nmol O2/sec/U citrate synthase)  (U/mg protein) 
Complex I Complex II Complex I Complex II 
Thoracic aorta 2.32 1.25 6.34 0.54 2.74 
Abdominal aorta 1.87     
Carotid artery 0.24     
Renal artery 0.60     
Iliac artery 0.14     
Femoral artery 0.61 0.43 1.49 0.71 2.44 
 
‡ We determined the respiratory rate in the presence of glutamate and malate (complex I dependent) or 
succinate (complex II dependent) according to Srere (15). The data were corrected for respiratory state 1. 
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4.04 Discussion 
 
The aim of this study was to clarify ALA induced PpIX pharmacokinetics in various rat 
arteries to determine if artery type-dependent differences may play a role in the accumulation of 
the endogenous photosensitizer PpIX.It is well known that smooth muscle cells produce PpIX 
from exogenous ALA (4). ALA is normally converted into PpIX in the tissues via PBG, 
UROgen and COPROgen. This PpIX loses its photosensitivity upon its conversion into heme. 
However, if excessive amounts of zinc are present, some PpIX will be converted into zinc PpIX 
that may be photosensitive as well [17].  
The results of this study showed that after intravenous injection of ALA, the highest 
concentration of ALA was found in the wall of the renal artery. However, with exception to the 
renal artery, the mean peak concentrations of ALA in the central and peripheral arteries were not 
significantly different.  
Furthermore, the time-intervals to reach the peak value did not differ between the various 
arteries either. Thus, any difference in the formation of PpIX between the artery types cannot be 
due to a varying availability of the precursor ALA. With regard to the levels of PBG, we 
measured the highest concentration in the renal artery, but the mean peak concentrations of PBG 
of the central and peripheral arteries did not differ significantly. PBG peaked in all arteries after 
at least 1 hr. Noteworthy, the ALA and PBG concentrations in the arterial wall showed 
synchronous courses. In accordance to earlier reports, the short time interval between the peaks 
indicates that the zinc-dependent enzyme ALA dehydratase is not rate limiting [18].  
Remarkably, the mean peak concentration of COPRO(gen) was significantly higher in the 
central arteries than the peripheral arteries, and showed a strong inverse association with the 
peak concentration of PpIX in the various arteries. PpIX was not even detectable in the 
abdominal aorta and was significantly lower in the thoracic aorta as compared to the peripheral 
arteries. Apparently, in the central arteries the conversion of COPROgen into PpIX was 
inhibited. Normally, COPROgen produced in the cytosol is converted first into 
protoporphyrinogen by coproporphyrinogen oxidase. This enzyme is located in the 
intermembrane space of the mitochondrion [19,20] and uses oxygen as the only oxidant [21].  
Protoporphyrinogen is converted next into PpIX by protoporphyrinogen oxidase that is 
anchored within the lipid bilayer of the inner membrane of the mitochondrion [22]. Therefore, a 
simple explanation for the low amounts of PpIX, but high amounts of COPROgen in the central 
arteries may be that those arteries contain only few mitochondria. The study of Gibson et al. 
[23], which showed a direct relationship of the mitochondrial content in neoplastic cells to the 
level of PpIX, supports that assumption. Those authors based their conclusion on the selective, 
fluorescent probe MitoTracker Green that preferentially accumulates in the lipid membranes of 
the mitochondrion [24].  
In seeming contrast, we found that the mitochondrial mass of central arteries, reflected by 
the amount of citrate synthase, was high. However, if central arteries contain relatively large 
mitochondria the fact that the surface to volume ratio of large objects is small may unite the 
seemingly disagreeing results. In apparent support of this hypothesis, a preliminary 
morphometric study showed that not only the area of mitochondria of the thoracic aorta was 
about two times larger than of the femoral artery, amounting to 0.41 (SD: 0.17; n=4) and 0.17 
(SD: 0.15; n=10) µm2, respectively (p=0.048), but the morphology of those mitochondria 
differed as well <Fig.4.4>.  
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Figure 4.4 Representative electronmicrographs of a mitochondrion (M) in the vascular wall of the thoracic   
(central)aorta (A) and of the femoral (peripheral) artery (B). Magnification factor: 44 000.     
The length of the white bars is 500 nm. 
M 
M 
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Large mitochondria are in a high-energy state [25]. Such mitochondria will not likely accumulate 
PpIX, because this porphyrin enhances the dissipation of the electrochemical potential gradient 
across the inner membrane of the mitochondria [26]. However, an alternative explanation of the 
low PpIX content of central arteries may be a lower coproporphyrinogen oxidase activity in 
analogy of the imbalance between PBG deaminase and ferrochelatase activities determining the 
high PpIX concentration of tumor cells [18,27]. Obviously, further study is needed to clarify this 
issue.  
The levels of zinc PpIX and PpIX showed synchronous courses in the arteries under 
study. Although zinc PpIX is likely photoactive, it will be activated along with PpIX only if the 
Soret band is used in the treatment, because the shift in the Q-band upon the formation of 
metalloporphyrins is considerable [28]. However, as shown in the present study, the zinc PpIX 
levels were only 10% of the PpIX levels and are thus not expected to make a significant 
contribution to the photodynamic effect.  
In the timing of illumination for effective vascular ALA-PDT, the determination of the 
time-point at which the arterial PpIX content reaches some threshold level seems essential. 
Iinuma et al. [29] showed for a number of cell lines that a threshold of cellular PpIX is required 
for PDT-induced cell killing. Cell lines accumulating less than 140 ng PpIX per mg of protein 
exhibited no phototoxic response. In the present study we have shown that the peak 
concentrations of PpIX (Mw 562.7) in central arteries varied between 0 and 5.3 ng/mg of protein 
and in peripheral arteries between 11.5 and 13.5 ng/mg of protein. While the latter PpIX level is 
about ten times less than the in vitro threshold, we recently were able to show that in vivo this 
dose is effective in ALA-PDT of the rat iliac artery to prevent balloon induced intimal 
hyperplasia [30]. Presently, we do not know if the concentration of PpIX in the central arteries is 
indeed too low for effective PDT. Nevertheless, these results indicate that more factors beside 
the PpIX level determine the efficacy of PDT in vivo.  
In conclusion, ALA accumulation is not artery type dependent, with the exception of the 
renal artery, but peak concentrations of COPROgen were higher and of PpIX were lower in 
central compared to peripheral arteries. Central arteries possibly contain relative large 
mitochondria that are not directed to the synthesis of PpIX. It may be of importance for effective 
PDT in vivo that the time to reach the maximal PpIX level in the peripheral arteries varied 
between 2:08–2:27 hr.  
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5.00 Abstract 
 
Background: PDT can prevent the development of intimal hyperplasia (IH) and negative 
remodelling after angioplasty. The effect of PDT on the adjacent normal artery may influence 
the treatment outcome. Therefore, we assessed the vascular geometry in time after endovascular 
PDT at varying light doses in the normal artery.  
Materials & Methods: Rats were subdivided into experimental, reference and baseline groups. 
The experimental PDT groups were illuminated with 12.5, 25, 50 or 100 J/cm diffuser length 
(dl). The reference light only (LO) groups animals underwent illumination. The fiber only (FO) 
groups served as baseline control. Histogeometric analysis was performed after 2hrs, 4 and 16 
weeks.  
Results: After 16 weeks, a thin layer of IH had developed ( 0.01-0.02 mm2) in the PDT groups, 
whereas no IH had developed in the LO and FO groups (p<0.05). The medial area size was 
increased (0.05±0.03 mm2) in the PDT groups at 12.5, 25 and 50 J/cm and in the LO and FO 
groups (0.09±0.02 mm2). In the PDT groups, a fluence of 12.5-25 J/cm dl resulted in partial 
transient medial acellularity while at 50-100 J/cm dl complete transient medial acellularity 
occurred. After 16 weeks, the media was completely repopulated and did not show constriction. 
The maximal lumen diameter (MLD) in the PDT groups was comparable with the LO and FO 
groups.  
Conclusion: PDT of the normal iliac artery induced a transient medial acellularity and minor IH 
development. As the normal lumen diameter was preserved, no consistent adverse effects of 
PDT to adjacent normal vessel are expected. 
PDT in the normal artery 
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5.01 Introduction 
  
     Endovascular photodynamic therapy (PDT) is a new treatment modality for the prevention of 
vascular restenosis following surgical interventions or percutaneous transluminal angioplasty. 
PDT is based on the generation of high amounts of the oxidising singlet oxygen after light 
activation of an accumulated light sensitive substrate (photosensitization) in the target cells[1-3].                    
    This treatment-modality aims at the inhibition of fibrocellular induced arterial constriction 
(restenosis) by killing of activated arterial cells and deactivating cytokines bound to the 
subcellular matrix. Successful intermediate-term results after PDT have been described, but 
varying in long-term success rates exist [4-6]. Only two reports described the importance of the 
normal arterial response to aminolaevulinic acid (ALA)-based PDT, but used external 
illumination, various light-dosimetry and various arteries [4-5]. Local cytotoxicity after external 
PDT in combination with balloon angioplasty has also been reported [7]. Because the response 
of the adjacent healthy part of the artery to PDT may have an impact on the outcome of treating 
the adjacent lesion area [8], which is of clinical importance, we examined the effect of 
endovascular PDT and fiber-insertion in normal iliac arteries in a rat model. 
5.02 Materials & methods 
  The experimental protocol was approved by The Committee on Animal Research of the 
Erasmus University of Rotterdam and complied with “Principles of Good Laboratory Practice”. 
Male inbred Wistar rats (Harlan CPB, Austerlitz, The Netherlands) weighing 200-300 g were 
used. The animals had free access to rat chow (AM ΙΙ, Hope Farms, Woerden, The Netherlands) 
and tap water acidified to pH 4.0, while maintained in a standard 12-hour light/dark cycle.  
5.02.1 Study design 
 A hundred and eight rats were randomly assigned to respectively the experimental PDT, 
reference Light Only (LO) groups or baseline fiber only (FO) group. Both PDT and LO groups 
underwent a fiber-introduction in the right common iliac artery, and were subdivided into their 
corresponding illumination parameters (n=4 per fluence parameter), 12.5, 25, 50 and 100 J/cm 
diffuser length (dl). In the PDT-group (n=48), δ-Aminolaevulinic Acid (ALA) was administered 
2 ½ hours before illumination. The LO-groups were only illuminated (LO: n=48). In the FO 
(n=12) group only a fiber was inserted. The animals were sacrificed 2 hours after the procedure, 
4 or 16 weeks later. 
5.02.2 Photosensitization 
            The PDT groups received intravenous 200 mg/ kg ALA (Sigma-Aldrich Chemie, 
Zwijndrecht, The Netherlands) dissolved in phosphate buffered saline (PBS, Merck) of pH 
7.45at 40 mg/ml. The solution was freshly made for each animal and kept from light exposure. 
The photosensitised rats were kept in the dark 2 ½ hours prior to surgery and 12 hours after 
surgery to prevent photosensitivity. The time interval after ALA administration is based on a 
previous study, where it was we found that at that time-point the accumulation of the 
photosensitive protoporphyrin IX (PpIX) became maximal [9]. 
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5.02.3 Laser                             
A dye laser (600 Series Dye Module, Laserscope, Surgical Systems, San Jose, CA, USA), 
pumped by a 532 KTP  surgical laser (Laserscope, Surgical Systems, San Jose, CA, USA), was 
used to generate monochromatic light of 633 nm. The power emitted from the cylindrical 
diffusing tip (core diameter 200 µm, outer diameter 1.0 mm, tip length 20 mm: LightsticTM, 
Cardiofocus, West Yarmouth, MA, USA)<Fig.5.1>[10] was calibrated with an in-built power 
meter, and verified with an external linear diffuser in an integrating cylindrical sphere 
(Optometer Model 370, Graseby Optronics, Orlando, FL, USA). A spectroscope (WaveMate, 
Coherent, Auburn, CA, USA) was used to verify the accuracy of the wavelength.  
Temperature 
         The real-time temperature during endovascular PDT was checked at a fluence of 100 J/cm 
dl using an irradiance of 100 mW/cm dl. Fiber-optic thermosensors with a diameter of 0.5 mm 
were coupled to a Luxtron thermometry unit (Luxtron Corp., Santa Clara, CA, USA) and were 
approximated parallel to the laser fiber both outside the artery at an axial distance of 10 mm in 
the fiber tip. The temperature was determined every second and stored using a computer. 
Linear fluence calibration with an isotropic probe                           
The linear fluence of 100 J/cm dl from the cylindrical diffuser in the arterial wall was 
measured at an irradiance of 100 mW/cm dl (illumination time of 1000 seconds). An isotropic 
probe was approximated parallel to the laser fiber outside the artery at axial distances of 10 mm 
from and 0, 10 and 20 mm in the fiber tip. 
5.02.4 Surgical technique                          
A median laparotomy was performed under general anaesthesia with intramuscular 
injection of ketamine (Ketalar, Parke Davis and Co.,Inc.,40 mg/kg) and xylazin (Rompun Bayer 
Ag, Leverkusen, Germany; 5 mg/kg). Subdued light using a yellow filter (620-650 nm Kodak) 
was applied during the procedure [11].  The right common iliac artery was cranially and caudally 
temporarily occluded with vascular clamps (Haemostat B1, Stöpler, Utrecht, The Netherlands). 
To create a blood free lumen, the artery was flushed with 1.0-ml heparin (50 IU/ml 0.9% NaCl, 
Infusion solution Baxter) through an arteriotomy 5 mm cranially from the abdominal aortal 
bifurcation. Hereafter, the clamps were removed. Reperfusion of the treated section was 
observed directly after flushing with heparin and two layer closing (interrupted 9-0 prolene 
sutures). The abdominal wall was closed in two layers (continuous 2-0 prolene sutures).  
 
5.02.5 Endovascular Photodynamic Therapy (PDT)         
 
         A 400 µm fiber (Lightstic 360, Rare Earth Medical Inc., West Yarmouth, MA, USA) with 
a 20 mm long cylindrical diffusing tip was applied. The fiber tip was centred endovascularly to 
illuminate 20 mm <Fig.5.1>. Because of the cylindrical illumination, the fluence rate was 
expressed in Joule per cm diffuser length (J/cm dl). The target area was illuminated at 100 
mW/cm dl. After treatment, the lumen was thoroughly flushed with 1ml heparin (50 IU/ml). 
Abdominal organs were protected from light exposure with a light absorbing plastic folium 
during illumination. The animals recovered in subdued light after treatment. 
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Figure 5.1 A photograph of the laser fiber at the target   
              area illustrating the illuminated  segment. 
 
 
5.02.6 Specimen handling 
 
            A standard perfusion-fixation procedure via the thoracic 
aorta was performed under ether anaesthesia, in which the lumen 
was flushed with PBS for 2 min, followed by a 10-min perfusion 
with formaldehyde (3.7%) at 100 mm Hg. The distally marked 
segment of 20 mm was carefully harvested after length 
measurement and stored in formaldehyde (3.7%) for at least 24 
hours. Thereafter, the specimens were embedded in paraffin. 
Three cross sections of 10 µm each were cut with a microtome 
from distal to proximal at 3, 5 and 10 mm, mounted on a microscopic object glass and stained 
with haematoxylin and eosin for conventional light microscopy.  All mounted sections were 
video taped with a digital camera for geometrical analysis. A digital video analyser system (IBM 
Corp., Boca Raton, USA) was used for the assessment of the absolute intimal and medial area in 
mm2 [12]. Intimal hyperplasia (IH) was defined as the area of the cell layer between the lumen 
and the internal elastic lamina. The medial area was defined as the area between the internal and 
external elastic lamina (EEL). The maximal lumen diameter (MLD in mm) was measured to 
evaluate arterial remodelling. Asymmetry was corrected by using the perimeter 
(D=circumference/π) assuming a circular configuration to calculate the MLD. 
 
5.02.7 Statistics  
                      
The area of IH, the tunica media and MLD were expressed as mean ± standard error of 
the mean (SEM). Comparisons were made using the Student’s T-test. A difference was 
considered to be significant at P-values less than 0.05. 
 
 
5.03 Results 
In 2 rats diarrhoea occurred during 2 days after PDT 50 J/cm dl. Other animals appeared 
healthy, without significant weight loss during the study. No skin photosensitivity reactions were 
noted in the rats exposed after PDT. All right common iliac arteries were patent at harvesting. 
All sutured arteriotomies were covered with peri-adventitial fat and adjacent lymph nodes. No 
aneurysms were noted. During the PDT procedure, the vessel temperature of 33.5 ± 0.18 °C (n=4 
at 100 J/cm dl) and the room temperature of 20.1 ± 1.9 °C did not increase. Our previous study 
showed that the linear fluence in the vascular wall at the applied irradiances matched with the 
output (100 to 110 %) without loss or significant backscatter interference [13].    
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5.03.1 Histological and Morphological Analysis 
5.03.1.1 Histology 
         No histological and morphological abnormalities were found in the FO, LO 12.5, 25, 50 
and 100 J/cm dl group at 0, 4 and 16 weeks. Ruptures of the arterial wall were not seen 
microscopically in the PDT and LO groups. Inflammation in the tunica intima and tunica media 
was microscopically absent in all groups. LO at 12.5, 25, and 50 J/cm dl, did not affect the 
appearance of SMC's in the media. However, directly after illumination with 100 J/cm dl 
superficial SMC eradication was seen. PDT at 12.5 and 25 J/cm dl showed partial cellular 
eradication of the media. Immediately after illumination with 50 and 100 J/cm dl the media was 
found acellular in the PDT groups. Endothelial cells also disappeared. The media was completely 
repopulated after 16 weeks. 
5.03.1.2 Histo-geometry of the intima        
   
 No IH was seen 2 hours after PDT. Sporadic IH developed during the following 16 
weeks in all PDT treated groups  (p<0.05)  (12.5 J/cm dl: 0.01±0.007 mm2; 25 J/cm dl: 
0.02±0.007 mm2; 50 J/cm dl: 0.01±0.006 mm2 and 100 J/cm dl: 0.02±0.009 mm2), whereas no 
IH developed in the LO groups. IH development in the PDT groups was not significantly 
different than in the LO groups.        
5.03.1.3 Histo-geometry of the media    
In none of the groups immediately following LO or PDT any significant changes of the 
medial area were seen in comparison with FO (mean medial area 0.12±0.02 mm2)<Fig.5.2a>. At 
4 weeks, the medial area of the LO groups was not significantly different <Fig.5.2b> and not 
higher than at immediately after treatment <Fig.5.2a>. PDT treatment tended to increase the 
medial area at fluences of 25 J/cm dl and higher <Fig.5.2b>, but these increases did not reach 
statistical significance. Another 12 weeks later, the medial area did not change significantly after 
PDT at 100 J/cm dl compared to the LO and FO groups. However, the medial area was 
significantly higher than at immediately after treatment in the PDT groups at lower fluences, 
(12.5: 0.17±0.03 mm2 p<0.02; 25: 0.20±0.05 mm2 p<0.02; 50: 0.19±0.04 mm2 p<0.01) and LO 
groups (12.5: 0.26±0.03 mm2 p<0.004; 25: 0.18±0.03 mm2 p<0.03; 50: 0.21±0.02 mm2 p<0.001; 
100: 0.18±0.01 mm2 p<0.01) <Fig.5.2c>.                    
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Figure 6.2 Diagrams a,b,c representing the mean media area at 0, 4 and 16 weeks 
 in the LO() and PDT(❍)groups. 
a 
b 
c 
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5.03.1.4 Histogeometry of the lumen and the vessel wall 
Compared to the FO (MLD: 0.82±0.05 mm), no significant changes in the maximal 
lumen diameter (MLD) between the PDT groups and the LO groups were seen immediately after 
the procedure. However, 16 weeks after PDT the MLD increased significantly at 12.5 (1.11±0.13 
mm p<0.04) and 50 J/cm dl (1.17±0.06 mm p<0.02) and at 12.5 (1.23±0.23 mm p<0.01), 50 
(1.10±0.14 mm p<0.05) and 100 J/cm dl (1.10±0.05 mm p<0.01) in the LO groups compared to 
0 weeks. The MLD did not change significantly after 16 weeks in the FO (MLD 0: 0.96±0.10 
mm; 16: 1.02±0.45mm p<0.80), the PDT 25 J/cm dl (16: 1.18±0.09 mm p<0.33), PDT 100 J/cm 
dl (16: 1.09±0.21 mm p<0.80), FO (16: 1.02±0.45 mm p<0.80) and LO 25 J/cm dl (16: 
1.01±0.11 mm p<0.58).  
5.04 Discussion 
In this study, the aim was to gain insight in the effect of endovascular PDT on the normal 
iliac artery of the rat. Histo-geometric analysis was used to evaluate the endovascular PDT effect 
compared to light application only. It was found that endovascular PDT with low fluences of 
either 12.5-25 J/cm dl  resulted in partial media eradication, whereas high fluences of 50-100 
J/cm dl (irradiance: 100 mW/cm dl) resulted in complete media eradication in the healthy iliac 
artery. Remarkably, despite the complete cellular eradication of the media in the PDT groups 
with high fluences the blood vessels under study were capable to maintain the vascular 
haemodynamics without long-term constriction. The minimal threshold of endovascular light 
dose to obtain complete acellularity of the media was 50 J/cm dl at 100 mW/cm dl. 
 Indeed, early reports described fluences of 50 (at 100-180 mW/cm2), 100 (at 150 
mW/cm2) and 250 J/cm2 (at 150 mW/cm2) to be effective external light doses [4-5].  An 
important difference between the previous reports and our study is that they used external 
illumination and more importantly, higher fluence rates. Indeed, it has been reported that the 
fluence rate is a more important determinant in the eradication of cells than the total fluence [18]. 
This may explain the permanent (6 months) flaccid acellularity [4-5], while under the present 
conditions we found that the media always repopulated within 16 weeks in all endovascular PDT 
treated arteries combined with patchy intimal hyperplasia (IH).     
 Apparently, under the latter conditions PDT did not promote cross-linking of the extra 
cellular matrix proteins as shown by Van Eps et al preventing the influx of smooth muscle cells 
into the media. In the low fluence light only groups the media was not affected. However, 
selective cytotoxicity of the medial cells can also be obtained by high light only doses. It is not 
unlikely that some protoporphyrin IX (PpIX) is present in the cells and function as endogenous 
photosensitizer underlying the light only effect on the vascular wall. Indeed, early PpIX-based 
PDT reports using external illumination support the increased effective depth due to the 
stimulated accumulation of PpIX [14] compared to the application external light only [15]. 
 With regard to remodelling as the putative cause of long-term constriction [16;17], we 
found that endovascular PDT of the media with fluences of 12.5, 25 and 50 J/cm dl resulted in a 
media area increase after 16 weeks. No change of the media area was seen in the PDT group 
with 100 J/cm dl. Also in the light-only group, fluences of 12.5, 25, 50 and 100 J/cm dl showed a 
medial increase after 16 weeks.Those increases in medial area could have a negative effect on 
the diameter of the lumen. However, no significant changes of the maximum lumen diameter 
(MLD) in time were seen in all groups. Rather, a tendency to a beneficial increased MLD was 
observed in the PDT and high light only groups.       
 An important mechanism in the normal vascular healing response to injury is the 
balanced effect of numerous growth factors, cytokines and other mediators orchestrating an 
PDT in the normal artery 
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adequate compensation to the vascular damage to maintain the vascular haemodynamics and to 
prevent a future event [19]. Endovascular ALA-based PDT is a promising tool to modulate this 
balance.  
In conclusion, it was found that PpIX-based endovascular PDT of normal rat iliac arteries 
only caused  a transient acellularity of the tunica media. This phenomenon did not affect the 
patency of the blood vessel and appeared even to be beneficial with respect to the MLD in long-
term.  
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6.00 Abstract 
Background and Objective: Intimal hyperplasia (IH) and constrictive remodelling are important 
causes of restenosis following endovascular interventions, such as percutaneous transluminal 
angioplasty. Photodynamic therapy (PDT) with 5-aminolaevulinic (ALA) may prevent 
restenosis by cellular depletion and eliminating the cholinergic innervation. 
Materials & Methods: Rats (n=90) were subdivided into 4 main groups. In the experimental 
group (n=36: 3 replications x 4 doses x 3 examination time-points), ALA was administered (200 
mg/kg iv.) 2-3 hr before balloon injury (BI) of the common iliac artery followed by 
endovascular illumination with 633 nm at either 12.5, 25, 50 or 100 J/cm diffuser length 
(dl)(BI+PDT group). As control groups served the BI+Light only (LO) group (n=36) that 
received no ALA, the BI only group (n=9) (BI), and a group (n=9) that received a Sham 
procedure (Sham group). 
Results: Planimetric analysis showed IH of 0.18±0.12 mm2 (BI), 0.15±0.12 mm2 (BI+LO at 100 
J/cm dl) in contrast to 0.02±0.02 mm2 after BI+PDT at 100 J/cm dl at 16 weeks (p<0.05). In the 
BI+PDT groups, a light-dose increase of a factor 2 led to an IH decrease of 17.2% (p<0.05). In 
the BI and BI+LO groups constrictive remodelling was found, in contrast to BI+PDT treated 
groups at 16 weeks. The staining of cholinergic innervation of the tunic media of the blood 
vessel wall in BI+PDT showed no damage at the highest fluence. 
Conclusion: Endovascular ALA-PDT prevents IH and constrictive remodelling after BI without 
damage of cholinergic innervation of the tunica media. The effective light fluence rate in the rat 
is 50-100 J/cm dl. 
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6.01 Introduction 
 
The long-term success rate of (endo)vascular interventions to treat stenosed or occluded 
peripheral arteries, is determined by arterial lumen preservation, which results in the 
maintenance of flow and reperfusion of tissue [1]. Unfortunately, the success rate is limited by 
restenosis, a constriction of the artery due to either an inadequate compensation to injury or a 
progression of the arterial disease itself [2]. Therefore, re-interventions are still required in 20-
40% of the treated patients within 6 months [3].  
In the development of restenosis, two pathophysiological determinants play a pivotal 
role: 1. intimal hyperplasia (IH)†, characterised by a fibrocellular hyperproliferation that 
obstructs the lumen, and 2. constrictive vascular remodelling (CVR)[4].   
The initiation of restenosis occurs when the clotting cascade is activated after endothelial 
denudation, fibronectin exposure and over-stretching of the tunica media. Then, the 
thrombogenicity is increased and smooth muscle cells (SMC) start to proliferate and migrate 
from the tunica media into the tunica intima. With time, IH develops and the ultrastructure of the 
extracellular matrix reorganises [5].  
With regard to the development of IH, a positive correlation to the migration of SMCs 
from the tunica media into the tunica intima has been described [6]. Therefore, the tunica media 
plays a pivotal role in IH development.  
In iliac arteries, the cholinergic innervation of the tunica intima seems to be upregulated 
after balloon injury [7]. A possible hypothesis is that the innervation of the tunica media may 
regulate the development of IH and the rearrangement of the extracellular ultrastructure in 
peripheral arteries as well [8-15].   
With regard to the prevention of IH, numerous experimental models described various 
degrees of success [16-24]. Brachy therapy with gamma irradiation shows promise as a means to 
inhibit restenosis [25;26]. Presently, coated-stenting has the best long-term outcome [27], but in-
stent restenosis [28], stent-dislocation and stent-wire failure compromises it.  
Alternatively, adjuvant vascular photodynamic therapy (PDT) may prevent restenosis by 
eradicating proliferating SMCs. PDT is based on illumination of an accumulated inert light-
sensitive compound (photosensitizer) in the SMCs of the target artery. Subsequently, the use of 
monochromatic light activates the photosensitizer and generates free radicals, which eradicate 
the SMCs [29]. In this study, the endogenous pro-drug amino laevulinic acid (ALA) was used, 
which is a naturally occurring intermediate in the heme biosynthetic pathway. Then, ALA is 
tissue-dependently metabolised to the photosensitizer, protoporphyrin IX (PpIX). 
Experimental studies described the effectiveness of photosensitizer based PDT with 
either external or internal illumination to prevent IH after balloon injury (BI), but permanent 
focal ablation of IH without CVR has not been accomplished [30-33]. Already, clinical studies 
have recently been described. A phase II trial in the USA (Antrim-based with external 
illumination [34] and a phase III trial in the UK (ALA-based with endoluminal illumination [35]) 
have been initiated.  
The aim of our study was to establish the dosage-effect relationship between light 
treatment and the prevention of unfavourable arterial remodelling using endovascular ALA-PDT 
in a rat model.   
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6.02 Materials & Methods 
6.02.1 Animals 
The experimental protocol was approved by The Committee on Animal Research of the 
Erasmus University of Rotterdam and complied with “Principles of Good Laboratory Practice”. 
Male inbred Wistar rats (Harlan CPB, Austerlitz, The Netherlands) weighing 200-300g were 
used. The animals had free access to rat chow (AM ΙΙ, Hope Farms, Woerden, The Netherlands) 
and acidified tap water, while maintained at a standard 12-hour light/dark cycle.  
6.02.2 Study design 
Ninety rats were randomly assigned to 4 groups <Table 6.1>. Balloon injury (BI) was 
used to induce intimal hyperplasia (IH) in 3 groups. In the first group (BI+PDT; n=36: 3 rats (per 
rat, the mean was determined using 3 heights of the damaged area) x 4 doses x 3 examination 
time-points), ALA was administered 3 hours before BI, followed by endovascular illumination 
of the occluded artery at a fluence of 12.5 (n=9), 25 (n=9), 50 (n=9) and 100 (n=9) J/cm diffuser 
length (dl). In the second and third groups, either light only (LO) without ALA (BI+LO: n=36) 
or BI only (BI: n=9) was performed. The BI and BI+LO groups served as references to study the 
inhibitory effect of PDT on the IH development. A fourth group underwent a Sham procedure to 
serve as baseline control (Sham group: n=9). The animals were sacrificed after either 0 hours, 4 
or 16 weeks for pressure fixation of the artery (at each fluence in the group: n=3 per time-point). 
Cross sections were evaluated using light microscopic planimetric analysis.  
 
Sham  9      Sham n=9 
Balloon injury 
without light 
0 3  3  3  BI n=9 
12.5 3 3 3 3 3 3 
25 3 3 3 3 3 3 
BI + LO (-ALA) 
n=36  
50 3 3 3 3 3 3 
Balloon injury 
+ light 
100 3 3 3 3 3 3 
BI + PDT (+ALA)
n=36 
- 
ALA 
+ 
ALA
- 
ALA
+ 
ALA
- 
ALA
+ 
ALA
Method Fluence 
J/cm dl 
0 weeks 4 weeks 16 weeks 
GROUP 
 
Table 6.1 The study-design of randomised rats in the Sham, balloon injury, balloon injury with light and 
balloon injury with PDT groups. 
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6.02.3 Photosensitization  
All groups received either iv 200 mg/ kg ALA (Sigma-Aldrich Chemie, Zwijndrecht, The 
Netherlands) dissolved in phosphate buffered saline (PBS) at 40 mg/ml or PBS only of pH 7.45. 
The ALA solution was freshly made and kept from light exposure. The photosensitised rats were 
kept in the dark 2 hours prior to microsurgery, and 12 hours after the operation to prevent 
uncontrolled phototoxicity. 
6.02.4 Laser  
A dye laser (600 Series Dye Module, Laserscope, Surgical Systems, San Jose, CA, USA), 
pumped by a 532/KTP surgical laser (Laserscope, Surgical Systems, San Jose, CA, USA), was 
used to generate monochromatic light at 633 nm wavelength. The power emitted from the 
cylindrical diffusing tip (core diameter 200 µm, outer diameter 1.0 mm, tip length 20 mm: 
LightsticTM, Cardiofocus, West Yarmouth, MA, USA)[36] was calibrated with a built-in power 
meter, and verified with an external linear diffuser in an integrating cylindrical sphere 
(Optometer Model 370, Graseby Optronics, Orlando, FL, USA). A spectroscope (WaveMate, 
Coherent, Auburn, CA,USA) was used to verify the accuracy of the wavelength.  
Temperature 
 The real-time temperature during endovascular PDT was checked at 100 mW/cm dl for 
16 minutes and 40 seconds (100 J/cm dl) to exclude high-energy induced hyperthermal effects 
instead of low-energy induced phototoxicity. Two fibre-optic thermosensors with a diameter of 
0.5 mm were coupled to a Luxtron thermometry unit (Luxtron Corp., Santa Clara, CA, USA). 
One was approximated parallel to the laser fibre along the artery at an axial distance of 10 mm in 
the fibre tip and the other next to the rat. The temperature was determined continuously. 
Linear fluence with an isotropic probe  
The linear fluence from the cylindrical diffuser in the arterial wall was measured at an 
output of 100 mW/cm dl for 16 minutes and 40 seconds (100 J/cm dl) . An isotropic probe was 
approximated parallel to the laser fibre outside the artery at axial distances of 10 mm from and 0, 
10 and 20 mm in the fibre tip. 
6.02.5 Surgical technique 
 A median laparotomy was performed under general anaesthesia with intramuscular 
injection of ketamine (Ketalar, Parke Davis and Co.,Inc.,40 mg/kg) and xylazine (Rompun Bayer 
Ag, Leverkusen, Germany; 5 mg/kg). The procedure was performed in subdued light using a 
yellow filter (620-650 nm Kodak). The right common iliac artery was cranially and caudally 
temporarily occluded with vascular clamps. To create a blood free lumen, the arteries were 
flushed with 1.0 ml heparin (50 IU/ml 0.9% NaCl) through an arteriotomy 5 mm cranially of the 
abdominal aortal bifurcation. Then, a balloon catheter (Fogarty arterial embolectomy catheter, 
2F, 60 cm, Baxter BV, Utrecht, The Netherlands) was inserted and inflated with deionised water 
to 2.0 bar with a manometer (Basix25TM, Medioterm, USA) [37]. A right iliac artery section of 
15 mm from the bifurcation was damaged by inflating the balloon distally of the bifurcation. 
Then, after simultaneously pulling and rotating at 120° towards the bifurcation, the balloon was 
deflated at the end of the section. This procedure was consecutively performed 3 times. A single 
external suture in the vascular sheet marked the middle of the denuded area. After flushing the 
lumen with heparin and a two layer closing (interrupted 9-0 prolene sutures) of the arteriotomy,
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both the caudal and the cranial clamp were removed. The abdominal wall was closed in two-
layers (continuous 2-0 prolene sutures).  
 
6.02.6 Endovascular Photodynamic Therapy (PDT) 
 
In the BI+LO- and BI+PDT group, immediately after BI the fibre tip was centred 
endovascularly in the denuded area to illuminate 15 mm of the damaged and 2.5 mm of the 
untreated arterial wall both cranially as caudally. PDT was given when the artery was occluded 
(no blood flow present). Because of the cylindrical illumination, the fluence (J) and fluence rate 
(mW) was expressed per cm diffuser length (J or mW/cm dl). An output power of 100 mW/ cm 
dl was used in all experiments. After treatment, the lumen was thoroughly flushed with 1ml 
heparin solution (50 IU/ml). Abdominal organs were protected from light exposure with light-
absorbing plastic during illumination. The animals recovered in subdued light after treatment.  
 
6.02.7 Specimen handling  
 
A standard perfusion-fixation procedure via the thoracic aorta was performed during 
ether intoxication, in which the lumen was flushed with PBS (pH 7.45) for 2 minutes, followed 
by a 10-minute perfusion with formaldehyde (3.7%) at 100 mm Hg. The distally marked 
segment of 20 mm was carefully harvested after length measurement and stored in formaldehyde 
(3.7%) for at least 24 hours. Thereafter, the specimens were embedded in paraffin. Three cross 
sections of 10 µm each were cut with a microtome from the distal end to the proximal direction 
at 3, 5 and 10 mm from the distal end, mounted on a slide and stained with haematoxylin and 
eosin for conventional light microscopy.  All mounted sections were video-taped with a digital 
camera for geometrical analysis at a magnification of 100x. A digital video analyser system 
(IBM Corp., Boca Raton, USA) was used for the assessment of the absolute intimal and medial 
cross-sectional area in mm2. Intimal hyperplasia (IH) was defined as the cross-sectional area of 
the cell layer between the lumen and the internal elastic lamina. The medial area was defined as 
the cross-sectional area between the internal and external elastic lamina (EEL). The maximal 
lumen diameter (MLD in mm) and maximal wall diameter (MWD in mm) were measured to 
evaluate the remodelling process. Asymmetry was corrected by using the perimeter 
(D=circumference/π) assuming a circular configuration to calculate the MLD and MWD. The 
amount nuclei of SMCs represented the amount of SMCs per cross-section and were counted 
using frame grabber-software (Leica analysis, Germany). 
 
6.02.8 Cholinergic unmyelinated innervation staining of the media  
 
Six rats from the BI (n=3) and the BI+PDT at 100 J/cm dl (n=3) groups were sacrificed 
after 1 day for acetylcholinesterase staining (Schwann cell staining S-100 polyclonal, Dako, 
Kluströp, Denmark) of the frozen transverse sections from the iliac segment (38). The presence 
of cholinergic nerves adjacent to respectively the intima, internal elastic lamina (IEL), circular 
elastic fibres (CEF) in the media between the smooth muscle cells (SMC), external elastic lamina 
(EEL) and adventitia of the cross-sections were graded using a scoring-scheme to plot the mean 
layer score. The following scoring-grade was used: 0 indicated absent staining, 1 sporadic 
hypodense staining (<5 dots per microscopic field at a magnification of 200x) and 2 hyperdense 
staining (>10 dots, nerve fibre staining). 
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6.02.9 Statistical analysis  
 
The area of intimal hyperplasia (IH), media, the maximal lumen diameter (MLD), the 
maximal wall diameter (MWD) and the amount of SMCs were expressed as  averages of three 
measurements. Each of these variables was analysed separately after natural logarithmic 
transformation as dependent variable in a multiple linear regression analysis.  The independent 
variables in this analysis were light dose (after log2 transformation), ALA (Y/N) and the time of 
sacrificing as categorical variable (weeks 4 or 16 for IH; weeks 0, 4 or 16 for MLD and MWD). 
Interest is in the regression coefficient B of light dose, expressing a dosage-effect trend 
relationship. The formula 100(eB – 1) represents the mean percentage of change in the dependent 
variable as a consequence of doubling the light dose. The light dose by ALA interaction term in 
the regression model allows one to estimate and test a difference in mean percentage of change 
between the groups with and without ALA.  
 
With regard to the cholinergic anti-S-100 staining, the Spearman rank correlation coefficient 
between the treatment and staining score  was used. Effects were considered to be significant at 
p-values less than 0.05 (p<0.05).  
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6.03 Results 
 
One rat developed thrombosis within 24 hours following balloon injury in the BI+PDT 
group (100 J/cm dl) and was excluded from further analysis. All other animals appeared healthy, 
without significant weight loss during the study. No skin photosensitivity reactions were noted in 
the rats exposed after ALA injection. Omental adhesions along the abdominal scar were seen 
after harvesting the iliac arteries. All right common iliac arteries were patent at harvesting. All 
sutured arteriotomies were covered with peri-adventitial fat and an adjacent lymph node. No true 
or spurial aneurysms were noted.  
 
6.03.1 Temperature and applied irradiance 
 
During the PDT procedure no hyperthermia in the treated arterial segment was measured. 
The arterial wall temperature of 32.5 ± 0.18 °C (100 J/cm dl) and the room temperature of 19.4 ± 
1.8 °C did not change. The linear fluence in the vascular wall at the applied irradiance matched 
with the output (100 to 110 %) and no loss or significant backscatter interference was measured.  
 
6.03.2 Histological and Morphological Analysis 
6.03.2.1 Histology 
 No histological and morphological abnormalities were found in the Sham group at 0 
hours. Besides disruptions of the internal elastic lamina caused by BI, no signs of complete 
ruptures of the arterial wall were seen microscopically in all groups. Inflammation of the intima 
and media was absent at the microscopic level in all groups. 
6.03.2.2 The tunica intima 
 BI+PDT statistically significantly inhibits IH compared to the control BI and BI+LO 
groups (p<0.0001). If the light-dose is increased with a factor 2 than an inhibition of 17.7% was 
obtained compared to the control BI and BI+LO groups <Fig.6.1>. At 16 weeks, a statistically 
significantly decrease of 65.5% was obtained compared to the controls (p<0.009) 
<Fig.6.2a,6.2b,6.2c>. 
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Figure 7.1 The absolute area of intimal hyperplasia (IH) formation expressed in mm2 in the BI(--), 
BI+LO() and BI+PDT(❍)groups plotted against the fluence in Joule/cm diffuser length at time 
4 weeks (up) and 16 weeks (bottom). The dotted reference lines of the BI group are based on the 
means of n=3. In all groups, no IH was seen at 0 weeks. 
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a.            b. 
        c. 
Figure 6.2 Photomicrographs of HE stained cross sections of IH development in the right iliac artery 
at 100x magnification. The geometric characteristics in relation to IH are illustrated. The 
scale bar represents 0.1 mm. a. BI (16 weeks). IH area reduced the maximal lumen 
diameter (MLD), b. BI+LO 50-100 J/cm dl (16 weeks), c. BI +PDT 50-100 J/cm dl (16 
weeks). 
6.03.2.3 The tunica media 
 BI+PDT did not statistically significantly change the area of the tunica media in 16 
weeks compared to the control BI and BI+LO groups (overall mean: 0.14±0.04 mm2).  
 
6.03.2.4 Lumen and vessel wall  
 
BI+PDT statistically significantly inhibits a decrease of the maximal lumen diameter 
compared to the control BI and BI+LO groups in 16 weeks (p<0.01) <Table 6.2>. In general, if 
the light dose increased a factor 2 in the BI+PDT groups than the maximal lumen diameter 
(MLD) increased statistically significantly with 9.8% compared to the control BI and BI+LO 
groups (p<0.04). At 16 weeks, a statistically significant increase of 72.3% was found in the 
BI+PDT groups compared to the control BI and BI+LO groups in 16 weeks. No significant 
difference within the control BI and BI+LO groups was found.  
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0 wk   
 MLD 
4 wk 
  
16 wk
  
0 wk 
 MWD 
4 wk 
  
16 wk
Sham 0.92  0.93  1.11  1.06  1.11  1.29 
            
BI+LO            
0 1.01  1.23  0.49  1.24  1.24  0.66 
12.5 1.01  1.04  0.60  1.24  1.24  0.66 
25 1.06  1.03  0.64  1.24  1.16  1.02 
50 1.24  1.28  0.72  1.47  1.52  0.76 
100 0.92  1.19  0.85  0.87  1.36  1.10 
            
BI+PDT            
12.5 1.01  0.97  0.86  1.16  0.99  1.08 
25 1.16  1.00  1.20  1.35  1.14  1.34 
50 1.09  1.37  0.96  1.24  1.52  1.11 
100 0.99  0.98  0.97  1.07  0.90  1.07 
            
 
Table 6.2 The mean maximal lumen diameter (MLD) in mm and the maximal wall diameter (MWD) of the 
Sham, BI, BI+LO and BI+PDT groups at 0, 4 and 16 weeks (wk) with n=3 per group per time-
point.  
 
Likewise, BI+PDT statistically significantly inhibits a decrease of the maximal wall 
diameter (MWD) compared to the control BI and BI+LO groups in 16 weeks (p<0.03)       
<Table 6.2>. If the light dose was increased with a factor 2 than a MWD increase of 3.9% was 
seen (p<0.02). While no statistically significant difference was seen at 0 weeks, an MWD 
increase of 43.3% was seen in the BI+PDT groups compared to the BI and BI+LO groups in 16 
weeks (p<0.01). No significant difference between the control BI and BI+LO groups was found 
(p<0.34). 
7.03.3 Amount of SMCs in the tunica media  
BI+PDT significantly decreased the amount of SMCs with 73.4% compared to the 
control BI and BI+LO groups (p<0.05) at 0 weeks <Table 6.3>. If the light dose increased a 
factor 2 than a decrease of 26.9% SMCs was seen (p<0.01). A decrease of 30% was seen in the 
BI+PDT groups compared to the BI and BI+BI+LO groups in 16 weeks (p<0.008). The tunica 
media repopulated in the BI+PDT groups in 16 weeks. 
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Groups 0 wk  4 wk  16 wk  
      
0 173  189  348  
12.5 177  220  357  
25 169  194  350  
50 185  200  318  
100 133  169  290  
BI+PDT       
12.5 123  163  233  
25 97  180  281  
50 7  33  241  
100 3  25  196  
 
Table 6.3 The mean amount of SMCs of the BI, BI+LO and BI+PDT groups at 0, 4 and 16  
weeks (wk) with n=3 per group per time-point. 
 
6.03.4 Effect of PDT on the cholinergic innervation 
 
The cholinergic innervation of the tunica media was seen in all layers of all groups (mean 
1.15±0.01).  A slight decrease of the anti-S-100 staining in the IEL and CEF between the SMCs 
was seen in the BI+PDT groups compared to the control BI and BI+LO groups (r:-0.187; 
p<0.01). However, a statistically significantly increase was seen in the tunica adventitia (r:0.204; 
p<0.001) of the BI+PDT group compared to the control BI and BI+LO groups <Fig.6.4a,6.4b>. 
 
  
a.       b. 
Figure 6.4 Photomicrographs of M-100 stained cross-sections of the right iliac artery at  
200x magnification. The cholinergic nerves are stained black-brownish (*). 
 a. BI (0weeks), b. BI +PDT 50-100 J/cm dl (0 weeks). 
* * 
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6.04 Discussion 
In this study, the use of endovascular aminolaevulinic acid (ALA)-based photodynamic 
therapy (PDT) to prevent balloon-induced (BI) stenosis was evaluated in a rat model. Our data 
show that BI+PDT with light fluences of 50 and 100 J/cm dl at the fluence rate of 100 mW/cm 
dl, inhibits intimal hyperplasia (IH) and constrictive vascular remodelling at long-term (16 
weeks). In the BI+PDT groups, a light-dose increase of a factor 2 led to an IH decrease of 
17.2%. However, fluences of 12.5 and 25 J/cm dl at 100 mW/cm dl were inappropriate for IH 
inhibition. To our knowledge this is the first report that describes the inhibition of constrictive 
vascular remodelling in relation to light-dosimetry as a possible mechanism of the PDT induced 
inhibition of restenosis after BI.                  
 Both the maximal lumen diameter (MLD) and maximal wall diameter (MWD) were 
unchanged at long-term at 50 and 100 J/cm dl in the BI+PDT group, compared to the untreated 
arteries. The BI-damaged arteries not only showed IH, but also a reduction of both MLD and 
MWD, reflecting late lumen loss due to constrictive remodelling after balloon injury          
<Table 6.2>. It became clear that restenosis of blood vessels resulting from angioplasty is mainly 
determined by constrictive remodelling of the vascular wall and not only by the occurrence of IH 
[39]. This could explain why treatment modalities that are only directed against the development 
of IH were clinically not successful in preventing restenosis so far.  Presently, new treatment 
modalities are under development to prevent constrictive remodelling by inhibiting matrix 
metallo-proteinases that are involved in remodelling the subcellular matrix [40].   
 The presence of cholinergic staining was semi-quantitatively evaluated because we were 
mainly interested whether or not nerve damage occurred after PDT. For evaluating the 
cholinergic function, a quantitative analysis would have been required. As the toxic effect of 
PDT occurs immediately and depletion of acetylcholinesterase from a damaged nerve is fast 
process, the impact on vascular innervation was studied on the first day after treatment.  This 
study shows that ALA-PDT inhibits IH as well as constrictive vascular remodelling without 
innervation damage of the tunica media. In fact, this treatment appeared to decrease cholinergic 
staining of the tunica media and increase the cholinergic innervation staining of the tunica 
adventitia. As described by Furchgott, cholinergic innervation causes dilation in the presence of 
endothelial cells in the tunica intima and constriction of SMCs if achetylcholine is directly 
exposed to smooth muscle cells in the tunica media [41]. The not responding of SMCs in the 
tunica media to cholinergic stimulation may be due to SMC eradication after BI+PDT, which 
explains the absence of arterial constriction. The underlying mechanism is not completely 
elucidated, but warrants further study. A direct cytotoxic effect resulting in permanent focal 
acellularity of the area of the tunica media is one of the mechanisms previously described with 
external PDT [32;42].         
 However, in this study only focal acellularity of the tunica media in the BI+PDT groups 
with 50 and 100 J/cm dl from 0 up to 4 weeks was found and the tunica media was completely 
repopulated after 16 weeks. Grant and Nyamekye [43;44] described acellularity of the tunica 
media upto 6 months after external illumination of damaged and undamaged ALA-
photosensitised arteries in a rat without giving any explanation for this phenomenon. 
Additionally, earlier reports described that in vitro innervation of the tunica media stimulated 
hyperplasia [8], which may be source for IH. This finding may also be relevant for our 
observation of repopulation of the tunica media. Another possible explanation is that in our study 
the vascular wall was illuminated from the luminal side, whereas most previous experimental 
studies used external illumination [32;44;45]. In that manner the ultrastructure of the 
extracellular matrix may not so severely and permanently be altered by endovascular PDT 
treatment and therefore, the tunica media could be repopulated. Notably, we found that light 
alone at high fluence can prevent IH to some extent as well, which was also described by others
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[46]. Presumably intracellular photosensitizers mediate this selective cytotoxicity in the arterial 
wall.             
 How BI+PDT led to the inhibition of constrictive vascular remodelling is unknown. In a 
previous study on PDT in the rat oesophagus we found that PDT dependent damage to the nerve 
plexus caused dilation of the oesophagus [38]. In this study no nervous damage at the 
microscopic level could be observed, but the function of the nerves in the tunica media was not 
evaluated. This makes it less likely that permanent constriction of the blood vessel is prevented 
by switching-off the nerves. Because innervation of the tunica media likely plays an important 
role in the repopulation of the media and extracellular ultrastructure organisation, the stimulatory 
effect of BI+PDT on the innervation of the tunica adventitia may underlie the beneficial outcome 
of this treatment. The problem of compensatory back-growth of IH and constrictive remodelling 
with time will need further studies, because despite significant inhibition, slight IH development 
was seen at 16 weeks in the experimental groups. 
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7.00 Abstract 
 
Background: Photodynamic Therapy (PDT) effectively inhibits IH after angioplasty, but induces 
endothelial cell (EC) injury and may interfere with  EC regrowth. To study these effects , 
reendothelialization, and transforming growth factor-beta (TGF-β) protein expression were 
determined after PDT of  balloon injured (BI) rat iliac arteries.  
Materials & Methods: In the experimental groups, PDT was performed 2.5 h after i.v. 
administration of  200 mg/kg aminolevulinic acid (ALA) with 633 nm light at either 50 or 100 
J/cm (100 mW/cm) diffuser length just after balloon injury (BI) with  15 mm length of 
denudation. In the control group, BI was performed only. Normal iliac arteries served as 
untreated reference. The animals (n=5 per time-point) were sacrificed after 2 hours, 1, 3 and 6 
weeks for assessment of the remaining area of endothelial denudation using Evans blue staining 
and after 2 hours and 3 weeks for TGF-β expression using immunohistochemistry . 
Results: In the experimental groups IH was prevented effectively at 50 J/cm (p<0.05). Complete 
reendothelialization occurred after 6 weeks both in the control group and in the experimental 
groups. Immediately after BI and BI+PDT, there was increased TGF-β expression on the 
internal border of the tunica adventitia.  After 3 weeks, the TGF-β was mostly expressed in the 
external border of intimal hyperplasia in the control-group, while in the experimental groups, no 
TGF-β expression was detected.  
Conclusion:  PDT significantly reduces the TGF-β expression in the vessel wall, but does not 
significantly delay EC regrowth following BI in rat iliac arteries. This implies that PDT may be 
a safe method of inhibiting IH following endovascular interventions . 
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7.01 Introduction 
 
Endovascular PDT prevents restenosis by inhibiting intimal hyperplasia (IH) and 
fibrocellular constrictive remodelling following angioplasty [1]. Although this phenomen has 
been proved by several authors in various experimental set-ups, the underlying mechanisms are 
not well understood [1-5]. PDT is based on a photocytotoxic reaction induced by local 
illumination of a light sensitive substrate (photosensitizer) after its accumulation in the arterial 
wall [6-7]. The pro-drug aminolaevulinic acid (ALA) is a naturally occurring hydrophilic 
intermediate in the heme biosynthetic pathway, that is artery type-dependently metabolised to 
photoactive porphyrins like protoporphyrin IX (PpIX)[4]. Vascular PDT results in a transmural 
eradication of photosensitised vascular cells and superficial EC´s. 
The pace and extent of reendothelialization is known to be a major factor in determining 
the outcome of the arterial healing response to vascular injury [8]. Because of the antithrombotic 
properties of endothelial cells (EC) and their inhibitory effect on the proliferation of smooth 
muscle cells (SMC), proper reendothelialization is thought to inhibit IH development [9].  
We have previously found a PDT dependent stimulation of EC growth by inactivation of 
the cytokine transforming growth factor-beta (TGF-β), a potent inhibitor of EC growth in vitro 
[10]. In vitro, the cells involved in both the development of IH and fibrosis, like EC’s, SMC’s, 
platelets and monocytes, produce TGF-β [11]. On the contrary, [12] in vivo the SMC’s are the 
major source of TGF-β and thus different effects may occur [13].  
In this study, the effect of PDT on reendothelialization was examined in vivo in a balloon 
injury model of the rat iliac artery. Because of the important role of TGF-β in regulating 
endothelial cell growth, the PDT effects on TGF-β staining in the vascular wall were assessed 
[14]. 
 
 
7.02 Materials & Methods 
The experimental protocol was approved by The Committee on Animal Research of the 
Erasmus University of Rotterdam and complied with “Principles of Good Laboratory Practice”. 
Male inbred Wistar rats (Harlan CPB, Austerlitz, The Netherlands) weighing 200-300g were 
used. The animals had free access to rat chow (AM ΙΙ, Hope Farms, Woerden, The Netherlands) 
and acidified tap water, while maintained in a standard 12-hour light/dark cycle.  
7.02.1 Study design 
The first part of this study focused on the endothelial regrowth after balloon injury (BI) 
and PDT using Evans blue staining. Seventy rats were assigned to 4 groups and underwent a 
laparotomy. In the experimental groups, PDT with a fluence of at random 50 (n=20) or 100 J/cm 
diffuser length (dl) (n=20) at an irradiance of 100 mW/cm dl was delivered after intravenously 
ALA administration. In the control group, rats (n=20) underwent BI without PDT. In each group, 
the animals were sacrificed after 2 hours (n=5), 1 week (n=5), 3 (n=5) and 6 weeks (n=5) for 
Evans Blue staining of the artery. The untreated reference group underwent only a laparotomy 
(n=10).  
Secondly, in a separate series of experiments, the TGF-β protein expression in the 
vascular wall was assessed using immunohistochemistry. Forty rats were assigned to 4 groups: 
BI+PDT 50 J/cm dl (n=10), BI+PDT 100 J/cm dl (n=10); BI only (n=10) and an untreated
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reference group (n=10). In each group, the animals were sacrificed after 2 hours (n=5) and after 
3 weeks (n=5) for harvesting the arterial segment for staining of the TGF-β protein expression.  
7.02.2 Photosensitization  
All groups received either 200 mg/kg ALA (Sigma-Aldrich Chemie, Zwijndrecht, The 
Netherlands) dissolved in phosphate buffered saline at 40 mg/ml or an equal volume of 
phosphate buffer (PBS, Merck; pH 7.45) administered intravenously. The solution was freshly 
made for each animal and kept from light exposure. The photosensitised rats were kept in the 
dark 2 ½ hours prior to surgery and 12 hours after the operation to prevent skin phototoxicity. 
7.02.3 Laser  
A dye laser (600 Series Dye Module, Laserscope, Surgical Systems, San Jose, CA, USA), 
pumped by a 532/KTP surgical laser (Laserscope, Surgical Systems, San Jose, CA, USA), was 
used to generate monochromatic light at 633 nm. The power emitted from the cylindrical 
diffusing tip (core diameter 200 µm, outer diameter 1.0 mm, tip length 20 mm: LightsticTM, 
Cardiofocus, West Yarmouth, MA, USA)[15] was calibrated with a built-in power meter, and 
verified with an external linear diffuser in an integrating cylindrical sphere (Optometer Model 
370, Graseby Optronics, Orlando, FL, USA). A spectroscope (WaveMate, Coherent, Auburn, 
CA, USA) was used to verify the accuracy of the wavelength.  
Temperature  
The real-time temperature during endovascular PDT was checked at a fluence of 100 
J/cm dl with an irradiance of 100 mW/cm dl (illumination time of 1000 sec) to rule out 
hyperthermic lesions. Two fibre-optic thermosensors with a diameter of 0.5 mm were coupled to 
a Luxtron thermometry unit (Luxtron Corp., Santa Clara, CA, USA). One was approximated 
parallel to the laser fibre along the artery at an axial distance of 10 mm in the fibre tip and the 
other next to the rat. The temperature was determined continuously and measurements saved 
using a computer [7]. 
Linear fluence calibration with an isotropic probe  
The linear fluence of 100 J/cm dl from the cylindrical diffuser in the arterial wall was 
measured at an irradiance of 100 mW/cm dl (illumination time of 1000 seconds). An isotropic 
probe was approximated parallel to the laser fibre outside the artery at longitudinal distances of 
10 mm from and 0, 10 and 20 mm in the fibre tip. 
7.02.4 Surgical technique  
A median laparotomy was performed under general anaesthesia with intramuscular 
injection of ketamine (Ketalar, Parke Davis and Co.,Inc.,40 mg/kg) and xylazine (Rompun Bayer 
Ag, Leverkusen, Germany; 5 mg/kg). Subdued light using a yellow filter [16](620-650 nm 
Kodak) was applied during the procedure.  The right common iliac artery was cranially and 
caudally temporarily occluded with vascular clamps (Haemostat B1, Stöpler, Utrecht, The 
Netherlands). To create a blood free lumen, the arteries were flushed with 1.0 ml heparin (50 
IU/ml 0.9% NaCl, Infusion solution Baxter) through an arteriotomy 5 mm proximal to the 
abdominal aortal bifurcation. Then, a 2F balloon catheter was inserted and inflated with 
deionized water to 2.0 bar using a manometer that caused a dilatation of 45% [17]. A right iliac
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 artery section of approximately 15 mm was damaged by inflating the balloon distal from the 
bifurcation. Then, after simultaneously pulling and rotating at 120° towards the bifurcation, the 
balloon was deflated at the end of the section. This procedure was repeated 2 times. Then, only 
in the BI+PDT groups, endovascular PDT was performed directly after BI. A single suture in the 
vascular sheet marked the middle of the denuded area. After flushing the lumen with heparin and 
closing of the arteriotomy (interrupted 9-0 prolene sutures), both the caudal and the cranial 
clamp were removed. Directly thereafter, reperfusion of the dilated section was observed. The 
abdominal wall was closed in two layers. 
7.02.5 Endovascular Photodynamic Therapy (PDT) 
                
In the BI+PDT groups, a 400 µm fibre (Lightstic 360, Cardiofocus, West Yarmouth, MA, 
USA) with a 20 mm long cylindrical diffusing tip was applied directly after BI. The fibre tip was 
centred in the denuded area to illuminate 15 mm of the damaged and 2.5 mm of the untreated 
arterial wall both cranially and caudally. The clamps were not included in the treatment field. 
Because of the cylindrical illumination, the fluence was expressed in Joule per cm diffuser length 
(J/cm dl). The target area was illuminated at random with either 50 or 100 J/cm dl, applied with 
100 mW/cm dl. After treatment, the lumen was thoroughly flushed with 1ml heparin (50 IU/ml). 
Abdominal organs were protected from light exposure with a light absorbing plastic folium 
during illumination.  
 
7.02.6 Specimen handling- Evans blue staining 
         
Thirty minutes before the animals were sacrificed, an intravenous injection of 6 ml of 
0.5% Evans blue dye was delivered intravenously via the penile vein to identify the remaining 
nonendothelialized area. The area of the intimal surface that was stained blue after opening the 
treated section longitudinally depicted the denuded area. These vessel segments were videotaped 
and measured to determine the area of endothelial denudation (AED) using a digital video 
analyser system (IBM Corp., Boca Raton, USA)[18]. Thereafter, these 20-mm sections were 
carefully harvested and stored in formaldehyde (3.7%) for at least 24 hours. The specimens were 
embedded in paraffin. Longitudinal sections of 10 µm each were cut with a microtome, mounted 
on a microscopic object slide and stained with haematoxylin and eosin for conventional light 
microscopy. All mounted sections were scored for the presence of endothelium, and damage 
(scored for laminal microruptures, cell eradication/ necrosis or hyperplasia) of the tunica media 
and tunica adventitia. The area of IH was measured using a digital analyser system. 
 
7.02.7 Specimen handling- staining of TGF-β protein expression 
 
Staining of TGF-β (Serotec mouse anti human cross-reacting with rat pan-TGF-β MCA 
797, 0.1 mg, batch NR 210301) was performed using the following protocol: Frozen sections 
were thawed at room temperature for 1 night, fixed with acetone for 3 minutes and air dried for 
10 minutes. With a Peroxidase Anti Peroxidase (PAP)-pen lines were drawn around the tissue 
sections and washed 3x4 minutes with Tris-buffered saline (TBS; pH 7.4). Next, in a humidified 
atmosphere the sections were incubated for 30 minutes with TBS containing 10% normal goat 
serum and 10% normal human to block non-specific antigenic epitopes. Then, primary antibody 
against TGF-β, diluted 1:200 in TBS containing 1% normal human plasma was added to the 
sections, following an incubation period of 60 minutes in humidified atmosphere. Thereafter, the 
sections were rinsed 3x3 minutes with TBS containing 0.1% Tween 20, and incubated for 60 
minutes with secondary rabbit anti mouse (biotin) antibody, 1:400 diluted in TBS containing 5%
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 BSA, 2% normal rabbit serum, 2% normal human plasma and 1% rat serum (2nd stepbuffer).  
The sections were rinsed 3x3 minutes with TBS containing 0.1% Tween 20, and incubated for 60 
minutes with ABC complex (1:100 diluted in 2nd stepbuffer). Then, the sections were first rinsed 
for 3 minutes with TBS followed by TBS at pH 8.5, and next incubated in the dark for 30 
minutes using chromogen solution. After rinsing with tap water, the sections were counterstained 
using Mayer’s Hematoxylin for 10-15 seconds, flushed with water again. Finally, after covering 
with Imsol-Mount, the sections were kept at 40 ºC for 20 minutes. The cross-sections were 
microscopically analysed. To correct for normal growth, control arteries at each time period were 
included in the analysis. Because of TGF-β’s laminal ordening, its expression was described as 
percentage of the total perimeter of the elastic lamina (EL). 
 
7.02.8 Statistical analysis                
 
The data were expressed as mean ± standard error of the mean (SEM). Differences 
between the means of various groups were evaluated for statistical significance by linear 
regression analysis and analysis of variances where appropriate. A difference was considered to 
be significant at p values less than 0.05. 
 
 
7.03 Results 
 
All animals appeared healthy without significant weight loss during the study. No skin 
photosensitivity reactions occurred in the rats exposed to PDT. No temperature changes were 
seen during PDT and the linear fluence in the vascular wall at the applied irradiance matched 
with the output (100 to 110%)[7]. 
 
 
7.03.1 Area of endothelial denudation 
 
Two hours after BI, the area of endothelial denudation (AED) was 60±5 mm2 in the BI, 
and 75±8 mm2 in the BI+PDT 50 group and 77±6 mm2 in the BI+PDT 100 J/cm dl group 
compared to 0 mm2 in the untreated control. The AED did not significantly differ between the BI 
and PDT groups (p<0.59) <Fig.7.1, 7.2a, 7.2b>. There was reendothelialization with a rapid 
decrease of the AED in all groups <Fig.7.1, 7.2c, 7.2d>. The AED in the BI+PDT 100 J/cm dl 
group was higher compared to BI at 3 weeks but this did not reach statistical significance 
(p<0.06). Complete reendothelialization was found in the BI, BI+PDT 50 J/cm dl and BI+PDT 
100 J/cm dl groups after 6 weeks <Fig. 7.2e, 7.2f>. Before complete reendothelialization, 
endothelial growth was more pronounced distally than proximally in all groups, but in general to 
a slightly lesser degree in the BI+PDT 100 J/cm dl group compared to BI and BI+PDT 50 J/cm 
dl group. 
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Figure 7.1 A graph showing the area of endothelial denudation in mm2 on the y-axis, plotted against the time 
in weeks on the x-axis. The BI, BI+PDT 50 J/cm dl and BI+PDT 100 J/cm dl are expressed as 
means± SEM (n=5 per time-point). 
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  a.         b. 
    
c.          d.              e.  
 
Figure 7.2 Photographs showing the Evans Blue stained areas of denudation in  
 longitudinally opened right common iliac arteries: a. the untreated control at 0  
weeks, b. the BI and BI+PDT treated artery at 0 weeks. The denudated area is blue (arrows) and    
cotton buds are marked with *, c. the BI artery at 3 weeks, d. the BI+PDT 50 J/cm dl at 3 weeks, e.  
the untreated control at 6 weeks and f. the BI and BI+PDT treated artery at 6 weeks. 
 
7.03.2 Light microscopic evaluation 
 
Complete EC denudation with dehiscence of the basal lamina of the tunica intima and 
minor interruptions of elastic lamina in the tunica media was found directly after balloon injury. 
BI+PDT with 50 and 100 J/cm dl resulted in an acellular tunica media at 2-3 hr after the 
intervention <Fig.7.3a, 7.3b, 7.3c>. There was a time dependent IH development in the BI group 
whereas PDT resulted in a significant inhibition of IH up to 6 weeks <Fig. 7.3d, 7.4>. 
Noteworthy is the increased accumulation of IH at the laminal microruptures in the BI group 
compared to the fibrin deposition or proteoglycan accumulation at the laminal microruptures in 
the BI+PDT groups at 6 weeks <Fig. 7.3e, 7.3f, 7.3g>. The tunica media was repopulated with 
SMC’s and fibroblasts in all groups after 6 weeks. Cellular hyperplasia and fibrin deposition in 
the tunica adventitia was more pronounced in the BI+PDT groups compared to the untreated 
control and BI group. Reendothelialization combined with a sealed basal and elastic lamina was 
seen during follow-up and completed after 6 weeks in all groups. 
** * 
*
* 
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7.03.2 Light microscopic evaluation 
 
Complete EC denudation with dehiscence of the basal lamina of the tunica intima and 
minor interruptions of elastic lamina in the tunica media was found directly after balloon injury. 
BI+PDT with 50 and 100 J/cm dl resulted in an acellular tunica media at 2-3 hr after the 
intervention <Fig.7.3a, 7.3b, 7.3c>. There was a time dependent IH development in the BI group 
whereas PDT resulted in a significant inhibition of IH up to 6 weeks <Fig. 7.3d, 7.4>. 
Noteworthy is the increased accumulation of IH at the laminal microruptures in the BI group 
compared to the fibrin deposition or proteoglycan accumulation at the laminal microruptures in 
the BI+PDT groups at 6 weeks <Fig. 7.3e, 7.3f, 7.3g>. The tunica media was repopulated with 
SMC’s and fibroblasts in all groups after 6 weeks. Cellular hyperplasia and fibrin deposition in 
the tunica adventitia was more pronounced in the BI+PDT groups compared to the untreated 
control and BI group. Reendothelialization combined with a sealed basal and elastic lamina was 
seen during follow-up and completed after 6 weeks in all groups. 
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a.       b.                        c. 
  
d.      e. 
  
f.     g. 
 
Figure 7.3 Photographs of HE stained longitudinal sections: a. the untreated control at 0 weeks, b. the BI at 0 
weeks, c. the BI+PDT section at 0 weeks, d.  the BI section at 6 weeks, e. A magnification of the 
IH. Note the dehiscence marked by a black arrow of the internal elastic lamina covered by 
hyperplasia, f. the BI+PDT section at 6 weeks, g. A magnification of 200x showing the typically 
dehiscent laminal fixation by fibrin (*)  after PDT.  
 
 
*
IH IH
*
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Figure 7.4 A graph showing the area of intimal hyperplasia in mm2 on the y-axis plotted  
against the time in weeks on the x-axis. The BI, BI+PDT 50 J/cm dl and BI+PDT  
100 J/cm dl are expressed as means± SEM (n=5 per time-point). 
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7.03.3 Expression of TGF-β  
 
Immediately after the intervention, there was increased TGF-β expression at the inner 
border of the tunica adventitia in all treatment groups compared to the untreated group (p<0.05) 
<Fig.7.5, 7.6a, 7.6b, 7.6c>. In the BI+PDT 100 J/cm dl group the TGF-β expression was 
significantly higher than in the other groups (p<0.05). At 3 weeks after BI+PDT with both 50 
and 100 J/cm dl, TGF-β expression was absent (p<0.01 vs BI), but remained high (40±20%) at 
the outer border of intimal hyperplasia in the BI group <Fig.7.5, 7.6d, 7.6e>.  
 
 
Figure 7.5 Bars showing the percentage TGF-β expression of the total perimeter of the elastic lamina on the 
y-axis, plotted against the time after the procedure. The untreated, BI, BI+PDT 50 J/cm dl and 
BI+PDT 100 J/cm dl are expressed as mean± SEM (n=5 per time-point). At 3 weeks, TGF-β is 
absent in the untreated (*), BI+PDT 50 (**) and BI+PDT 100 J/cm dl (***) and not in the 
corresponding group of 2 hr after the procedure. 
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           a.                               b.       c. 
               
d.                      e.        f. 
           
                                            g. 
Figure 7.6 Photographs of pan-TGF-β stained (reddish:*) cross-sections. a. the untreated control at 0 weeks, 
b. the BI section at 0 weeks with TGF-β staining along the external elastic lamina (EEL), c. the 
BI+PDT section at 0 weeks with an acellular media and TGF-β staining along the EEL, d. the 
untreated control at 3 weeks, e. the BI section at 3 weeks with persistent TGF-β staining along the 
external border of IH, f. A magnification showing the TGF-β staining upon the external border of 
fibrocellular hyperplasia, g. the BI+PDT section at 3 weeks lacking TGF-β expression. 
IH 
IH 
*
*
* * 
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7.04 Discussion 
 
This study examined for the first time the reendothelialization process after endovascular 
PDT of the rat iliac artery using aminolaevulinic acid (ALA). The pace and extent of endothelial 
cell (EC) regrowth is assumed to be of major importance in the vascular healing process [9] 
because lack of EC regrowth is believed to contribute to arterial narrowing [19]. For effective 
vascular PDT, a small area of uninjured vessel wall should be included in the treatment field to 
prevent ingrowth of smooth muscle cells from the edges [20].This study shows that PDT did not 
impair the reendothelialization process after balloon injury. In all groups, there was a rapid 
reendothelialization with complete EC regrowth at 6 weeks. As reported earlier, PDT effectively 
inhibited IH in this study, whereas intimal hyperplasia (IH) developed in the control BI group, as 
expected in this model [4, 21]. Apparently, the development of IH at the dehiscence in the 
lamina and the rate or the extent of EC regrowth was not related in this model. It may be relevant 
in this regard, that fibrin deposition and proteoglycan accumulation was seen at the 
microruptured sites of the basal and elastic lamina of the BI+PDT treated vessels, instead of IH 
in the BI only treated vessels.  
An earlier report described an incomplete reendothelialization of the balloon injured 
carotid artery (1-year follow-up) dependent on the length of denudation [8]. As compared to the 
carotid artery, there are more vasa vasorum in the tunica media and tunica adventitia in the iliac 
artery, which may affect the rate and extent of reendothelialization via transport of cytokines, 
chemokines and cells involved in the stimulation of EC growth. Comparisons with other studies 
related to reendothelialization in the rat iliac after BI could not be done, because of lack of exact 
reference models. 
Because of the important role of TGF-β in regulating EC growth [22], we examined the presence 
of TGF-β after BI and after BI+PDT. Immediately after BI, there was an increased expression of 
TGF-β at the inner border of the tunica adventitia along the external elastic lamina. After 3 
weeks, TGF-β expression remained high, but was seen at the outer border of intimal hyperplasia 
along the internal elastic lamina in the tunica media. PDT did not affect this pattern of TGF-β 
expression immediately after injury, but inhibited the expression of TGF-β after 3 weeks. This is 
in contrast with our previous in vitro study where the acute release of TGF-β by SMCs was 
inhibited after 100 J/cm2 PDT [20], but was increased with a subtherapeutic dose of 10 J/cm2, 
TGF-β activity. The present study indicated that PDT with 100 J/cm dl did not inhibit the acute 
release of TGF-β. It may well be that the different photosensitizer used in these studies may have 
been of influence. The photosensitizer chloroaluminum tetrasulfonated phtalocyanine (CASPc) 
used previously binds mainly to proteins in the extracellular matrix [23], while ALA induced 
intracellular formation of the photosensitiser protoporphyrin IX.  
After 3 weeks, TGF-β expression at the outer border of intimal hyperplasia along the 
internal elastic lamina in the tunica media in the BI only group was still high. This persistent 
staining of TGF-β was not seen in the BI+PDT groups. This finding may be explained by the 
eradication of SMC in the tunica media of the BI+PDT group with only partial repopulation at 4 
weeks [11]. However, it can not be excluded that differences in SMC function between the 
repopulating SMC’s in the BI+PDT groups and proliferating SMC’s in the BI group account for 
this phenomenon.  
In contrast to the inhibitory effects of TGF-β on EC regrowth as described by Madri et 
all, the present study did not demonstrate a relation between TGF-β and EC growth [22]. 
However, we demonstrated here that the expression of TGF-β is far distant from the tunica 
intima. Therefore, it is conceivable that TGF-β can not exert its action there. 
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The fact that TGF-β was absent at 3 weeks after endovascular ALA-based PDT, while 
still present in the BI group, emphasises that PDT affects the vascular healing response in 
multiple ways. A recent study from our group described the prevention of constrictive 
remodelling of the iliac artery after endovascular ALA-based PDT [7]. It is tempting to speculate 
that the rapid down regulation of TGF-β expression plays an important role in the inhibitory 
effect of PDT on constrictive remodelling. 
In conclusion: In this study, it was demonstrated that reendothelialization of the denuded 
iliac artery did not differ between BI and BI+PDT groups. The development of IH was not 
related to the pace and the extent of reendothelialization. Additionally, TGF-β appeared not to be 
directly involved in reendothelialization but its down regulation may be of crucial importance in 
the PDT dependent remodelling. 
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8.00 Abstract 
Background: Endovascular Photodynamic Therapy (PDT) prevents intimal hyperplasia 
following angioplasty. How PDT exerts this beneficial effect is unknown. Since the 
inflammatory reaction plays a role in the wound healing of the injured artery, we questioned if 
PDT affected the inflammatory response. Therefore, we studied the accumulation of leukocytes 
in the artery after treatment.  
Materials & Methods: Rats were divided into 2 main groups. 1.The BI, BI+LO 50 J/cm dl and 
BI+LO 100 J/cm dl groups served as reference. 2. The experimental BI+PDT groups were 
illuminated with fluences of either 50 or 100 J/cm diffuser length (dl). The rats were sacrificed 
after either 2 hours or 16 weeks. 
Results: Directly after procedure, more leukocytes (mean 309±82 cells/section: 94% neutrophils; 
18% mast cells; 6% T-cells; 1% monocytes) were found in the reference groups than in the 
experimental groups (mean 155±19 cells/section: 22% neutrophils; 13% mast cells; 65% T-cells; 
1% monocytes)  (p<0.05). After 16 weeks, a significant decrease was seen in all groups, but still 
more leukocytes 49±12 cells/section (18% neutrophils; 16% mast cells; 56% T-cells; 5% 
monocytes) were present in the reference than in the experimental groups; 16±3 cells/section 
(35% neutrophils; 50% mast cells; 16% T-cells; 6% monocytes) (p<0.05). The IH after 16 weeks 
was significantly less in the BI+PDT groups compared to the BI+LO groups. 
Conclusion: Endovascular PDT modifies the inflammatory response after BI. The decrease of 
the influx of neutrophils into the vessel wall may be one of the mechanisms underlying the 
inhibition of late lumen loss by PDT after vascular intervention. 
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8.01 Introduction 
 
Arterial injury-induced restenosis after dilation of a stenotic or occluded artery decreases 
the long-term success rate to 70 or even 50% [1].  
In the development of restenosis, the inflammatory response to arterial injury plays a crucial role 
[2]. This response begins with the recruitment neutrophils and monocytes [3]. These leukocytes 
play an ambiguous role at the injured site, and precede the influx of T-cells.  
On the one hand, the neutrophils and monocytes eliminate redundant necrotic arterial 
tissue and apoptotic cells by phagocytosis. On the other hand, the growth of smooth muscle cells 
and the subsequent deposition of extracellular matrix is stimulated via the release of cytokines.  
Apparently, these processes are often misbalanced, which leads to fibrocellular stenosis [4].  
The first cells to arrive at the lesion site in the vasa vasorum of the tunica adventitia are 
neutrophils [5;6]. It has been reported that an excessive influx of neutrophils and of activated 
monocytes after arterial injury is related to late lumen loss [3;7], whereas T-cells are related to 
medial fibrosis [8].  
A successful experimental-adjuvant strategy to prevent restenosis is vascular 
photodynamic therapy (PDT)[9-13]. It has been shown that this preventive potential of PDT is 
partly based on the selective killing of excessively proliferating smooth muscle cells (SMC) and 
partly on structural modifications of the extracellular matrix [14]. This is induced by the 
generation of highly cytotoxic oxygen radicals upon illumination of a photosensitizer that has 
accumulated within these cells or in the matrix (15;16). 
Since the accumulation of leukocytes at the lesion site of the vascular wall is directly 
related to arterial stenosis, inhibition of the inflammatory reaction by PDT may underlie the 
beneficial effect of this treatment modality as well. It could be possible that by decreasing the 
number of vasa vasorum in the tunica adventitia, PDT hampers the entry of the inflammatory 
cells into the lesion. 
Therefore, the effect of endovascular PDT after balloon injury was assessed on the 
number and type of infiltrating leukocytes including mast cells in the tunica intima, tunica media 
and tunica adventitia. Furthermore, the effect of PDT on the vasa vasorum in the tunica 
adventitia was studied as well.  
 
 
8.02 Materials & methods 
8.02.1 Rats  
The experimental protocol was approved by The Committee on Animal Research of the 
Erasmus University of Rotterdam and complied with “Principles of Good Laboratory Practice”. 
Male inbred Wistar rats (Harlan CPB, Austerlitz, The Netherlands) weighing 200-300 g were 
used. The animals had free access to rat chow (AM ΙΙ, Hope Farms, Woerden, The Netherlands) 
and tap water acidified to pH 4.0, while maintained in a 12-hr light/dark cycle.  
8.02.2 Study design  
Fifty rats were randomly assigned to 2 main groups, in which arterial damage was 
induced via standard balloon injury (BI) of the right common iliac artery (17).                                                 
The references consisted of the groups BI (n=10), BI+ light only (LO) at 50 J/cm diffuser length 
(dl) (n=10) and BI+LO at 100 J/cm dl (n=10). In the experimental groups BI+PDT at 50 J/cm dl 
(n=10) and BI+PDT at 100 J/cm dl (n=10), aminolaevulinic acid (ALA) was administered 2½ hr 
before BI, followed by endovascular illumination with fluences of either 50 or 100 J/cm diffuser
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 length (dl). The animals were sacrificed after either 2 hr (n=5 per group) or 16 weeks for 
perfusion-fixation of the artery. Transverse sections were evaluated by light microscopic 
planimetric analysis. 
8.02.3 Photosensitization  
The PDT groups received iv 200-mg/ kg ALA (Sigma-Aldrich Chemie, Zwijndrecht, The 
Netherlands) dissolved in phosphate buffered saline at 40 mg/ml of pH 7.45. The solution was 
freshly made for each animal and kept from light exposure. The photosensitised rats were kept in 
the dark 2½ hr prior to surgery until 12 hr after the operation to prevent uncontrolled 
phototoxicity. 
8.02.4 Laser  
A dye laser (600 Series Dye Module, Laserscope, Surgical Systems, San Jose, CA, USA), 
pumped by a 532/KTP  surgical laser (Laserscope, Surgical Systems, San Jose, CA, USA), was 
used to generate monochromatic light of 633 nm. The power emitted from the cylindrical 
diffusing tip (core diameter 200 µm, outer diameter 1.0 mm, tip length 20 mm: LightsticTM, 
Cardiofocus, West Yarmouth, MA, USA)[18] was calibrated with an in-built power meter, and 
verified with an external linear diffuser in an integrating cylindrical sphere (Optometer Model 
370, Graseby Optronics, Orlando, FL, USA). A spectroscope (WaveMate, Coherent, Auburn, 
CA, USA) was used to verify the accuracy of the wavelength. Temperature and linear fluence 
measurements in the arterial wall were performed in an earlier study for optimal PDT effect 
determination. In this study only the irradiance and fluences were calibrated.   
    
8.02.5 Balloon injury  
A median laparotomy was performed under general anaesthesia with intramuscular 
injection of ketamine (Ketalar, Parke Davis and Co., Inc., 40 mg/kg) and xylazin (Rompun Bayer 
Ag, Leverkusen, Germany; 5 mg/kg). Subdued light using a yellow filter (620-650 nm Kodak) 
was applied during the procedure [19]. The right common iliac artery was cranially and caudally 
temporarily occluded with vascular clamps (Haemostat B1, Stöpler, Utrecht, The Netherlands). 
To create a blood free lumen, the arteries were flushed with 1.0-ml heparin (50 IU/ml 0.9 % 
NaCl, Infusion solution Baxter) through an arteriotomy 5 mm cranially from the abdominal 
aortal bifurcation. Then, a balloon catheter (Fogarty arterial embolectomy catheter, 2 F, 60 cm, 
Baxter BV, Utrecht, The Netherlands) was inserted and inflated to 2.0 bar with a manometer 
(Basix25TM, Medioterm, USA) and deionised water [20]. A right iliac artery section of 15 mm 
from the bifurcation was damaged by inflating the balloon distally from the bifurcation. Then, 
after simultaneously pulling and rotating at 120° towards the bifurcation, the balloon was 
deflated at the end of the section. This procedure was consecutively performed 3 times. Then, in 
the BI+LO and BI+PDT groups, endovascular illumination was performed.  A single suture in 
the vascular sheet marked the middle of the denuded area. After flushing the lumen with heparin 
and a two layer closing (interrupted 9-0 prolene sutures) of the arteriotomy, both the caudal and 
the cranial clamp were removed. Directly thereafter, reperfusion of the dilated section was 
observed. The abdominal wall was closed in two layers (continuous 2-0 prolene sutures).  
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8.02.6 Endovascular Photodynamic Therapy (PDT)  
 
In the BI+LO and BI+PDT groups, a 400-µm fibre (Lightstic 360, Rare Earth Medical 
Inc., West Yarmouth, MA, USA) with a 20 mm long cylindrical diffusing tip was applied 
immediately after BI(18). The fibre tip was centred endovascularly in the denuded area to 
illuminate 15 mm of the damaged and 5 mm of the untreated arterial wall both cranially as 
caudally. Because of the cylindrical illumination, the fluence was expressed in Joule per cm 
diffuser length (J/cm dl). The target area was illuminated at a fluence rate of 100 mW/cm2. After 
treatment, the lumen was thoroughly flushed with 1ml heparin solution (50 IU/ml). Abdominal 
organs were protected from light exposure with a light absorbing plastic folium during 
illumination. The animals recovered in the dark after treatment  
 
8.02.7 Specimen handling  
 
A standard perfusion-fixation procedure via the thoracic aorta was performed under ether 
anaesthesia, in which the lumen was flushed with PBS (pH 7.45) for 2 min, followed by a 
perfusion of 10 min with formaldehyde (3.7 %) at 100 mm Hg. The distally marked segment of 
15 mm was carefully harvested after length measurement and stored in formaldehyde (3.7 %) for 
at least 24 hr. Thereafter, the specimens were embedded in paraffin. Three cross sections of 10 
µm each were cut with a microtome from distal to proximal at 3, 5 and 10 mm, mounted on a 
microscopic object slide and stained for conventional light microscopy. All mounted sections 
were video taped with a digital camera for histologic analysis. Perivascular arteriole and 
inflammatory cells in the tunicas intima, media and adventitia were counted at 400x 
magnification. The tunica adventitia was defined as 2 microscopic fields from the external elastic 
lamina. A digital video analyser system (IBM Corp., Boca Raton, USA) was used for the 
assessment of the absolute intimal area in mm2.  
 
8.02.8 Immunohistochemistry staining of pan-leukocytes 
 
Following dehydration and paraffin embedding, sections of 4 µm thick were cut and stained for 
CD-45 (OX-1, Serotec MCA 43 R) using the following protocol: Firstly, the sections were fixed 
with acetone for 10 min and air dried for 15 min at 37°C. With a Peroxidase-Anti-Peroxidase 
(PAP) pen circles were drawn around the tissue sections and washed with PBS three times. Then, 
the endogenous peroxidase activity was blocked with 0.05 % H2O2 in PBS for 15 min and rinsed 
three times with PBS. After preincubation of the sections for 15 min with 0.1 % normal rabbit 
serum, diluted (1:1000) mouse-anti-rat CD-45 antibody was added for an incubation period of 60 
min in humidified atmosphere. Importantly, we found that CD45 of Santa Cruz (35-Z6: sc-1178) 
was only suitable for FACS analysis of rat leukocytes, but not for their detection in paraffin 
embedded sections. Next, the sections were rinsed with PBS for three times, incubated with 
secondary rabbit-anti-mouse antibody for 30 min and again rinsed three times with PBS. Di-
amino-benzidin Substrate-Chromogen solution (DAB) was added and sections were incubated 
for 5-15 min. Rinsing with water for 5 min stopped the DAB-reaction.  The sections were put in 
Mayer’s haematoxylin for 40 sec, rinsed and shortly kept in an ammonia-solution. Next, the 
sections were stepwise dehydrated using a series of 70 %, 90 % and 100 % ethanol, followed by 
a xylene step. Then, the sections were covered with a coverslip for examination using a light 
microscope. The intensity of the depositions / expression in the arterial samples was scored 
blindly via quantitative analysis.  
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8.02.9 Staining of polymorphonuclear neutrophils and of mast cells  
 
For identifying the neutrophils and mast cells, we used the staining method according to 
Leder. In short, the sections were deparaffinated, dehydrated using xylene, graded alcohols, 
rinsed with tap water, and finally one time with destilled water. Next, the sections were 
incubated in freshly made Leder solution (solution A: 1 drop 4 % pararosaniline, 1 drop 4 % 
sodium nitrite diluted with 30 ml Veronal buffer pH 7.2, acidified to pH 6.3 with 2M 
hydrochloric acid, mixed with solution B: 0.1M sodium Veronal and 10 mg of naphtol-AS-D-
chloroacetaat in 2 ml dimethyl formamide) for 30 min at 37°C, followed by rinsing with tap 
water for 10 min.  The sections were incubated in Mayer haematoxylin for 5 min, followed by 
rinsing with tap water and next, the sections were covered with a drop IMSOL (IP). After being 
air-dried at 37°C, the sections were covered with PERTEX. 
 
8.02.10 Staining of pan-T cells 
 
We used a CD-3 antibody (Serotec MAR, CD-3, MCA 772) for pan-T cell staining 
according to the same protocol as for the CD-45 staining. The marker stained T-helper cells and 
cytotoxic T-cells only. 
 
8.02.11 Staining of monocytes  
   
For identifying the monocytes the specific esterase 1 staining according to Ornstein was 
performed. In short, the sections were deparaffinated with xylene, graded alcohols and rinsed 
with tap water and next, the fixed sections were incubated for 25 min with freshly made Ornstein 
solution (Solution A: 0.8 ml of 1 g Basic Fuchsin in 30 ml 2M HCl with 0.8 ml of 1 g NaNO2 in 
30 ml water acidified after 30 sec with 4 ml 0.40 M sodiumcacodylate, was added to 15 ml 
destilled water and 0.15 ml of 10 % Tween 20. Then A was mixed with Solution B: 2 ml of 260 
mg naphtylbutyrate in 50 ml dioxane was added to 3 ml methanol and diluted with destilled 
water to 50 ml). After staining with Giemsa for 4 min, the sections were covered with PERTEX.  
We found that detection of rat monocytes using CD-20 of Santa Cruz (C-20:sc-7733) and of 
Serotec (MAR ED-1: MCA 341 R) was not possible in paraffin embedded sections, but only by 
FACS analysis. 
 
8.02.12 Statistical analysis                     
 
The area of intimal hyperplasia (IH) was expressed as mean ± standard error of the mean 
(SEM). The mean area of IH was compared using a paired Student’s t-test. Differences between 
the means of the number of leukocytes in the tunica intima, tunica media and tunica adventitia, 
their differential counts, i.e. neutrophils, mast cells, T-cells and monocytes, and the numbers of 
arteriole were evaluated for significance using a General Linear Multivariate analysis. A 
difference was considered to be significant at a p-value of less than 0.05. 
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8.03 Results  
 
All rats were healthy during the study and no side effects of phototoxicity were seen after 
ALA application. Eosinophils and basophils were not detected in any tissue under study. 
 
8.03.1 Tunica intima 
 
Immediately after BI, the mean number of leukocytes was 1.4±0.4 cells per section in the 
BI group, 1.6±0.81 cells/section in the BI+LO 50 J/cm dl group and 0.4±0.24 cells/section in the 
BI+LO 100 J/cm dl group <Fig.8.1a>. After 16 weeks, a significant, but small increase to 
5.17±2.56 cells/section in the BI and to 10±6.16 cells/section in the BI+LO 50 J/cm dl was seen 
(p<0.05). The number of leukocytes remained at 0.4±0.24 cells/ section in the BI+LO 100 J/cm 
dl after 16 weeks <Fig.8.1a>.  Immediately after the procedure and after 16 weeks, no leukocytes 
with the exception of sporadic leukocytes were seen in the tunica intima of the sections of the 
BI+PDT 50 J/cm dl and of the BI+PDT 100 J/cm dl groups <Fig.8.1a>. Directly after BI  the 
leukocytes mainly consisted of neutrophils, while sporadic mast cells, T-cells and monocytes 
were seen after 16 weeks <Fig.8.2a>. Directly after PDT and after 16 weeks, only some T-cells 
were seen.  
With regard to the development of IH after 16 weeks, the mean IH area in the BI group of 
0.21±0.05 mm2 was significantly (p<0.05) higher than the mean area IH of 0.07±0.03 mm2  that 
occurred in the BI+PDT groups. 
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Figure 8.1a A bar diagram representing the amounted number of neutrophils (stripes), mast  
cells (white) , T-cells (black) and monocytes (gray) per section plotted against the control  
groups: control, LO and PDT at 2 hrs and at 16 weeks, in the tunica intima. 
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8.03.2 Tunica media 
 
Immediately after BI, BI+LO 50 J/cm dl and BI+LO 100 J/cm dl, there were no 
leukocytes in the tunica media with exception of 3.0±1.10 cells/section in the BI+LO 50 J/cm dl 
group <Fig.8.1b>. After 16 weeks, respectively 1.0±0.45 (BI), 0.8±0.58 (BI+LO 50) and 0.4±0.4 
cells/section (BI+LO 100) were seen <Fig.8.1b>. No leukocytes were observed in the BI+PDT 
50 J/cm dl or BI+PDT 100 J/cm dl groups immediately after PDT and 16 weeks thereafter   
<Fig.8.1b>. The few leukocytes present in the tunica intima of the BI, BI+LO 50 J/cm dl or 
BI+LO 100 J/cm dl groups after 16 weeks, showed that they were neutrophil or T-cell 
<Fig.8.2b>.  
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Figure 8.1b A bar diagram representing the amounted number of neutrophils (stripes), mast  
cells (white), T-cells (black) and monocytes (gray) per section plotted against the control  
groups: control, LO and PDT at 2 hrs and at 16 weeks, in the tunica media. 
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8.03.3 Tunica adventitia 
 
In the tunica adventitia the number of leukocytes directly after BI, BI+LO 50 or BI+LO 
100 J/cm dl was high and amounted to respectively 340±89, 181±68 and 406±89 cells/ section. 
After 16 weeks significantly less leukocytes were present in those groups, respectively 84±31, 
30±3 and 33±3 cells/section. Immediately after PDT using 50 J/cm dl (BI+PDT 50 J/cm dl 
group) the number of leukocytes amounted to 205±28 cells/section, which were similar in the 
respective BI+LO group. However, after PDT using 100 J/cm dl 104±9 cells/ section were 
present in the tunica adventitia, which is about a factor 4 less than in the respective BI+LO group 
<Fig.8.1c>. After 16 weeks the number of leukocytes in both BI+PDT groups significantly 
decreased to 16±3 and 16±2 cells/section <Fig.8.1c>.  
Directly after BI, BI+LO 50 J/cm dl and BI+LO 100 J/cm dl, the infiltrate mainly existed of 
neutrophils amounting to respectively 313±90 (92%), 153±71 (81%), 393±97 (98 %) per section, 
and decreased to 29±5 (34%), 3±2 (10%), 3±1(9 %) per section respectively after 16 weeks 
<Fig.8.1c>. In the experimental groups, the number of neutrophils was much smaller. Directly 
after BI+PDT 50 and 100 J/cm dl respectively only 49± 26 (24%) and 20± 7 (19%) per section 
were present, but this number decreased after 16 weeks to 11± 2 (69%) and 0 per section 
<Fig.8.1c>. 
The number of mast cells directly after BI, BI+LO 50 J/cm dl and BI+LO 100 J/cm dl was small, 
respectively 6±1(2%), 11±5 (6%) and 7±1 (2 %) per section. Those numbers did not change 
much after 16 weeks and were respectively 4±2 (5%), 7±2 (23%), 7±1(21 %) per section. The 
number of mast cells directly after PDT using 50 and 100 J/cm dl was slightly higher than after 
BI+LO, being 15±7 (7%) per section respectively, and 20±1 (19%), and after 16 weeks 4±1 
(25%), 12±2 (74%) per section.  
The number of T-cells directly after BI, BI+LO 50 J/cm dl and BI+LO 100 J/cm dl was 
respectively 20±7 (6%), 21±2 (11%), 5±1(1 %) per section and remained at that level after 16 
weeks, respectively 53±27 (42%), 19±1 (63%) and 21±2 (64 %) per section <Fig.8.1c>.  
The numbers of T-cells directly after PDT using 50 and 100 J/cm dl were much higher than after 
BI+LO, respectively amounting to 142±11 (69%), 63±6 (61%) per section, and after 16 weeks 
decreased to only 1±0.4 (6%), 4±2 (25%) per section <Fig.8.1c>. 
The number of monocytes directly after BI, BI+LO 50 J/cm dl and BI+LO 100 J/cm dl was 
respectively 2±1 (1%), 4±1 (2%), 1±0.2 (0%) per section and after 16 weeks 5±3 (6%), 1±0.2 
(3%), 2±1(6 %) per section. The number of monocytes directly after PDT using 50 and 100 J/cm 
dl was 0 and 2±1(1 %) and after 16 weeks 1±0.4 (6%), 1±0.2 (6%) <Fig.8.1c>.
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Figure 8.1c A bar diagram representing the amounted number of neutrophils (stripes), mast  
cells (white), T-cells (black) and monocytes (gray) per section plotted against the control  
groups:control,LO and PDT at 2 hrs and at 16 weeks, in the tunica adventitia. 
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8.03.4 Vasa vasorum in the tunica adventitia 
 
The number of vasa vasorum (vv) in the tunica adventitia directly after the procedure 
<Fig.8.2> was significantly higher (p<0.011) in the reference groups compared to the 
experimental groups.  In the BI, BI+LO 50 and BI+LO 100 J/cm dl groups there were 
respectively 12±5, 16.8±3.4 and 13.4±2.2 vv/section compared to the BI+PDT groups having 
respectively 4.17±1.4 (50 J/cm dl) and no vv/section (100 J/cm dl). However, after 16 weeks, the 
number of vasa vasorum increased significantly in all groups (p<0.001) and did not differ 
between the treatments anymore, i.e. in the reference groups (25-36 vv/section) and in the 
experimental groups (28-31 vv/section). 
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Figure 8.2 A bar diagram representing the number of vasa vasorum in the tunica  
adventitia plotted against the control group: control, BI and PDT 100 at 2 hours and  
at 16 weeks. The error bars are standard error of the mean (SEM: n=5 per time- 
point). 
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8.04 Discussion 
 
In this study, we evaluated the effect of endovascular aminolaevulinic acid (ALA) based 
photodynamic therapy (PDT) on the inflammatory response in a standard balloon injured (BI) 
artery to find an explanation for the earlier reported inhibitory effect of PDT on the occurrence 
of intimal hyperplasia after interventions [13;21].  
The major findings of this study were a significant decrease in accumulation of 
neutrophils and a significant increase of T-cells in the tunica adventitia directly after balloon 
injury (BI) followed by PDT compared to BI (+light only), whereas after 16 weeks, the T-cells 
were significantly reduced compared to the reference groups. 
In the reference BI groups, neutrophils accumulated in the tunica intima, tunica media 
and particularly in the tunica adventitia 2 hours after treatment, preceding the accumulation of T-
cells and monocytes in the tunica media and tunica adventitia after 16 weeks. These observations 
support the classic pattern of inflammatory cell accumulation in response to arterial injury that 
has earlier been described [3]. It is not unlikely that these neutrophils enter the lesion via the 
tunica intima, but due to the high shear stress of the blood in the iliac artery permeable vasa 
vasorum in the tunica adventitia offer a much easier entry site. This is indicated by the increased 
accumulation of neutrophils in the tunica adventitia.  
Most interestingly, in our study, we found that upon endovascular PDT less neutrophils 
accumulated in the tunicas intima, media, and adventitia, than after BI only.  
The inhibition of the accumulation of neutrophils by PDT may underlie the prevention of intimal 
hyperplasia and fibrocellular constriction of the media as shown earlier using antibodies against 
neutrophil adhesion receptors [22]. Wilson et al. described that antibodies against the neutrophil 
membrane receptor CD18 reduced myocard damage [23]. That study may indicate the 
importance of neutrophil adhesion in the development of dysplastic intimal hyperplasia. 
It is not clear, how PpIX based-PDT prevented the entry of neutrophils into the lesion. Recently, 
it has been shown that the permeability of the tunica layers decreased after PDT due to cross-
linking of [14] extracellular matrix proteins [24]. It may well be that by this PDT dependent 
phenomenon, the accumulation of neutrophils into the vessel wall is hampered. 
Another remarkable finding in this study is the slight increase in the number of mast cells 
in the tunica adventitia directly after PpIX-based PDT. Interestingly, because mast cells are 
involved in hypersensitivity reactions [25;26]. Once activated, mast cells secrete TNF-α, 
chemokines and anti-coagulant heparines to prevent anti-thrombin III- induced coagulation. 
However, heparin is also a well-known inhibitor of smooth muscle cell proliferation [27;28].  
We showed here a relatively fast and strong T-cell accumulation after PpIX based-PDT 
following BI. Interestingly, it has been reported that the amount of T-cells is related to the 
amount of medial fibrosis [8]. An in vitro study regarding experimental autoimmune 
encephalomyelitis described the unique potential of T-cells to penetrate strong basal membranes 
in contrast to other leukocytes [29]. Since we indeed found less other leukocytes in the vessel 
wall, this indicates that a strengthening of the arterial wall underlies the altered inflammatory 
reaction after PDT of the balloon-injured artery.  
Relatively few monocytes were present in the tunicas of the arterial wall, after both BI (+LO) 
only as BI followed by PDT. The decrease in IH after PDT therefore does not likely reside in 
those phagocytes.  
Upon PDT, the number of [13] vasa vasorum in the tunica adventitia decreased. We do not know 
if increased thrombogenicity, luminal collapse or constriction causes this decrease. It is likely 
that a decrease in the number of vasa vasorum will hamper the entry of inflammatory cells into 
the balloon-injured lesion. Indeed, we found that the number of vasa vasorum was inversely 
associated to the number of leukocytes in the tunica adventitia after injury.  
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In conclusion, this study underlines the importance of the tunica adventitia in the 
development of dysplastic intimal hyperplasia. The role of the tunica adventitia in that process 
had earlier been described by Okamoto in a balloon injured porcine coronary artery model [5], 
by Völker in a copper-induced rat carotid artery model [30], and by Yutani studying de novo 
caused by stents in patients [31]. By strengthening the matrix of the vessel wall and transiently 
decreasing the number of vasa vasorum, PDT specifically inhibits the accumulation of 
neutrophils in the tunicas intima, media and adventitia. Since it is generally accepted that 
neutrophils promote IH, the prevention of the accumulation of these cells into the injured vessel 
wall may be one of the mechanisms by which PDT after vascular intervention favours a 
beneficial clinical outcome. 
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9.00 Abstract 
 
Background: Vascular photodynamic therapy (PDT) inhibits intimal hyperplasia induced by 
angioplasty in rat iliac arteries by eradicating the proliferating smooth muscle cells. This process 
may jeopardise the structure and strength of the arterial wall,  reflected by a decreased bursting 
pressure.  
Materials & Methods: Thirty male Wistar rats of 250-300 g were subdivided into 3 groups 
(n=10). In all groups intimal hyperplasia was induced by balloon injury (BI). One experimental 
group received PDT at 50 J/cm diffuser length, the other group at 100 J/cm diffuser length. The 
third group served as control group and received no PDT. In half of each group the bursting 
pressure was analysed after 2 hours (n=5),in the other half after one year. 
Results: Two hours after the procedure the bursting pressure was 3.37±0.58 (±SEM) bar in the 
BI+PDT 50 and 3.96±0.43 bar in the BI+PDT 100 group, compared to 2.20±0.27 bar in the BI 
group (p<0.05). After 1 year these values were 3.18±0.87 bar in the BI+PDT 50 (p<0.05) and 
2.02±0.31 bar in the BI+PDT 100 group, compared to 2.10±0.30 bar in the BI group (NS). In the 
BI+PDT 100 group 3 out of 5 rats appeared to have aneurysmal dilatation after one year.   
Conclusion: Endovascular PDT increases the arterial wall strength as measured by the bursting 
pressure at short-term. After one year, wall strength is not diminished as measured by bursting 
pressure, but aneurysmal dilatation nevertheless developed with 100 J/cm dl. This may limit the 
use of high energy PDT.
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9.01 Introduction 
 
Restenosis due to intimal hyperplasia (IH) and constrictive remodelling decreases the 
long-term success rates of therapeutic vascular interventions for recanalisation of stenotic or 
occluded arteries. The incidence of this complication varies between 30 and 50% within 6 
months [1], which is still an unfavourable therapeutical outcome that needs to be improved.  
In the patho-etiology of restenosis, an excessive proliferation of smooth muscle cells 
(SMC) after arterial injury leading to IH plays a major role [2]. Remodelling is another important 
factor [3;4]. The exact contribution of SMCs in the development of constrictive remodelling 
remains to be elucidated, but various preventive studies showed that the elimination of these 
SMCs prevent or inhibit restenosis [5-10].  
An adjuvant strategy to prevent restenosis may be the use of photodynamic therapy 
(PDT), a modality based on the light induced cytotoxicity of a light sensitive substrate 
(photosensitizer) that accumulates in the SMCs of the arterial wall after oral or intravenous 
administration (photosensitization) [11;12]. 
Since the first unsuccessful PDT based dose-finding study with Photofrin reported in 
1985 [13], the search to find the optimal protocol in PDT studies to prevent restenosis was 
initiated [14]. Despite the following successful inhibition of IH using this first generation 
photosensitizer, its use was limited by systemic side effects of photocytotoxicity. This led to the 
development of second generation photosensitizers like phtalocyanines [15-17]. These 
photosensitizers are easily absorbed in arterial tissue but with less systemic side effects. 
However, lipophilic photosensitizers are only activated at high energy levels and are not really 
tissue specific. 
In 1995 the first reports with the pro-drug aminolaevulinic acid (ALA) proved to be 
successful in the prevention of IH without systemic side effects [18-20] and therefore resulted in 
the first clinical application [21]. ALA is a naturally occurring intermediate of the heme 
biosynthetic pathway, which is artery type- and tissue-dependently metabolised to the 
photosensitizer protoporphyrin IX [22].  
It became clear that the dose of the photosensitizer, the timing of illumination, the energy level 
and the type of artery are important parameters to determine the therapeutical outcome.     
However, the direct and long-term effect of PDT induced SMC elimination on the 
structure of the arterial wall as a safety measure for this strategy is unknown. In this study, the 
bursting pressure of BI and PDT treated arteries was determined to study the strength of the 
arterial wall directly after the procedure and one year later. 
 
 
 
 
 
 
 
                                                                                                                         Chapter 9                 
  135  
9.02 Materials & methods 
The experimental protocol was approved by The Committee on Animal Research of the 
Erasmus University of Rotterdam and complied with “Principles of Good Laboratory Practice”. 
Male inbred Wistar rats (Harlan CPB, Austerlitz, The Netherlands) weighing 200-300 g were 
used. The animals had free access to rat chow (AM ΙΙ, Hope Farms, Woerden, The Netherlands) 
and tap water, while maintained in a standard 12-hr light/dark cycle.  
9.02.1 Study design 
Thirty male Wistar rats of 250-300 g were subdivided into 3 groups (n=10). In all groups 
intimal hyperplasia was induced by balloon injury (BI) in the right common iliac artery. One 
experimental group received PDT at 50 J/cm diffuser length using endovascular laser 
illumination at 2 ½ hr after the administration of ALA, the other group at 100 J/cm diffuser 
length. The third group served as control group and received no PDT. In half of each group the 
bursting pressure was analysed after 2 hours (n=5), in the other half after one year. 
9.02.2 Photosensitization 
The PDT groups received 200 mg/ kg ALA (Sigma-Aldrich Chemie, Zwijndrecht, The 
Netherlands) intravenously dissolved in phosphate buffered saline at 40 mg/ml. The solution was 
freshly made for each animal and kept from light exposure. The photosensitised rats were kept in 
the dark during 2 ½ hr prior to treatment and 12 hr afterwards to prevent skin reactions from 
photosensitivity. The time interval after ALA administration is based on a previous study, where 
we found that at that time point the accumulation of the photosensitive compound 
protoporphyrin IX became maximal. 
9.02.3 Laser  
A dye laser (600 Series Dye Module, Laserscope, Surgical Systems, San Jose, CA, USA), 
pumped by a 532/KTP  surgical laser (Laserscope, Surgical Systems, San Jose, CA, USA), was 
used to generate monochromatic light of 633 nm. The power emitted from the cylindrical 
diffusing tip (core diameter 200 µm, outer diameter 1.0 mm, tip length 20 mm: LightsticTM, 
Cardiofocus, West Yarmouth, MA, USA)[23] was calibrated with a built-in power meter, and 
verified with an external linear diffuser in an integrating cylindrical sphere (Optometer Model 
370, Graseby Optronics, Orlando, FL, USA). A spectroscope (WaveMate, Coherent, Auburn, 
CA,USA) was used to verify the accuracy of the wavelength.  
Temperature 
       The real-time temperature during endovascular PDT was checked at 100 mW/cm dl for 16 
minutes and 40 seconds (100 J/cm dl) to exclude high-energy induced hyperthermal effects 
instead of low-energy induced phototoxicity. Two fibre-optic thermosensors with a diameter of 
0.5 mm were coupled to a Luxtron thermometry unit (Luxtron Corp., Santa Clara, CA, USA). 
One was approximated parallel to the laser fibre along the artery at an axial distance of 10 mm in 
the fibre tip and the other next to the rat. The temperature was determined every second. 
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Linear fluence calibration with an isotropic probe 
     The linear fluence of 100 J/cm dl from the cylindrical diffuser in the arterial wall was 
measured at an irradiance of 100 mW/cm dl (illumination time of 1000 seconds). An isotropic 
probe was approximated parallel to the laser fibre outside the artery at axial distances of 10 mm 
from and 0, 10 and 20 mm in the fibre tip. 
9.02.4 Surgical technique 
A median laparotomy was performed under general anaesthesia with intramuscular injection of 
ketamine (Ketalar, Parke Davis and Co., Inc., 40 mg/kg) and xylazin (Rompun Bayer Ag, 
Leverkusen, Germany; 5 mg/kg). Subdued light using a yellow filter (620-650 nm Kodak) was 
applied during the procedure to prevent a photodynamic reaction caused by the operating lamp 
[24]. The right common iliac artery was cranially and caudally temporarily occluded with 
vascular clamps (Haemostat B1, Stöpler, Utrecht, The Netherlands). To create a blood free 
lumen, the arteries were flushed with 1 ml heparin (50 IU/ml 0.9% NaCl) infusion solution 
(Baxter) through an arteriotomy 5 mm proximal to the abdominal aortic bifurcation. The artery 
was then only balloon injured in the control group and BI +PDT was performed in the 
experimental groups (see Balloon injury and Endovascular Photodynamic Therapy). Hereafter, 
the clamps were removed. Reperfusion of the dilated section was observed directly after flushing 
with heparin and closing the arteriotomy (interrupted 9-0 prolene sutures). The abdominal wall 
was closed in two layers (continuous 2-0 prolene sutures). The animals recovered in subdued 
light after treatment. 
 
9.02.5 Balloon injury 
 
A 2F Fogarty embolectomy catheter (Baxter Health Care Corp., Edward’s Div., Irvin, 
Ca., USA) was inserted to denude the arterial wall at a pressure of 2 bar (manometer, Baxter, 
USA) by pulling and rotating the insufflated balloon from distally to proximally over a 15-mm 
long segment for 3 successive times [25]. The balloon was desufflated proximally and 
insufflated distally. Then, the arteries were flushed with 1ml heparin solution, closed with 
Prolene 8-0 and marked halfway the denuded segment with a suture.  
 
 
9.02.6 Endovascular Photodynamic Therapy (PDT) 
 
In the PDT group, a 400 µm fibre (Lightstic 360, Rare Earth Medical Inc., West 
Yarmouth, MA, USA) with a 20 mm long cylindrical diffusing tip was applied. The fibre tip was 
centred endovascularly in the denuded area to illuminate 10 mm of the balloon damaged arterial 
wall and 5 mm of the untreated arterial wall both cranially and caudally. Because of the 
cylindrical illumination, the fluence was expressed in Joule per cm diffuser length (J/cm dl). The 
target area was illuminated at random with 50 (n=5) or 100 J/cm dl (n=5), applied with a fluence 
rate of 100 mW/cm dl. After treatment, the lumen was thoroughly flushed with 1 ml heparin 
solution. Abdominal organs were protected from light exposure with a light absorbing plastic 
folium during illumination.  
 
9.02.7 Bursting pressure 
 
The bursting pressure was determined in situ. A 2F cannula was fixed proximally in the 
iliac artery with Vicryl 6-0. At 15 mm distally, the segment was occluded with Vicryl 4-0. The 
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cannula was connected with a T-piece to an analog pressure transducer (WIKA type Ecotronic) 
coupled to a converter module matrix. The intra-luminal pressure was gradually increased by 
pushing a glycol solution (Sigma-Aldrich 5000 MW, 5 g/ml 0.9% NaCl) into the sealed arterial 
segment via the cannula using a syringe with pressure manometer. Simultaneously, the intra-
luminal pressure was digitally displayed on the video screen. The pressures at which the tunica 
media became transparent due to compression, and at which the tunica adventitia bursted were 
recorded on S-VHS for analysis <Fig. 9.1>. Just before bursting, the arterial diameter (AD) 
expressed in mm was determined from the digital images using a scale bar as reference. 
 
 
 
 
Figure 9.1 A schedule representing the model to determine the bursting pressure of the treated right iliac 
artery as illustrated in the photograph <1>. The 2F sheet is linked to a pressure manometer and a 
pressure transducer coupled <2> to a converter module matrix 3>. The analog voltage signal 
evoked by the pressure is converted to digits in the video screen. These digits are integrated in the  
display of the bursting pressure analysis using an A/D converter and synchronize separator <1-
4>. This signal is incorporated using a video mixer and for tracing a second video mixer <5>. For 
recording the output of the second video mixer is connected to a S-VHS system <6>.  The 
incorporated signal is displayed on a monitor and digitally converted using a computer <7> and 
CD <8>.
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9.02.8 Histopathology  
 
After the measurement of the bursting pressure the iliac artery was removed and 
processed for histopathological analysis. The arteries were fixed in formalin, cross-sectioned and 
embedded in paraffin. 4 µm sections were cut and stained with H&E and Elastic von Gieson. 
 
9.02.9 Statistical analysis  
 
The presence of aneurysmal dilatation after treatment was analysed using a Fisher’s exact 
test. The bursting pressure was expressed as mean ± standard error of the mean (SEM).  
ANOVA with a Dunnett’s correction was used to compare the experimental means with the 
means of the control group. ANCOVA was used to study if the arterial diameter (AD) has a 
significant effect on the outcome of the bursting pressure. A difference was considered to be 
significant at p values less than 0.05.  
 
9.03 Results 
 
Two rats of the BI+PDT 50 group died directly after the procedure and were excluded 
from further analysis. All other rats appeared healthy after treatment without significant weight 
loss or skin phototoxicity during the experiments. In all groups, after 52 weeks macroscopic neo-
vascularization in the fascia covering the treated arterial area was seen in contrast to 0 weeks 
<Fig.9.2>.  
 
Figure 9.2 Photograph a shows the fascia covering the iliac artery before the procedure. Photograph b shows 
the increased neo-vascularization in the fascia covering the treated iliac artery seen after 52 
weeks in the treated groups. Here an iliac artery treated at 50 J/cm dl using a fluence rate of 100 
mW/cm dl. 
 
 
Strikingly, 3 out of 5 rats of the BI+PDT 100 group developed an aneurysmal dilatation 
at the proximal site of the PDT treated segment after 52 weeks of which one developed a distally 
occluded segment <Fig. 9.3>. The fluence of 100 J/cm dl had a significant effect on the 
development of the aneurysmal dilatation (p<0.03). The temperature in the arterial wall did not 
increase during illumination and the light fluence was distributed homogenously in the arterial 
wall (20).
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Figure 9.3  A photograph showing the developed aneurysm like dilatation after 52 weeks in the proximal 
segment of the PDT treated iliac artery at 100 J/cm dl using a fluence rate of 100 mW/cm dl. 
Bursting pressure digits are given in the photograph. 
 
 
 
9.03.1 Bursting pressure of the tunica adventitia 
 
The bursting pressure of the tunica adventitia at 2 hours after the procedure was 
2.20±0.27 bar in the control group, compared to 3.37±0.58 bar in the BI+PDT 50 group 
(*:p<0.05) and compared to 3.96±0.43 bar in the BI+PDT 100 group (**:p<0.05). The bursting 
pressure of the tunica adventitia at 52 weeks was 2.10±0.30 bar in the control group compared to 
3.18±0.57 bar in the BI+PDT 50 group (†:p<0.05) and to 2.02±0.31 bar in the BI+PDT 100 
group (NS) <Fig. 9.4>.  In general, the tunica media got compressed and became transparent in 
all groups at a pressure of between 0.22 and 0.46 bar. 
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Figure 9.4 A bar diagram representing the mean bursting pressure expressed in bar at which the tunic 
adventitia ruptures. The control group, BI+PDT 50 and BI+PDT 100 group is plotted against the 
time at 2 hr and 52 weeks (n=5 per time-point).  The error bars are standard errors of the mean 
(SEM). 
 
 
9.03.2 The arterial diameter (AD) 
 
After 1 year, the AD just before the bursting pressure had increased significantly in the 
BI+PDT 50 (1.89±0.04 mm) and 100 group (2.58±0.14 mm) compared to the control group 
(1.42±0.03 mm) (p<0.05) <Table 9.1>. The AD did not significantly correlate with the mean 
bursting pressure (c:-0.33, p<0.12). 
 
Groups  
     2 hours  
Arterial
SEM 
Diameter in mm  
    52 weeks 
 
SEM 
Control 1.24± 0.15  1.42± 0.03 
BI+PDT 50 1.19± 0.11  1.89± 0.04 
BI+PDT 100 1.07± 0.13  2.58± 0.14 
      
 
Table 9.1 The mean arterial diameter in mm at 2 hours and after 52 weeks in respectively the control group, 
the BI+PDT 50 J/cm dl group and the BI+PDT 100 J/cm dl group (n=5 per group for each time-
point). 
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9.03.3 Histopathology 
 
In the BI group after 2 hours only slight disruption of the internal area of the vessels was 
seen. In addition, in both the BT+PDT50 and 100 group, the tunica media became partly 
acellular <Fig. 9.5a>. The most striking difference was seen after 52 weeks. Intimal hyperplasia 
was much more prominent in the BI+PDT100 group than in the BI group <Fig.9.5b>. However, 
the BI+PDT50 group showed no intimal hyperplasia at all. In all groups fragmentation of elastic 
laminae occurred <Fig. 9.5c1>, but the amount of elastin seemed larger in the PDT groups  
<Fig. 9.5c2>. Quantitative assessment was not possible with the techniques used. Rupture of the 
elastic layer with development of aneurysmal dilatation was seen in the PDT100 group  
<Fig. 9.5d>. 
 
a.      c1.      c2. 
 
Figure 9.5  Photograph a shows the partial acellularity in the tunica media at 50 J/cm dl after 2 hours at a 
magnification of 200. 
Photograph b shows focal intimal hyperplasia at 100 J/cm dl at a magnification of 200 after one 
year. 
Photograph c1 shows a fragmentation of elastin in the tunica media at 50 J/cm dl after 2 hours at 
a magnification of 400. An increased density of elastin is shown in photograph c2 at a 
magnification of 400 in the same group. 
Photograph d shows an aneurysmal dilatation in the PDT group at 100 J/cm dl after one year at a 
magnification of 100. 
 
b.  d.
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9.04 Discussion 
 
Vascular PDT, intended to inhibit intimal hyperplasia, eliminates proliferating smooth 
muscle cells resulting in a temporary acellular arterial wall [20;26]. A concern of this method is 
the potential formation of aneurysmal dilatation due to weakening of the arterial wall. This 
would limit the application of PDT as a measure to inhibit IH. 
Grant et al. reported that external PDT with a fluence of 100 J/cm2 and a fluence rate of 
150 mW/cm2, did not reduce the arterial wall strength in the carotid artery of rabbits at a follow-
up of 21 days using a similar method of measuring, despite of an acellular tunica media [26].  
In our study we found that the means of the bursting pressure in all groups were above 
the normal physiological range (1.0-1.5 bar). The bursting pressure increased significantly at 2 
hours after BI+PDT, both at 50 J/cm diffuser length (dl) and 100 J/cm dl. After 52 weeks, the 
bursting pressure was significantly increased in the BI+PDT 50 J/cm dl group compared to the 
control and BI+PDT 100 J/cm dl group. Apparently, a fluence of 50 J/cm dl increased the arterial 
wall strength permanently.  
The increase in arterial wall strength shortly after 100 J/cm dl was transient and after one 
year aneurysmal dilatation developed in this treatment group. This indicates that the light dose 
for endovascular PDT is limited to a value between 50-100 J/cm dl.  
But how can the increase in bursting pressure of the arterial wall be explained after 
endovascular PDT ? Statius van Eps et al. suggested that PDT induces clustering or cross-linking 
of various protein components in the extracellular matrix, which seals the damaged vascular wall 
[20]. In a chicken microvascular in vivo model it was also found that ALA based PDT led to an 
increased deposition of collagens in the arterial wall [27;28]. Furthermore, experiments in rats 
with methylene blue based PDT showed post treatment a significant increase of the amount of 
procollagen type I in the vascular wall, which may strengthen the blood vessel wall [29].  
An important enzyme of the normal arterial healing response is lysyl oxidase that cross-
links (tropo)collagens, fibrils and elastin,  and is located in cellular lysosomes and in the 
extracellular matrix [30-33]. An earlier report described that high laser light output inhibited this 
particular enzyme in arteries [34]. However, relatively low energy PDT may activate this 
particular enzyme to induce an increased cross-linking of matrix proteins. In this manner, the 
vascular PDT-modified healing may form a barrier for smooth muscle cell migration preventing 
the development of IH [35].  
While that latter phenomenon could be beneficial, a possible disadvantage of the vascular 
PDT-modified healing is that the arterial contractility might be lost. However, the low fluence 
used in the present study enabled the repopulation of SMCs in the tunica media and tunica 
adventitia as reported in our earlier study [20]. Furthermore, we found that at long-term follow-
up endovascular PDT at 50 J/cm dl resulted in arterial dilatation and at 100 J/cm dl even to an 
increase in the mean arterial diameter with a factor 2, leading to aneurysmal proportions.  
Histopathologically, it seems that the amount of IH development is inversely related to 
bursting pressure after 52 weeks, with prominent IH in the BI+PDT100 group and no IH in the 
BI+PDT50 group. This could be due to unequivocal distribution of pressure forces at the arterial 
wall. In vivo this is probably also reflected by the occurrence of aneurysmal dilatation in the 
BI+PDT100 group. Histopathologically it is not clear how the differences in bursting pressure 
after 2 hours can be explained. The only histological difference after 2 hours was the partial 
acellularity in the vascular wall of the PDT groups. 
A relative limitation of the open liquid-based bursting pressure set up used in this study, 
is the difficulty of fixing the cannula waterproof. However, the location of ruptures at the origins 
of vasa vasorum in the tunica adventitia in the treated artery could accurately be detected, which 
can easily be overlooked in models using a balloon catheter for detection of bursts in the tunica 
adventitia.
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In our model, a transient ischemic period was obtained during PDT as similar to the 
clinical practice of balloon angioplasty and endarterectomy. A relative bloodless environment is 
necessary to avoid excessive absorption of the laser light by hemoglobine that would prevent 
light penetration into the vascular wall. This would result in an unpredictable photodynamic 
effect.  
We conclude that PDT at 50 J/cm dl increases the arterial wall strength, maximal wall 
diameter and lumen diameter permanently in a rat IH model. However, high fluences (100 J/cm 
dl) promote the development of aneurysmal dilatation. Therefore, the therapeutic window of 
high energy endovascular PDT is limited.  
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10.00 General discussion 
 
Vascular diseases leading to stenosis of arteries are the primary cause of mortality 
particularly in the elderly population of the western society [1;2]. The experienced discomfort by 
patients during the progression of stenosis, depends on the localization and the severity of the 
stenosis in the arterial network [3-5]. Most of these patients are impaired in their daily activity 
and suffer from symptoms caused by insufficient blood perfusion. If stenosis progresses and the 
symptoms become unbearable for the patient, vascular interventions are indicated [6].  
In the present clinical policy to treat vascular diseases, a vascular intervention is usually 
performed at stenosis rates of more than 50%. The overall success rate of these vascular 
interventions is between 50 to 90% at long-term (>6 months) [7].  
Unfortunately, an unwanted side effect after present vascular interventions is the 
development of restenosis in 30 to 50% within 6 months [8]. This complication impedes the 
overall success rate and needs to be prevented to improve the outcome of the treatment.  
In this thesis, we evaluate endovascular photodynamic therapy as an adjuvant therapy to 
prevent restenosis in order to improve the outcome of the vascular treatment. 
 
10.01 What do we presently know about restenosis? 
 
It is well-known that denudation, overstretching and anastomoses stitches trigger 
restenosis [9-11], but the mechanism how restenosis develops is still not well-understood.  
Typically, ‘the cellular and extracellular synthetic repair mode’ of the arterial healing 
response to injury, has difficulties with fine-tuning to the local and systemic hemodynamic 
requirements [12-17]. This arterial healing response is characterized by 5 phases: 1. the 
hyperacute phase of complement activation; 2. the acute phase of platelet aggregation; 3. the 
intermediate phase of leukocyte infiltration; 4. the phase of cellular proliferation and migration, 
and 5. the chronic phase of cellular and extracellular remodelling.  
A logic deduction is that the arterial healing response on one hand depends on the type of 
artery and arterial injury or pathology and on the other hand on the quality of the local and 
systemic compensatory mechanisms.  
Despite the detection of numerous molecular interactions throughout these phases, the 
hierarchy in the cascade of events remains to be unraveled in order to find the key target to 
prevent the development of restenosis. In Chapter 3 we have validated a rat model to study the 
potential of endovascular PDT as adjuvant therapy of vascular interventions for the prevention of 
restenosis. 
 
10.02 Why did we use the rat model? 
 
We used a rat model for its usefulness in fundamental studies, the ease to handle the 
animals in the laboratory setting, the existing information on studies in rats and the relative low 
costs. 
 Furthermore, we questioned what artery of the rat would be most suitable to evaluate the 
effects of endovascular PDT. Our challenge was to develop a model in a larger vessel to enable 
endovascular PDT with the existing laser fiber. Other questions we dealt with were: Does 
standardised arterial injury induce intimal hyperplasia and constrictive remodelling? Does the 
‘arterial response to standardised injury’ differ between central and peripheral arteries? And if 
so, will the artery type determine the way to apply PDT? 
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Remarkably, we found a more excessive accumulation of cells and extracellular material 
in the peripheral arteries than in the central arteries after standardised balloon injury [18]. 
Apparently, restenosis developed more easily in the peripheral arteries than in central arteries. 
With regard to the peripheral arteries after standardised injury, restenosis in the carotid artery 
consisted of mainly dysplastic intimal hyperplasia, while in the iliac artery the IH was 
accompanied by constrictive remodeling. Taken the larger initial lumen diameter of the iliac 
artery and its response to injury, this model suited best to evaluate endovascular PDT. 
These findings indicated the differences in the arterial healing between the various 
arteries that have to be considered in the expected (calculated) outcome after vascular PDT. In 
other words, the effects of the various PDT dose regimes likely depends on the artery type. 
Taken together, PDT may be more effective in peripheral arteries than in central arteries, given 
its important effect on inhibiting IH. The present rat model of standardised balloon injury of the 
iliac artery appears suitable to evaluate the effect of endovascular photodynamic therapy on 
dysplastic intimal hyperplasia and constrictive vascular remodelling. 
 
10.03 What do we know about the photosensitizer accumulation in the arterial wall? 
 
In Chapter 3 we observed differences in the response to injury between artery type. Next, 
we questioned if the artery type would determine the accumulation of the photosensitizer in the 
arterial wall.  
As shown, in Chapter 4 the time-intervals for endovascular illumination did not differ 
significantly between the peripheral and central arteries. However, the maximal amount of PpIX 
that accumulated in the vascular wall depended on the artery type.  More PpIX was formed in 
peripheral arteries than in central arteries by a lesser mitochondrial content. This contradiction 
may be explained by our preliminary finding that central arteries contain relatively large 
mitochondria of which the surface to volume ratio will be smaller than the mitochondria of the 
peripheral arteries. Since two crucial enzymes that catalyze the final formation of PpIX are 
located at or in the lipid surface of the mitochondria, i.e. coprogen oxidase and 
protoporphyrinogen oxidase, the mitochondrion of the central arteries may not be able to 
generate much PpIX. Alternatively, the activity of these enzymes may be lower in analogy of the 
imbalance between two other enzymes in the heme synthetic pathway. Thus, the absence of 
detectable PpIX concentrations in the thoracic aorta but detectable coproporphyrinogen 
concentrations are indicative for a lower coproporphorinogen oxidase activity in this central 
artery type. The ALA dosage should be determined depending on the artery type involved. 
 An optimal time interval of 2-3 hours between the administration of ALA and the 
maximal PpIX generation was found.  
 
10.04 How does the corresponding normal artery of the validated model respond to PDT? 
 
Given the validated model of Chapter 3 and the corresponding time-interval of the 
photosensitizer accumulation as described in Chapter 4, we questioned in Chapter 5 what light 
dose is necessary for effective PDT in the normal artery.These experiments prelude the 
experiments based on the prevention of restenosis. 
We found that light doses lower than 50 J/cm dl at 100 mW/ cm dl caused none to partial 
eradication of photosensitised cells, while light doses higher than 50 J/cm dl induced eradication 
of the tunica media. After 16 weeks, the tunica media was completely repopulated without the 
development of dysplastic intimal hyperplasia. Thus, endovascular ALA-PDT of the normal 
artery eradicates the cellular content of the tunica intima and tunica media without a significant 
intimal hyperplasia. What role the eradication of the tunica media has in the prevention of 
intimal hyperplasia remains to be studied.
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10.05 Does PDT prevent the development of restenosis? 
 
To answer this crucial question we applied the conclusions of Chapter 3, 4 and 5 in 
designing a vascular PDT protocol. We questioned what the effective light dose would be in a 
balloon-injured blood vessel. Furthermore, we wondered if PDT at this effective light dose 
would effect the hemodynamic regulation system, namely the nerve innervation of the arteries.  
In Chapter 6 we showed that PDT prevented restenosis at light doses higher than 50 J/cm 
dl. Remarkably, PDT resulted in a slight arterial dilation after 4 weeks without any dysplastic IH 
or constrictive remodeling. The innervation, which regulate arterial constriction and dilation, was 
not morphologically effected after PDT. After 16 weeks, the tunica media was completely 
repopulated. The question if the intercellular synapses in the tunica media were damaged after 
PDT and if the innervation of the tunica media was functionally impaired remained unanswered.  
Adjuvant endovascular ALA-PDT to balloon injury prevents the development of dysplastic 
intimal hyperplasia and of the constrictive remodelling. Remarkably, a light dose dependant 
vessel enlargement was found. 
These promising results with vascular PDT in inhibiting dysplastic IH and constrictive 
remodeling, bear many questions about the crucial step of the arterial healing response that was 
tackeled by PDT.  
 
10.06 What do we know about mechanisms of restenosis prevention by vascular PDT? 
 
Strikingly, inhibition of the excessive arterial healing response by PDT, appears to be 
achieved by the complete eradication of smooth muscle cells in the vascular lesion. Given the 
many indications from the literature that smooth muscle cell proliferation is inhibited upon 
reendothelialization of the vascular wall, we questioned whether increasing the rate of 
reendothelialization is an additional mechanism of PDT in the prevention of restenosis.  
In vitro studies showed that PDT induced cross-linking of proteins in the extracellular 
matrix which may strengthen the extracellular matrix of the treated artery [20-21] and inhibit the 
repopulation of the lesion. An important enzyme in that respect could be lysyl oxidase [22-27], 
that facilitates the cross-linking between collagen and elastin. We hypothesized that PDT inhibits 
transforming growth factor beta (TGF-β)  which plays an important role in the regulation of 
cellular and extracellular matrix synthesis. 
In Chapter 7 we found that the time of complete reendothelialization between PDT- and 
untreated balloon-injured  vessels did not differ. Thus, adjuvant endovascular ALA-PDT to 
balloon injury does not affect the rate of reendothelialisation at the lesion site. Remarkably, the 
cytokine TGF-β was only temporarily upregulated in the tunica adventitia after PDT in contrast 
to the sustained high expression after balloon injury only. Adjuvant endovascular ALA-PDT to 
balloon injury down-regulates the increased expression of TGF-beta upon arterial injury.The 
expression of TGF-beta in the arterial is associated with the development of dysplastic intimal 
hyperplasia and the development of constrictive remodelling.  
This important finding may indicate that TGF-β plays a key role in the exagerated 
vascular repair. It has been shown that TGF-β can stimulate the synthesis of lysyl oxidase [29]. 
Thus, TGF-β may promote the natural cross-linking of collagen and elastin in the lesion. 
However, if the expression of TGF-β decreases the subsequent decrease in activity of lysyl 
oxidase, it will inhibit the abundant synthesis of collagen as seen in arterial restenosis [27-28]. 
Obviously, further study is needed to clarify the relevance of this issue for PDT. 
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10.07 What is the role of the inflammatory response after vascular PDT? 
 
Normally, in the restenosing artery an inflammatory response is seen, which is 
characterised by a massive influx of leukocytes particularly into the tunica adventitia. Therefore, 
we questioned which is the effect of endovascular PDT on the inflammatory response to injury. 
We found in Chapter 8 that upon vascular PDT, less neutrophils, but more T-cells and 
mast-cells were seen in the tunica adventitia. Interestingly, T-cells infiltrate into ‘collagen rich or 
hyperdense fibrocellular areas’. Thus, these cells may be a marker for strengthening of the 
injured arterial wall.  
Shortly after PDT the number of vasa vasorum decreased. By strengthening the tunica 
media of the vessel wall and transiently decreasing the number of vasa vasorum, PDT probably 
inhibits the accumulation of neutrophils into the arterial wall. Since it is generally accepted that 
neutrophils promote IH, this may be one of the mechanisms by which PDT achieves a benifical 
clinical outcome of the vascular intervention.  
Thus, adjuvant endovascular ALA-PDT to balloon injury decreased the accumulation of 
neutrophils at the lesion site which are known to promote IH, by a transient decrease in the 
number of vasa vasorum. 
 
10.08 What do we know about the strength of the arterial wall after vascular PDT? 
 
The eradication of the tunica media may weaken the arterial wall with the consequence of 
aneurysm formation at long-term. We therefore studied the effect of PDT on the strength of the 
arterial wall. 
In Chapter 9 we found that on the contrary PDT resulted in an immediate strengthening 
of the arterial wall at high light doses and, in Chapter 7, we found fibrin-like-cross-links at the 
site of ruptured elastic laminae after PDT.  
After a follow-up of 1 year, PDT at the therapeutic light dose range of 50 to <100 J/cm dl 
still had a positive effect on wall strength. However, a light dose of 100 J/cm dl at 100 mW/cm 
dl resulted in an aneurysmatic dilatation of the treated artery. Unfortunately, we presently can 
not a solid explanation why PDT using high fluences led to a weakening of the vessel wall at 
long-term.  
 
10.09 What are the disadvantages of our model? 
 
A major disadvantage of our model is that it is focused on the injured healthy artery and 
not on the complex atherosclerotic artery with rigid plaques. It can be exspected that the reaction 
of the atherosclerotic plaques to PDT will be far more complex. This merits further study of the 
suitability of PDT treatment in other models.  
 
10.10 Which photosensitizer do we use in vascular PDT?  
 
In general, hydrophilic photosensitizers may diffuse in healthy tissue and are effective to 
modulate the ‘healthy’ arterial healing response after PDT [30].  
The use of ALA induced PpIX as described in Chapters 3-8 proved to be effective in the 
prevention of dysplastic IH in a peripheral rat iliac artery after standardized balloon injury.  
It is likely that this approach will work in patients as well, but as shown in this thesis, the 
therapeutic window will be narrow and artery type specific. 
As the sole treatment of atherosclerotic lesions a successful outcome is less likely: 
Jenkins and colleagues treated the femoro-iliac arteries of 7 patients in this way, but probably 
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their treatment was only partially effective because of bad vascularisation of the rigid plaques 
[31]. 
 However, in rigid lipid rich plaques, lipophilic photosensitizers like chloro-aluminium 
phtalocyanines (CASPc) [19;32-34] and texaphorins (Antrim)[35-36] may be absorbed more 
easily and may be more effective to modulate the ‘pathologic’ arterial healing response. These 
lipophilic photosensitizers are developed to target the plaques and the macrophages in the 
plaques, but they face the problem of a non-homogenous distribution and absorption in the 
arterial plaques and arterial tissue. Obviously, the one ideal photosensitizer is still not available. 
 
10.11 What type of illumination is preferable in vascular PDT?  
 
To illuminate the injured vessel there are two options: externally or endovascularly. In 
external illumination a fibre-tip for spatial divergent illumination is positioned above the tunica 
adventitia of the arterial lesion. The use of an external reflective mirror under the artery is a 
prerequisite for circumferential illumination of the artery. It should be taken into account that an 
important part of the light energy will dissipate via erythrocytes in the circulation because the 
blood flow is not interrupted during external illumination [37].  
 
In endovascular illumination a transparent cylindrical diffuser fibre-tip for homogenous 
illumination is endovascularly positioned within the transparent PTA balloon at the arterial 
lesion. The inflated balloon causes a relative bloodless environment at the illumination site thus 
preventing the unwanted loss of light energy.  
 
10.12 What timing do we use in vascular PDT?   
 
Presently, the timing to illuminate the PpIX-photosensitized artery in vascular PDT is 
based on the fundamental 2-step concept as described in Chapter 1 at which the fluorescence 
level is maximal [30;38-42].  
Our studies suggest an effective threshold concentration of photosensitive intermediates 
at which IH is inhibited, but at which the fluorescence level is not necessarily ‘maximal’. 
Apparently, the timing of vascular PDT does not only depend on the time-point at which the 
concentration of the photosensitizer in the treatment area is maximal, but on the magnitude of the 
light dose as well. Indeed, the reports of Nyamekye and colleagues [43] and Kipshidze and 
colleagues support these findings [44].  
 
10.13 What are the future goals? 
 
The experimental results described in this thesis and other studies give a solid basis for a 
phase II clinical trial to evaluate the potential role of ALA-PDT in inhibiting vascular restenosis 
after PTA or surgical procedures of peripheral arteries.  
The clinical challenge is nonetheless to prevent restenosis and to treat atherosclerotic 
plaques. 
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11.00 Summary 
 
1. General introduction. 
 
The concept of photodynamic therapy is based on the local use of light and a 
photosensitive substrate to generate free reactive radicals. These reactive radicals cause local 
cytotoxicity. The use of photodynamic therapy in the field of vascular medicine has been 
derived from the field of oncology and dermatology in treating hyperproliferative disorders. 
A review of vascular photodynamic therapy and the relevant physics of photodynamic 
therapy are given. The development of restenosis after vascular interventions to treat stenosis 
in (cardio) vascular diseased patients remains a problem, because it compromises the success 
rates of vascular interventions. A baseline problem of restenosis development is the 
unraveled patho-etiology. Presently, restenosis development is considered as a ‘response-to-
injury’ and a ‘reactive-adaptive remodelling’ of the vascular wall. The difficulty for the 
strategies of vascular interventions to prevent restenosis, is to find the key target in the 
complex multifactorial arterial healing response. Promising results in the prevention of 
dysplastic intimal hyperplasia are obtained by using vascular photodynamic therapy. 
 
2. Aims and study outline 
 
3. A rat model for the evaluation of endovascular techniques to prevent 
restenosis. 
 
In this chapter, reference models of standardized balloon injury in peripheral arteries, the 
right common carotid artery and the right common iliac artery and in a central artery, the 
abdominal aorta, were compared for the validation of a rat model to evaluate endovascular 
photodynamic therapy to prevent restenosis. The requirements for the suitability of the rat 
model were significant late lumen loss, significant dysplastic intimal hyperplasia, significant 
constrictive remodelling and reproducibility. In this study, rats underwent a standard balloon 
injury of 15 mm length at 2.0 bar in the carotid-, iliac artery and abdominal aorta.  After 16 
weeks, late lumen loss was 0.49±0.07 mm, 0.22±0.07 mm and 0.07±0.10 mm in respectively 
the carotid-, iliac artery and abdominal aorta (p<0.05). Dysplastic intimal hyperplasia was 
0.14±0.08 mm2, 0.14±0.03 mm2 and 0.12±0.04 mm2 in respectively the carotid-, iliac artery 
and abdominal aorta (p<0.001 vs 0 weeks and mutually NS). The constrictive remodelling 
was only detected in the iliac artery compared to the carotid and abdominal aorta. In this 
report we concluded that the standardized balloon injury resulted late lumen loss due to 
dysplastic intimal hyperplasia in the carotid artery, due to dysplastic intimal hyperplasia and 
constrictive remodelling in the iliac artery, and dilatory remodelling in the abdominal aorta. 
Apparently, the occurrence of late lumen loss is artery-type dependent. Therefore, the iliac 
artery appears to be most suitable artery to evaluate the effect of endovascular photodynamic 
therapy on dysplastic intimal hyperplasia and constrictive remodelling.       
 
4. Aminolaevulinic acid induced protoporphyrin IX pharmacokinetics: Optimum 
time interval of photosensitization for photodynamic therapy in peripheral and 
central arteries of the rat. 
 
In this chapter, the first prerequisite to perform endovascular aminolaevulinic acid (ALA) 
based PDT in the validated balloon injured iliac artery is photosensitization of the target 
artery. Therefore, this study focused on the pharmacokinetics of the conversion of ALA into 
protoporphyrin IX (PpIX) after its systemic application to determine the time-intervals of 
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maximal PpIX concentrations in the peripheral- and central arteries. The peripheral arteries 
were represented by the carotid-, renal-, iliac and femoral artery, and the central arteries by 
the thoracic- and abdominal aorta. In this study, rats underwent photosensitization after 
intravenous ALA administration at a dose of 200 mg/kg body weight.  At varying time-
points, respectively 0, 1, 2, 3, 6, 12 and 24 hours both peripheral and central arteries were 
isolated, homogenized and the PpIX concentration determined by a fluorometric extraction 
method. The time-interval of maximal PpIX accumulation after ALA administration was not 
significantly different in the peripheral and central arteries (2:09  vs 2:27  hours). The 
maximal PpIX concentrations in the peripheral arteries varied between 20.49±3.0 and 
24.0±7.5 pmol/mg protein and in the central arteries between 0 and 9.46±0.01 pmol/mg 
protein. The total protoporphyrin accumulation within 24 hours was significantly higher in 
the peripheral arteries than in the central arteries (p<0.007). This study demonstrated that as 
prerequisite for endovascular ALA based photodynamic therapy arteries should be 
illuminated between 2-3 hours after ALA administration if maximal photosensitizer 
concentrations are mandatory. 
 
 
5. The effect of endovascular aminolaevulinic acid-based photodynamic therapy 
on the normal rat iliac artery. 
 
In this chapter, the baseline histo-geometric effects of endovascular aminolaevulinic acid-
based photodynamic therapy (ALA-PDT) on the normal rat iliac artery were evaluated using 
the specifications of Chapter 4. This study described the normal arterial healing response  
that has to be taken into account when endovascular ALA-PDT as adjuvant strategy to 
endovascular balloon angioplasty is used during the treatment of the adjacent uninjured 
arterial segment next to the injured arterial segment. Rats underwent endovascular ALA-PDT 
at light doses of 12.5, 25, 50 or 100 J/cm dl at an irradiance of 100 mW/cm dl. As a result of 
endovascular ALA-PDT after 16 weeks, a negligible amount of intimal hyperplasia was seen 
with values of 0.01±0.007 mm2, 0.02±0.007 mm2, 0.01±0.006 mm2 and 0.02±0.009 mm2 at 
respectively 12.5, 25, 50 and 100 J/cm dl (NS). A fluence of 12.5-25 J/cm dl resulted in 
partial cellular erradication of the tunica media, while a fluence of 50-100 J/cm dl resulted in 
complete cellular erradication of the tunica media 3 hours after endovascular ALA-PDT. 
However, complete repopulation of the tunica media was seen without late lumen loss and 
constriction after 16 weeks. The observations in this study showed that endovascular ALA-
PDT only caused minor and transient damage to the normal iliac arterial wall that fully 
recovered within 16 weeks keeping its normal functions. 
 
6. Endovascular photodynamic therapy with aminolaevulinic acid prevents 
balloon induced intimal hyperplasia and constrictive remodelling in rat iliac 
arteries. 
 
      In this chapter, the effects of endovascular ALA-PDT adjuvant to balloon injury are 
reported on the development of dysplastic intimal hyperplasia and constrictive remodelling 
by elimination of smooth muscle cells in the tunica media and of elimination of endothelial  
      cells in the tunica intima. Additionally, the effect of endovascular ALA-PDT  
      on the cholinergic innervation of the tunica media was determined, because we  
      hypothesized that the presence of this innervation may be a prerequisite in the arterial  
      healing response for modulating the repopulation and re-configurating the tunica media.  
      The specifications for endovascular ALA-PDT adjuvant to balloon injury were derived  
      from Chapter 3, 4 and 5. Rats underwent at random either endovascular ALA-PDT 
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      adjuvant to balloon injury with a light dose of 12.5, 25, 50 or 100 J/cm dl at an irradiance     
      of 100 mW/ cm dl in the experimental groups or balloon injury with 0, 12.5, 25, 50 or 100   
      J/cm dl in the control groups. Planimetric analysis of the arterial cross-sections showed            
      negligible intimal hyperplasia of 0.02±0.02 mm2 after adjuvant endovascular ALA-PDT at  
     100 J/cm dl in the experimental groups, while significant intimal hyperplasia occurred of  
      0.28±0.12 mm2 and 0.27±0.12 mm2 in the balloon injury group respectively at 0 and 100  
      J/cm dl  at 16 weeks (p<0.05).  
      In the experimental endovascular ALA-PDT groups adjuvant to balloon injury, a light- 
      dose increase of a  factor 2 led to a decrease of intimal hyperplasia of 17.2% (p<0.05).  
      Constrictive remodelling remained absent in the experimental groups in contrast to the  
      control groups after 16 weeks. The staining of cholinergic innervation of the tunic media  
      of the blood vessel wall in the experimental groups was not decreased at the highest  
      fluence, indicating the preservation of the cholinergic innervation after endovascular  
      ALA-PDT. In this report we concluded that endovascular ALA-PDT prevents dysplastic  
      intimal hyperplasia and constrictive remodelling after balloon injury without damage of  
      cholinergic innervation of the tunica media. The effective light fluence rate in the rat is  
      50-100 J/cm dl. 
 
7. The effect of aminolaevulinic acid-based endovascular photodynamic therapy 
on reendothelialization after balloon injury of the rat iliac artery. 
 
            In this chapter, the effect of endovascular ALA-PDT on the reendothelialization of the   
      tunica intima during the arterial healing is evaluated because on one hand,  
      reendothelialization of the tunica intima is crucial to preserve laminar blood flow, and on  
      the other hand, it is a well-known inhibitor of intimal hyperplasia.  
      Furthermore, the effects of endovascular ALA-PDT upon balloon injury on the expression of  
      the multifactorial cytokine TGF-β, an important regulator of endothelial cell growth and   
      intimal hyperplasia development were studied.  
      Reendothelialization was detected by the exclusion of Evans Blue by the blood vessel (1)    
      and TGF-β expression by immuno-staining (2). In the experimental endovascular ALA-PDT  
      group upon balloon injury, endovascular illumination was performed with 50 J/cm dl  
      or 100 J/cm dl at an irradiance of 100 mW/cm dl. In the control group only balloon injury   
      was performed and untreated arteries served as base-line controls. We found a complete  
      reendothelialization at the lesion site after 3 weeks in the experimental and control groups  
      without a significant difference between the groups.  
      However, endovascular ALA-PDT upon balloon injury resulted in significant inhibition of  
      intimal hyperplasia and a modification of adventitial morphology as described in Chapter 6.   
      There was an immediate increase in the expression of TGF-β without significant differences  
      between the experimental and control groups.  Importantly, no TGF-β was detectable in the  
      experimental groups after 3 weeks in contrast to the control balloon injury group.  
             In this report we concluded that adjuvant endovascular ALA-PDT does not  
      significantly affect the rate of reendothelialization process in vivo. Besides inhibiting   
     dysplastic intimal hyperplasia, endovascular ALA-PDT reduced the increased expression of   
     TGF-β upon balloon injury, which may play a role in the favourable remodelling after         
     endovascular ALA-PDT as described in Chapter 6.  
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8. Endovascular photodynamic therapy altered the composition of leukocyte 
infiltrate in the arterial response to injury. 
 
                In this chapter, the effects of endovascular ALA-PDT upon balloon injury on the      
      inflammatory reaction in the vessel wall, described as phase 3 in Chapter1 is evaluated.  
      We assessed the number and type of leukocytes that accumulated in the rat iliac artery in the    
      experimental groups, treated with endovascular ALA-PDT using 12.5, 25, 50 or 100 J/cm dl  
      at an irradiance of 100 mW/cm dl after balloon injury and in the control groups with only  
      balloon injury.  
      Sixteen weeks after treatment,  statistically significantly fewer leukocytes of 28±4 were seen  
      in the experimental endovascular ALA-PDT groups than in the control balloon injury group  
      with 91±34 leucocytes (p<0.004). In the experimental group the leukocytes consisted of    
      20% neutrophils, 35% mastcells, 29% T-cells and 18% monocytes compared to  
      the control group with 31% neutrophils, 5% mastcells, 59% T-cells and 5% monocytes.  
      In this study we concluded that 1. Endovascular ALA-PDT after balloon  
      injury decreases the total number of leukocytes that enter the lesion site.  
      2. Endovascular ALA-PDT altered the composition of the inflammatory exudate after  
      balloon injury: it decreases the percentage neutrophils and  increases the percentage of  
      mastcells.  
 
9. Arterial strength after amino-laevulinic acid based endovascular 
      photodynamic therapy. 
 
              In this chapter, the effect of endovascular ALA-PDT adjuvant to balloon angioplasty on   
      the arterial wall strength and the local blood flow was evaluated with regard to the functional  
      quality of the treated arterial wall. In this study we determined the mean bursting pressure  
      of the artery and the local blood flow in the experimental groups with endovascular ALA- 
      PDT using 50 or 100 J/cm dl at an irradiance of 100 mW/cm dl upon balloon injury,  
      and in the control balloon injury only group. Two hours after the procedure the mean   
      bursting pressure in the experimental group was 3.37±0.58 bar at 50 J/cm dl and 3.96±0.43  
      bar at 100 J/cm dl, compared to 2.20±0.27 bar in the control group (p<0.05). After 1 year  
      these values were in the experimental groups 3.18±0.87 bar at 50 J/cm dl (p<0.05) and  
      2.02±0.31 bar at 100 J/cm dl (NS), compared to 2.10±0.30 bar in the control group.    
      Remarkably, in the experimental group at 100 J/cm dl 3/5 rats developed an aneurysm  
      proximally in the treated arterial segment. Apparently, endovascular ALA-PDT after balloon   
      injury increases the arterial wall strength as measured by the bursting pressure at short term  
      and at low fluence in longterm. However, at a fluence of 100 J/cm dl aneurysms formed after  
      1 year. The mean local flow in the treated artery was 5.02±0.09 ml/min and was not  
      significantly different between the experimental and control groups 3 hours after  
      intervention. After 1 year, the flow was significantly decreased in the experimental groups   
      compared to the control group due to dilational enlargement of the arterial segment.  In this  
      study we concluded that the light dose is crucial in endovascular ALA-PDT and should be  
      limited to 50 J/cm dl in this model to take full advantage of the beneficial effect of this  
      fluence on the characteristics of the treated blood vessel. 
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10. General discussion. 
 
In this chapter, the general concepts and challenges are discussed to prevent restenosis 
after vascular interventions by endovascular ALA-PDT.  
      Endovascular ALA-PDT is based at least two mechanisms : 1. The eradication of (hyper)  
      proliferative smooth muscle cells, and 2. Strengthening the arterial wall by the induction of  
      protein-protein cross links.  Since the patho-etiology of restenosis is characterized by two  
      phenomena, namely dysplastic intimal hyperplasia and constrictive remodelling, it is not  
      surprisingly that PDT is an effective treatment. 
      In Chapter 3, the role of the artery type in the arterial healing response after arterial injury  
      was described to illustrate the importance of the artery  
      type in restenosis prevention. Peripheral arteries appeared to be more prone to develop  
      restenosis by dysplastic intimal hyperplasia or constrictive remodelling than central  
      arteries. Indeed, the incidence of restenosis is higher in peripheral arteries than in central  
      arteries. Therefore, preventive measures are used more frequently in peripheral arteries.  
      The role of artery type for endovascular ALA-PDT in the conversion of ALA into the  
      photosenstive intermediate protoporphyrin IX (PpIX)was described in Chapter 4, in  
      which we concluded that the accumulation of PpIX was higher in the peripheral arteries  
      than in the central arteries. For effective endovascular ALA-PDT we hypothesized that the  
      criterion of maximal PpIX concentrations in the target artery is a favorable prerequisite.  
      Indeed, we reported in Chapter 5 and 6 promising results in the prevention of dysplastic  
      intimal hyperplasia and constrictive remodelling using this criterion, but the question what  
      threshold dose of PpIX or photosensitizer in general is required for effective ALA-PDT  
      remains to be studied. In our in vivo study described in Chapter 7, an important cytokine in  
      regulating the abundant synthesis of collagens occurring during restenosis was down  
      regulated after endovascular ALA-PDT. Furthermore, probably due to its decreasing effect  
      on the number of vasa vasorum in the tunica adventitia, a likely entry site of inflammatory  
      cells into the lesion site, the influx of leukocytes decreased in magnitude and changed into a  
      more favourable composition (less neutrophils, more T-cells) as was described and  
      discussed in Chapter 8. In Chapter 9 the importance of light-dose in  
      relation to the arterial bursting strength was described. It appeared that endovascular  
      ALA-PDT has a dilatory effect and results in aneurysms if too high light doses are used.  
      Therefore, the application of endovascular ALA-PDT bears some risk of complications if no  
       adequate dosimetry is taken into account. How to integrate endovascular ALA-PDT in the  
       prevention of restenosis in pathologic human arteries will depend on the predictability of the  
       arterial healing response under these circumstances. The issues with regard to the  
       complexity of the arterial healing response and the involved topics and challenges of  
       vascular photodynamic therapy have been discussed.  
 
11.  Summary 
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11.01 Samenvatting 
 
1. Introductie. 
 
Het fundamentele concept van fotodynamische therapie is gebaseerd op het gebruik van een 
locale lichtbron om een lichtgevoelig substraat in het doelgebied te activeren, hetgeen zal 
resulteren in de vorming van vrije radicalen. Deze radicalen zijn in principe cytotoxisch, 
hetgeen locaal zal leiden tot cel versterf. Het gebruik van fotodynamische therapie in het 
werkterrein van de vasculaire geneeskunde is afkomstig uit de oncologische en 
dermatologische hoek, waar fotodynamische therapie gebruikt wordt om kwaadaardige 
aandoeningen te behandelen. In dit hoofdstuk wordt een overzicht gegeven van het probleem 
restenose, de achtergrond van vasculaire fotodynamische therapie en de bijbehorende 
relevante fysische beginselen van fotodynamische therapie. 
Het slagen van een therapeutische vasculaire behandeling van ernstige vaatvernauwende 
aandoeningen bij patiënten met hart- en vaatziekten, wordt belemmerd door de ontwikkeling 
van een complicatie genaamd ‘restenose’. Restenose wordt gedefinieerd als het opnieuw 
ontstaan van een vaatvernauwing in het behandelde arteriële traject. Ten gevolge van 
restenose zullen deze patiënten wederom klachten ondervinden die worden veroorzaakt en 
uitgelokt door insufficiënte doorbloeding. Het een of meerdere malen herhalen van de 
belastende en dure therapeutische ingrepen is daarom vaak onvermijdelijk. Echter, het 
voorkomen van restenose is lastig gezien de onopgehelderde patho-etiologie van deze 
complicatie. 
Tot op de dag van vandaag worden twee hypothesen gebruikt om de ontwikkeling van 
restenose te verklaren, namelijk 1. de ‘response-to-injury’ hypothese die gestoeld is op de 
cellulaire en extracellulaire morfologische reacties na arteriële beschadiging en 
gekarakteriseerd wordt door de ontwikkeling van dysplastische intimale hyperplasie, en 2. de 
‘reactive-adaptive remodelling’ hypothese die beschrijft dat de locale en systemische 
hemodynamiek de uiteindelijke uitkomst van de arteriële genezingsresponse bepaalt welke 
gekarakteriseerd wordt door constrictieve remodellering. De ontwikkeling van deze twee 
hypothesen is niet verwonderlijk omdat intimale hyperplasie en constrictieve remodellering 
zowel afzonderlijk als in combinatie als reactie op vaatwandschade kunnen optreden. De 
moeilijkheid voor de te ontwikkelen strategieën om restenose te voorkomen is nu het vinden 
van een werkbare oplossing in deze complexe multifactoriële reacties van de arteriële 
genezingsrespons. De beschreven resultaten verkregen met vasculaire fotodynamische 
therapie hierbij zijn echter veel belovend.  
 
2. De doelstellingen en de indeling van deze dissertatie. 
 
3. Een validatie studie van ratten modellen voor de evaluatie van endovasculaire 
technieken om restenose te voorkomen.  
 
In dit hoofdstuk worden potentiële referentie modellen om restenose op te wekken na 
gestandaardiseerde ballon schade van de arteriële vaatwand in perifere en centrale arteriën 
met elkaar vergeleken  om te komen tot een gevalideerd ratten model voor de bestudering 
van de effectiviteit van endovasculaire fotodynamische therapie ter preventie van restenose. 
De vereisten waaraan dit ratten model aan moest voldoen waren een  significant verlies van 
de arteriële lumen diameter, de zogenaamde ‘late lumen loss’, een significante ontwikkeling 
van dysplastische intimale hyperplasie, een significante ontwikkeling van constrictieve 
remodellering, gedefinieerd als een afname van de arteriële vaatwand omtrek en luminale 
diameter, en uiteraard de reproduceerbaarheid van het model. In deze studie werden de 
  Chapter 11                 
  165  
arteria carotis communis, de arteria iliaca communis en de abdominale aorta van de ratten 
volgens een standaard protocol met behulp van een ballon opgeblazen tot 2.0 bar over een 
lengte van 15 mm. Na 16 weken was de diameter van het lumen van respectievelijk de arteria 
carotis communis, de arteria iliaca communis en de abdominal aorta 0.49±0.07 mm, 
0.22±0.07 mm and 0.07±0.10 mm kleiner, en de ontwikkeling van dysplastische intimale 
hyperplasie respectievelijk 0.14±0.08 mm2, 0.14±0.03 mm2 and 0.12±0.04 mm2 (p<0.001 vs 
0 weken en onderling NS). Constrictieve remodellering werd alleen gezien in de arteria iliaca 
communis. In dit rapport concludeerden wij dat de gestandaardiseerde ballonschade van de 
arteriële vaatwand resulteerde in vermindering van de luminale diameter in de arteria carotis 
communis ten gevolge van dysplastische intimale hyperplasie, in de arteria iliaca communis 
ten gevolge van dysplastische intimale hyperplasie en constrictieve remodellering, maar geen 
vermindering van luminale diameter in de abdominale aorta doordat de geringe intimale 
hyperplasie gecompenseerd werd door enige verwijdende remodellering. Klaarblijkelijk, is 
het verlies in luminale diameter afhankelijk van het type arterie. Het arteriële 
genezingsproces na beschadiging is dus afhankelijk van het vaat type in de rat. Voor ons 
onderzoek is de gestandaardiseerde ballonschade in de arteria iliaca communis dus het meest 
geschikt om het effect van endovasculaire fotodynamische therapie ter voorkoming van 
restenose te bestuderen. 
   
 
4. De farmacokinetiek van aminolevuline zuur geïnduceerde protoporfyrine IX in 
perifere en centrale arteriën van de rat. 
 
In dit hoofdstuk is de fotosensitizatie van de te behandelen arterie met behulp van de 
endogene heem metaboliet aminolevuline zuur (ALA) geevalueerd als eerste voorwaarde om 
endovasculaire fotodynamische therapie te verrichten. In het ontwerp van deze studie ligt de 
nadruk op de farmacokinetiek van de omzetting van systemisch toegediend ALA naar 
protoporfyrine IX (PpIX) om het tijdsinterval te bepalen waarbinnen de concentratie van 
PpIX in de vaatwand van een aantal perifere arteriën, zoals de arteria carotis communis, 
arteria renalis, arteria iliaca communis en in de arteria femoralis, en van de centrale arteriën, 
zoals de thoracale en abdominale aorta, de hoogste waarde bereikt.  Daartoe werden ratten 
gefotosensitizeerd door intraveneuze toediening van 200 mg ALA /kg lichaamsgewicht. Op 
0, 1, 2, 3, 6, 12 en 24 uur na ALA toediening werden de arteriën geïsoleerd en 
gehomogeniseerd. Vervolgens werd de concentratie PpIX in de vaatwand fluorometrisch 
bepaald met behulp van HPLC. Het bleek dat de tijd waarin de concentratie PpIX maximaal 
werd niet significant verschilde tussen de perifere en centrale arteriën (2:09 en 2:27 uur). 
Echter, de concentratie PpIX was hoger in de perifere arteriën, variëerend tussen de 
20.49±3.0 en 24.0±7.5 pmol/mg eiwit, dan in de centrale arteriën met waarden tussen de 0 en 
9.46±0.01 pmol/mg eiwit. Dit verschil in hoogte in de concentratie PpIX tussen de perifere 
en centrale arteriën was significant (p<0.007). De afwezigheid van detecteerbare 
concentraties PpIX bij aanwezigheid van coproporphyrinogeen in de thoracale aorta, in 
tegenstelling tot de aanwezigheid van detecteerbare concentraties PpIX en 
coproporphyrinogeen in de perifere vaten is dus indicatief voor een arterie type afhankelijke 
omzetting van ALA. Als een vereiste voor optimale fotodynamische therapie is dat de 
concentratie van PpIX maximaal is, moet op grond van deze studie belichting tussen de 2-3 
uur na systemische toediening van ALA plaatsvinden. 
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5. Het effect van endovasculaire fotodynamische therapie met aminolevuline 
zuur op de normale ratten iliacaal arterie. 
 
In dit hoofdstuk worden de histo-geometrische effecten op de normale ratten iliacaal 
arterie geevalueerd na aminolevuline zuur-gebaseerde endovasculaire fotodynamische 
therapie (ALA-PDT). De tijdsintervallen voor het belichtingsregime voor een veronderstelde 
optimale fotodynamische therapie zoals beschreven in Hoofdstuk 4 zijn hiervoor gebruikt. 
Deze studie beschrijft het genezingsproces in de gezonde arterie na endovasculaire ALA-
PDT. Op grond daarvan zou kunnen worden ingeschat wat het effect is van endovasculaire 
ALA-PDT op het aangrenzende onbeschadigde arteriële segment bij gebruik van PDT als 
adjuvante strategie voor de behandeling van het beschadigde arteriële segment na 
endovasculaire ballon angioplastiek. Hiervoor ondergingen ratten endovasculaire ALA-PDT 
met een licht dosis van 12.5, 25, 50 of 100 J/cm diffuser lengte (dl) bij een lichtsterkte van 
100 mW/cm dl. Het resultaat na 16 weken was een verwaarloosbare ontwikkeling van   
intimale hyperplasie met waarden van 0.01±0.007 mm2, 0.02±0.007 mm2, 0.01±0.006 mm2 
en 0.02±0.009 mm2 respectievelijk na 12.5, 25, 50 en 100 J/cm dl (NS). Een lichtdosis van 
12.5-25 J/cm dl resulteerde in partiële depletie van het aantal cellen in de tunica media, na 
een lichtdosis van 50-100 J/cm dl waren alle cellen in de  tunica media 3 uur na 
endovasculaire ALA-PDT verdwenen. Echter, na 16 weken werd weer een normale 
celdichtheid in de tunica media gezien zonder enige vermindering van de luminale diameter 
of constrictieve remodellering. Op basis van deze observaties concludeerden wij dat 
endovasculaire ALA-PDT geen blijvend nadelig effect had op de vaatwand. 
 
6. Endovasculaire fotodynamische therapie met aminolevuline zuur voorkomt  
ballon geïnduceerde dysplastische intimale hyperplasie en constrictieve 
remodellering in ratten iliacaal arteriën. 
 
               In dit hoofdstuk worden de effecten beschreven van endovasculaire ALA-PDT op de  
      ontwikkeling van dysplastische intimale hyperplasie en constrictieve remodellering na ballon  
      beschadiging van de vaatwand. Verder wordt het effect van endovasculaire ALA-PDT op de  
      cholinerge innervatie van de tunica media bestudeerd, omdat wij veronderstelden dat de  
      aanwezigheid van deze innervatie een voorwaarde kan zijn voor het sturen van de cellulaire  
      repopulatie en extracellulaire re-configuratie van de tunica media en tunica intima.  
      De specificaties voor optimale endovasculaire ALA-PDT zijn gebaseerd op de resultaten  
      beschreven in Hoofdstukken 3, 4 en 5.  
      Hiervoor werden ratten gerandomiseerd verdeeld over de experimentele groepen waarin  
      de iliacaal arterie door balloneren werd beschadigd en vervolgens endovasculaire ALA-PDT     
      werd toegepast met een licht dosis van 12.5, 25, 50 or 100 J/cm dl bij een lichtsterkte van     
      100 mW/ cm dl, en over  de  controle groepen waarin de ballon beschadigde iliacaal arterie   
      niet met PDT werd behandeld maar alleen belicht met een licht dosis van 0, 12.5, 25, 50 of  
      100 J/cm dl. De resultaten verkregen met behulp van een planimetrische analyse van de        
      arteriële coupes lieten slechts een verwaarloosbare intimale hyperplasie zien met een  
      gemiddelde waarde van 0.02±0.02 mm2 in de experimentele groep die behandeld werd met  
      100 J/cm dl ALA-PDT, terwijl de controle groep van 0 en 100 J/cm dl gekenmerkt werd   
      door dysplastische intimale hyperplasie met waarden van 0.18±0.12 mm2 en 0.15±0.12 mm2  
      na 16 weken (p<0.05). Een toename van de licht dosis met een factor 2 in de experimentele  
      endovasculaire ALA-PDT groepen resulteerde in een afname van intimale hyperplasie met  
      17.2% (p<0.05). Constrictieve remodellering trad in de experimentele groepen niet op in  
      tegenstelling tot de controle groepen. Op grond van immuno-histochemische kleuring  
      kon worden vastgesteld dat de cholinerge innervatie van de tunica media niet tussen de 
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      groepen verschilde, hetgeen erop duidt dat ondanks endovasculaire ALA-PDT de innervatie  
      werd gepreserveerd.  
      Wij concludeerden in dit rapport dat endovasculaire ALA-PDT dysplastische intimale   
      hyperplasie en constrictieve remodellering voorkomt binnen 4 maanden na ballon     
      beschadiging zonder schade van de cholinergische innervatie van de tunica media. De  
      effectieve licht dosis in dit ratten model was 50-100 J/cm dl. 
 
7. Het effect van endovasculaire fotodynamische therapie op de 
reendothelialisatie van de  ratten iliacaal arterie na ballon beschadiging. 
 
              In dit hoofdstuk wordt het effect geevalueerd van endovasculaire ALA-PDT op de  
        reendothelialisatie van de tunica intima omdat endotheel cruciaal is om de laminaire bloed  
       flow te kunnen garanderen zonder de ontwikkeling van thrombose, en een belangrijke factor  
        is om intimale hyperplasie te voorkomen. Vervolgens werd ook het effect van  
       endovasculaire ALA-PDT na ballon beschadiging van de iliacaal arterie in het gevalideerde  
       ratten model op de expressie van het multifactoriële cytokine ‘transforming growth factor- 
       beta’ (TGF-β) bestudeerd. TGF-β is een belangrijke regulerende factor van endotheliale cel  
      groei en de ontwikkeling van intimale hyperplasie. In de experimentele groep bestond de  
      behandeling na ballon beschadiging van de iliacaal arterie uit een endovasculaire belichting  
      met 100 mW/cm dl tot een totale lichtdosis van 50 of 100 J/cm dl ALA-PDT. In de  
      controle groep werd alleen ballon beschadiging verricht van de rechter iliacaal arterie en de  
      linker onbehandelde arterie gebruikt als controle. Op basis van Evans Blue kleuring kon  
      worden vastgesteld dat na 3 weken zowel in de experimentele als in de controle groepen de  
      beschadigde arterie weer compleet bedekt was met endotheel zonder enig significant verschil  
      tussen de groepen. 
      In zowel de experimentele als controle groepen nam de expressie van TGF-β direct na  
      beschadiging toe zonder significante verschillen tussen beide groepen.  
      Echter, in de experimentele groepen was na 3 weken  geen TGF-β meer detecteerbaar, maar  
      in de controle groepen bleef de expressie van TGF-β hoog. Endovasculaire ALA-PDT remt  
      dus de verhoogde expressie van TGF-beta na vaatwandschade volledig. 
      De langdurige expressie van TGF-beta wordt daarom geassocieerd met de ontwikkeling van  
     dysplastische intimale hyperplasie en de ontwikkeling van constrictieve remodellering. 
      In dit rapport concludeerden wij dat endovasculaire ALA-PDT het proces van   
      reendothelializatie in vivo niet beïnvloedt. Naast de eerder in Hoofdstuk 6 vermelde  
      remming van de ontwikkeling van dysplastische intimale hyperplasie, concluderen wij ook  
      dat endovasculaire ALA-PDT de verhoogde expressie van TGF-β kleuring in de door ballon  
      behandeling beschadigde arteriële vaatwand op termijn onderdrukt. Of dit effect van invloed    
      is geweest op de gunstige remodellering na endovasculaire fotodynamische therapie valt nog  
      te bezien.  
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8. Endovasculaire fotodynamische therapie beïnvloedt de grootte en 
samenstelling van het leucocyten infiltraat in de tunica adventitia na ballon 
beschadiging. 
 
             In dit hoofdstuk wordt het effect van adjuvante endovasculaire ALA-PDT geevalueerd  
      op de ontstekingsreactie na ballon beschadiging. 
      In de experimentele groepen werd adjuvante endovasculaire ALA-PDT verricht met een licht  
      dosis van 12.5, 25, 50 of 100 J/cm dl bij een belichting van 100 mW/cm dl na ballon  
      beschadiging, en in de controle groepen werd alleen ballon beschadiging verricht.       
      Vervolgens werd het ontstekingsinfiltraat in de tunica adventitia van de ratten arteria iliaca  
      communis getypeerd.  
      Het aantal leucocyten van gemiddeld 28±4 in de vaatwand van de experimentele groepen na  
      endovasculaire ALA-PDT was statistisch significant lager dan in de controle groep met een  
      gemiddelde van 91±34 (p<0.004). Daarvan was in the experimentele groepen 20%  
      neutrofielen, 35% mestcellen, 29% T-cellen en 18% monocyten, en in de  
      controle groep was 31% neutrofielen, 5% mestcellen, 59% T-cellen en 5%  
      monocyten. Op basis van deze studie concludeerden wij dat endovasculaire ALA- 
      PDT de ophoping van leucocyten in de vaatwand na ballon beschadiging vermindert en ook  
      de samenstelling van het leukocyten infiltraat (ten gunste) beïnvloedt: minder neutrofielen,  
      meer T-cellen.  
 
9. Het effect van endovasculaire fotodynamische therapie op de sterkte van de  
     arteriële vaatwand. 
 
              In dit hoofdstuk wordt het effect van endovasculaire ALA-PDT op de sterkte van de     
      ballon beschadigde arteriële vaatwand en of de lokale bloed stroming geevalueerd als maat   
      voor de functionele kwaliteit van de behandelde arteriële vaatwand.  
      De gemiddelde druk waarbij de arteriële vaatwand ruptureert, de zogenaamde ‘bursting  
      pressure’, en de lokale bloed stroming werden bepaald in de experimentele groepen die   
      endovasculaire ALA-PDT kregen met een licht dosis van 50 of 100 J/cm dl bij een belichting     
      van 100 mW/cm dl na ballon beschadiging, en in de controle groep waarin alleen ballon  
      beschadiging werd verricht. Twee uur na de procedure was de gemiddelde bursting pressure  
      in de experimentele groepen met 3.37±0.58 bar bij 50 J/cm dl en  3.96±0.43 bar bij 100  
      J/cm dl significant hoger dan in de controle groep met 2.20±0.27 bar (p<0.05).   
      Endovasculaire ALA-PDT na ballon angioplastiek kent klaarblijkelijk een optimale licht  
     dosis waardoor de arteriële vaatwand stugger wordt. Na 1 jaar was de bursting pressure in de  
     experimentele groepen van 50 J/cm dl nog steeds hoog met een waarde van 3.18±0.87 bar  
      (p<0.05), terwijl deze in de 100 J/cm dl groep gedaald was tot 2.02±0.31 bar, hetgeen niet  
      significant verschilde van 2.10±0.30 bar in de controle groep.  
      Opmerkelijk was de observatie in de experimentele groep bij 100 J/cm dl na 1 jaar, dat 3 van  
      de 5 behandelde ratten een aneurysma proximaal in het behandelde arteriële segment hadden  
      ontwikkeld. Op korte termijn doet endovasculaire ALA-PDT de arteriële vaatwand na ballon  
      beschadiging dus ongeacht de lichtdosis blijkbaar stugger worden. Ook op de langere   
      termijn van 1 jaar bleek de vaatwand ook nog stugger te zijn in de groep die behandeld was  
      met een licht dosis van 50 J/cm dl.  Echter in de  groep van 100 J/cm dl bleek de keerzijde   
      van endovasculaire PDT uit de ontwikkeling van aneurysmata. Overbelichting van de  
      behandelde arterie na endovasculaire ALA-PDT leidt potentieel tot de ontwikkeling van een  
      aneurysma. 
      De gemiddelde lokale bloed stroming 3 uur na de interventie in de behandelde arterie  
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      bedroeg 5.02±0.09 ml/min, zowel in de experimentele als in de controle groepen. Na 1 jaar  
      was de bloed stroming significant lager in de experimentele groepen vergeleken met de  
      controle groep door een verwijding van het behandelde arteriële segment. Endovasculaire  
      ALA-PDT na balloon beschadiging heeft een vaatverwijdend effect dat licht- dosis  
      afhankelijk is. 
      Daarom concludeerden wij op basis  van de gegevens uit deze studie dat de licht dosis  
      cruciaal is bij endovasculaire ALA-PDT en in dit gevalideerde ratten model beperkt dient te  
      blijven tot 50 J/cm dl bij een belichting van 100 mW/cm dl. 
 
10.  De algemene discussie. 
 
In dit hoofdstuk worden de algemene concepten en uitdagingen voor adjuvante 
 endovasculaire ALA-PDT na vasculaire interventies bediscussieerd om het probleem van 
 restenose en het herintreden van aan hypoperfusie gerelateerde symptomen te kunnen     
 voorkomen. De patho-etiologie van restenose wordt gekarakteriseerd door twee fenomenen,    
 namelijk door dysplastische intimale hyperplasie, en door constrictieve remodellering. 
       Het concept van endovasculaire ALA-PDT is nogal onconventioneel, omdat in eerste  
       instantie (bijna) alle cellen in de tunica intima en in de tunica media erdoor worden gedood  
       en de overblijvende extracellulaire matrix wordt gemodificeerd. Toch blijkt deze radicale  
       aanpak effectief in de arteriële genezing. Het is zeer waarschijnlijk dat endovasculaire ALA-  
       PDT de prikkel wegneemt voor de  overmatige reactie van dysplastische intimale  
       hyperplasie en constrictieve remodellering. In Hoofdstuk 3 werd de reactie van verschillende  
       typen arterie op vaatwandschade  beschreven. Hierbij bleken de perifere arteriën van de rat  
       vatbaarder te zijn voor het ontwikkelen van restenose door dysplastische intimale  
       hyperplasie of door constrictieve remodellering dan de centrale arteriën. Ook in patiënten  
       blijkt de algemene incidentie van restenose hoger in perifere arteriën dan in centrale arteriën.  
       Aansluitend werd een tweetal aspecten van de fotosensitizatie van verschillende arterie  
       typen na systemische toediening van ALA beschreven in Hoofdstuk 4. Hierin concludeerden     
       wij dat weliswaar het tijdstip waarop de concentratie PpIX maximaal  werd niet verschilde  
       tussen de perifere en de centrale arteriën, maar wel de hoogte ten gunste van de perifere  
       arteriën. Als voor effectieve endovasculaire ALA-PDT de hoogte van de PpIX concentratie  
       een criterium is, is de verwachting dat perifere arteriën effectiever met behulp van  
       endovasculaire fotodynamische therapie kunnen worden behandeld.  
       Inderdaad blijkt uit de Hoofdstukken 5 en 6 dat de ontwikkeling van dysplastische intimale  
       hyperplasie en constrictieve remodellering in de perifere iliacale arterie door endovasculaire  
       PDT op het moment dat de PpIX concentratie in de vaatwand maximaal was 
       effectief voorkomen kon worden. De vraag wat de effectieve drempel concentratie van  
       PpIX is voor vasculaire ALA-PDT hebben wij nog niet kunnen beantwoorden. 
       In onze in vivo studie beschreven in Hoofdstuk 7, bleek de expressie van een belangrijk  
       cytokine dat betrokken is bij de overmatige synthese van matrix eiwitten enige tijd na  
       endovasculaire ALA-PDT niet meer tot expressie te komen in de vaatwand, terwijl in de  
       vaatwand die alleen ballon beschadiging had ondergaan de expressie van dit cytokine  
       onverminderd hoog was. Endovasculaire ALA-PDT bleek ook een  afname van het aantal  
       leucocyten in de tunica adventitia te veroorzaken alsmede een gunstige verandering in het  
       type ontstekingscellen waaruit het ontstekingsexudaat bestond, zoals beschreven en  
       bediscussieerd in Hoofdstuk 8. In Hoofdstuk 9  werd het belang van de  
       licht dosis in relatie tot de arteriële vaatwand sterkte beschreven. Daarbij bleek dat  
       endovasculaire ALA-PDT een vaatverwijdend effect heeft en op de korte en lange termijn  
       een versterkend effect heeft op de vaatwand. Bij hoge licht dosis leidt endovasculaire  
       fotodynamische therapie echter uiteindelijk tot aneurysma ontwikkeling. Blijkbaar heeft 
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       endovasculaire ALA-PDT dus een nauw therapeutisch effect in dit gevalideerde ratten  
       model, een gegeven waar bij de humane klinische studies rekening meedient worden te  
       gehouden. 
       Hoe dit gegeven geïntegreerd dient te worden in de methodiek van endovasculaire ALA- 
       PDT bij patiënten zal volledig afhankelijk zijn van de voorspelbaarheid van het arteriële  
      genezingsproces onder deze omstandigheden. De kern begrippen met betrekking tot de  
      complexiteit van het arteriële genezingsproces, de betrokken raakvlakken en uitdagingen  
      voor vasculaire fotodynamische therapie zijn verder bediscussieerd in dit hoofdstuk.  
 
11. Samenvatting 
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De kleine commissie: Prof. Dr. P.M.T. Pattynama, Prof. Dr. T.H. van der Kwast en Prof. J.H.P 
Wilson. Hartelijk dank voor het beoordelen van dit proefschrift en uw bereidheid om deel te 
nemen in de kleine commissie. Prof. Dr. P.J. de Feyter, Prof. Dr. H.W.Tilanus, Dr. M.R.H.M. 
van Sambeek, hartelijk dank voor uw deelname in de grote commissie. 
Dr. R. de Bruin, beste Ron. Bedankt voor de goede en professionele werksfeer op het 
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experimenteel chirurgisch lab, waardoor ik de talrijke microchirurgische operaties probleemloos 
heb kunnen doen. Met veel plezier zal ik blijven terugdenken aan de tijd van aaneenstuk door 
opereren in het lab waar menig onderzoeker in opperste concentratie bezig was.   
Ir. J. Honkoop. Beste Jan, bedankt voor je technische expertische bij het opzetten van het 
bursting pressure model. Het gemak waarmee je de technische problemen wist op te lossen 
verdient alle lof. 
Dr. M. Kliffen, beste Mike. Bedankt voor je heldere histologische analyse bij het bursting 
pressure verhaal waardoor het gepubliceerd kon worden. Dr. J. Kros, Dr. Marc Bakker en Donal 
Hayes, bedankt voor jullie analyse. 
Ir. A. van Edixhoven, beste Annie, een super analiste op het gebied van de protoporfyrine 
analysen. Bedankt voor je inzet en expertise. Veel succes op je nieuwe werkplek.   
Dr. F.W.M. de Rooy, beste Felix, dankzij het meedenken in het begin stadium konden cruciale 
stappen genomen worden. Bedankt voor de nuttige gesprekken en de rit in de limo te Vancouver. 
Veel succes met de lopende projecten. 
Dr. P.D. Siersema, W. de Vrie, en J. Haringsma. Beste Peter, Wim en Jelle, bedankt voor de 
goede samenwerking bij de klinische PDT trial ter behandeling van Barret esofagitis. Met de 
inmiddels opgedane Amerikaanse ervaringen wil ik jullie veel succes wensen bij de vervolg 
projecten. 
Ir. E. Bruyn, beste Elly,  dankzij jouw expertise bij de ontstekingskleuringen kon het manuscript 
uitgewerkt worden, waarvoor mijn dank. 
Dr. A. Houtsmuller en Ir. A. Nigg de mannen van de digitale microscopische fluorescentie 
analysen. Bedankt voor de uitleg en jullie bijdrage bij de fluorescentie analyse. 
Dr. Piet van de Heul, hartelijk dank voor de electronen microscopische analyse van de 
mitochondriën. 
Dr. D.Sterenborg, beste Dik, je bent een echte fysicus met hart voor PDT. Bedankt voor de 
samenwerking en de adviezen. Ik wil je veel succes wensen met de PDT studies. 
Ir. R. van der Veen, beste Robert bedankt voor de samenwerking bij de klinische PDT trial en 
het co-auteurschap in het befaamde dosimetrie artikel. Succes bij jouw promotie. 
 
Van het laboratorium biochemie wil ik Prof. Dr. J.F. Koster bedanken voor de mogelijkheid om 
op het lab onderzoek te kunnen doen. Prof. Dr. J.M.J. Lamers,  Prof. Dr. H.R. Scholte, Prof. Dr. 
H. Jansen, Prof. Dr. A. van Tol, Prof. Dr. H.R. de Jonge, Dr. A.J.M. Verhoeven, Dr. B.C.Tilly, 
Karel Bestarosti, Dick H.W. Dekkers, Marcel Edixhoven, Teus van Gent, Lydia van Garstel, 
Cecile Hanson bedankt voor je secretariële steun en Rinus Machielsen bedankt voor je 
belangstelling. De analisten Regina Kraak-Slee en Elly Merbel-de Wit, bedankt voor het werken 
op jullie lab. 
De post-docs Thea van der Wijk, Delfina Vieira en Jet de Jonge veel succes met jullie carrière. 
De AIO’s Hans Hut (bedankt voor je tip!), Bas F.B.Tomassen, Jessica T. Lie, Gert-Jan Botma 
veel succes met jullie onderzoek. Wanneer gaan jullie de boel afronden?  
Ter nagedachtenis aan Dr. Wil J.Kort en aan Albert Kershof van het laboratorium experimentele 
heelkunde die hun bijdrage en interesse lieten blijken. 
De laser genoten Dr. Joos Heisterkamp, Dr. Jolande van den Boogert en Dr. Petra Hinnen, 
bedankt voor jullie practische tips en succes met jullie carrière. 
leuke en nuttige gesprekken.    
Van het laboratorium experimentele cardiologie wil ik Dr. Rob Krams, Dr. Stephane Carlier, Luc 
van Damme, Dr. Heleen van Beusenkom, Prof. Dr. Piet Verdouw en Prof. Dr. Dik J.G.M. 
Dunckers bedanken voor de interesse en de mogelijkheid te werken op het cath-lab.
Van het laboratorium kinderchirurgie wil ik Patricia Specht bedanken voor de flow metingen. 
Anne de Munck, bedankt voor de nuttige voordrachten en jullie interesse in het onderzoek. 
Van de PDT werkgroep wil ik Dr. Hugo van Staveren en Riëtte Bruine bedanken voor de 
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Coby Peekstok, Manon Holtman, Patricia Lobe, Frida van der Ham en Janine van Leeuwen van 
het laboratorium pathologie, bedankt voor de histologische kleuringen, waardoor ik de talloze 
coupes kon gaan analyseren. Lovenswaardig is de vanzelfsprekendheid en het gemak waarop dit 
altijd ging. Petje af, hoor! Dhr. F.L. van der Panne, bedankt voor de digitale foto instructies. 
Ing. Fred Bonthuis, Dr. Timo ten Hagen (hopelijk komt het gezamenlijke artikel ooit), Sandra 
van Tiel, An Seynhaven, Pim van Schalkwijk, Ton Boymans, Boudewijn van Etten en Dr. Frans 
Oei, bedankt voor jullie interesse en practische adviezen. 
Mika Vogel, bedankt voor de thermografische analyse en de CT scans van de gefotosensitiseerde 
ratjes. Veel succes met je promotie onderzoek. 
De Raman spectroscopie groep met Tom Bakker Schut, Dr. Kees Maquelin en Ron Wolthuis: 
Bedankt voor jullie interesse en hulp als ik weer iets voor de YAG laser nodig had. 
De technische dienst met Jan van de Berg en Anton Caldehoven. Voor technische zaken omtrend 
de laser stonden jullie altijd klaar. Keep those lasers running! Veel succes met jullie verdere 
loopbaan. Dhr. Jan Tuin van de afdeling thorax chirurgie, bedankt voor het digitaliseren! 
Van het experimenteel proefdier centrum wil ik vermelden Ed Lansbergen, Esther Fijneman, 
Albert Kloosterman, Enno Collij, Frans Schreeve, Marijke Lagerman, Henk Dronk, John 
Mahabier, Roy Spruijt en Piet Kreeft. Bedankt voor jullie goede zorg voor de proefdieren. 
Anneke de Zwart, bedankt voor de secretariële steun. 
De paranimfen, Dr. Ewout Kouwenhoven en Patrick Fungaloi, twee chirurgen in hart en nieren 
die het Rotterdamse avontuur hebben meegemaakt. Beste Ewout, bedankt dat je mijn paranimf 
wilt zijn. Je weet wat het is om te promoveren, te werken als chirurg en een goede balans te 
vinden tussen werk en het leven daarnaast. Beste Patrick, bedankt dat je mijn paranimf bent. De 
ervaring met het maken van een anastomose in het varkensmodel komt nu goed van pas in de 
kliniek. Veel succes met de laatste loodjes van je promotie m.b.t. fotodynamische therapie. 
 
Het thuisfront  
 
Lieve Pa, bedankt voor je goede zorg, vertrouwen en steun. Veel zaken uit het leven lijken 
inderdaad op een goede schaakpartij. Ervan leren en ook nogeens goed kunnen genieten met de 
nodige humor lijkt mij geen onaardige conclusie. Op naar de volgende uitdagingen! 
Ik heb het echt getroffen met 3 geweldige zussen. Jullie steun is onvervangbaar. Dankzij jullie is 
het relativeren van een boel zaken altijd weer gegarandeerd pret. Annette, met het credo ‘ervoor 
gaan’ kom je inderdaad ver. Jouw scherpe kijk op zaken heeft al menigmaal een verfrissende 
uitwerking gehad. Lydia, bedankt voor je inspiratie, betrokkenheid en luisterend oor. Volgens 
mij kun jij inmiddels ook een PDT sessie verrichten na alle verhalen over de gelaserde ratjes.  
Wanneer pakken we weer een filmpje? Ha Margriet, in één woord ‘Haarlem’. De waarde hiervan 
weet alleen jij op zijn merites te beoordelen. Het feit dat je afgezien hebt van de opleiding tot 
jachtvlieger heeft al meerdere malen zijn vruchten afgeworpen, en jou kennende zal dat wel zijn 
vruchten blijven afwerpen. Wanneer jij je diploma hebt gaan we naar NY! Josia, zwager! 
Bedankt voor je vriendschap. Er zijn er maar weinig met wie je lekker kunt door filosoferen over 
de zaken in het leven. Ik zal jouw support al vanaf dat ik je ken niet vergeten. Mijn neven 
Christian, Dennis John en Samuël. Kanjers! Bedankt voor jullie spontaniteit! Jullie komen er 
wel!  
Schoonfamilie in spé, bedankt voor jullie interesse en steun. Wonderen bestaan, en ik geloof dat 
jullie precies weten wat ik bedoel! 
Caroline, lieverd, jij weet precies wat het is om te promoveren en arts te zijn! Bedankt voor je 
steun en je bijdrage, maar bovenal voor wie je bent! Jouw vriendschap, vrolijkheid en 
enthousiasme is one-of-a-kind. Wat dacht je van het strand, de zee of het bos? 
Last but not least, alle dank aan God, immers ‘de vreze des Heren is de ware wijsheid’.
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He graduated in atheneum β in 1991 from the Spaarne Lyceum in Haarlem and continued his 
studies at the Faculty of Medicine of the University of Amsterdam.  
In the summer of 1991 he worked at the laboratory of the GG&GD in Haarlem. Since 1992 he 
participated in surgical research at the Department of Surgery of the Academic Medical Center 
of Amsterdam (Prof. Dr. T. M. van Gulik). The studied surgical related topics were respectively: 
1. the postoperative morbidity after the Whipple procedure, 2. the effect of Tissucol in the 
prevention of pancreatic duct leakage, 3. liver ischemia and reperfusion injury in a pig model, 
and 4. the role of bile acid in the preservation of bile ducts in UW solution. The last study was 
presented at the European Society of Surgical Research in Padua, Italy. In the summer of 1997, 
the author went for a short  clinical stay at the Department of Urology of the Medical Hospital of 
Modena, Italy (Dr. G. Berri).  
In 1998 the author was qualified as medical doctor and was offered a position as PhD student by 
Dr. R. van Hillegersberg at the Department of Vascular Surgery of the Erasmus Medical Center 
of Rotterdam. In this project on ‘Endovascular photodynamic therapy to prevent arterial 
restenosis’, he worked with Dr. W. Sluiter of the Department of Biochemistry and with Dr. R.G. 
Statius van Eps of the Department of Surgery, under supervision of Prof. Dr. H. van Urk of the 
Department of Vascular Surgery. As a PhD student he has been qualified for the ‘ex-article 9’ in 
1998 for ‘Good Laboratory Practice’, the Microsurgery course in 1999, the Oxford examination 
English, a basic course on Photochemistry and Photobiology in San Jose, California, USA and 
the Classical methods for data-analysis at the Erasmus MC in 2000. In 2001 he taught 
fundamentals of Clinical Lasers at the Laser Course organized by EMCO at the Erasmus MC. 
During the 4 years as a PhD student, he was involved in PDT-related research by Dr. P. Siersema 
and Dr. J. Haringsma on the project entitled ‘PDT in the treatment of Barrett’s Esophagitis’, by 
Dr. J. Heisterkamp on ‘Interstitial laser coagulation of liver tumors’, by Dr. D. Sterenborg and 
Dr. R. van der Veen in light dosimetry during PDT of Barrett’s Esophagitis and by Dr. R. Krams 
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The author worked as resident under the supervision of Prof. Dr. C. J. Avezaat at the Department 
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Het einde ener zaak is beter dan haar begin  
 Prediker 7:8 


